Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,transmitter-gated ion channel activity (GO:0022824),0.7977706314343851,2.5760322074888644,0.0,0.0,0.0,16/29,9.50%,GRID2;GRIK5;GRIK2;GRID1;GLRA3;GABRG3;GABRB1;GRIA4;GABRB3;HTR3A;GABRB2;GABRA2;GRIK1;GRIA2;GABRA3;GABRA1
prerank,glutamate receptor activity (GO:0008066),0.8542335142251876,2.5231799833634447,0.0,0.0,0.0,12/19,8.89%,GRID2;GRM5;GRIK5;GRIK2;GRID1;GRIA4;GRM8;GRIA1;GRM1;GRIK1;GRIA2;GRM7
prerank,voltage-gated cation channel activity (GO:0022843),0.5996675765451259,2.49007715305756,0.0,0.0,0.0,39/97,15.05%,KCND2;KCNC2;KCNQ3;HCN1;KCNMA1;GRIN2B;KCNA6;KCNH8;KCNQ5;KCNH7;OPRM1;KCNA5;CACNA1B;CATSPER4;CACNA2D1;KCNH4;GRIN2A;KCNH5;CACNA1A;KCNA2;NCS1;CACNB3;CACNG8;TMC1;CACNA1D;CACNA2D3;CACNG3;CACNB4;CACNA1E;CACNG2;CACNG4;TMC2;KCND1;CACNG5;GRIN3A;CACNA2D4;KCNS2;KCNC4;KCNA4
prerank,ligand-gated ion channel activity (GO:0015276),0.7567152387090198,2.4132205888951943,0.0,0.0,0.0,12/30,8.83%,GRID2;GRIA3;GRIK5;GRIK2;GRID1;GABRB1;GRIN2B;GRIA4;GRIN2A;GRIA1;GRIK1;GRIA2
prerank,ligand-gated channel activity (GO:0022834),0.7602671290494666,2.4042123929810284,0.0,0.0,0.0,12/29,8.83%,GRID2;GRIA3;GRIK5;GRIK2;GRID1;GABRB1;GRIN2B;GRIA4;GRIN2A;GRIA1;GRIK1;GRIA2
prerank,ionotropic glutamate receptor activity (GO:0004970),0.7935090756347241,2.2105400474480588,0.0,0.000146631562307512,0.001,9/17,8.83%,GRIA3;GRIK5;GRIK2;GRIN2B;GRIA4;GRIN2A;GRIA1;GRIK1;GRIA2
prerank,potassium channel activity (GO:0005267),0.5441747421670494,2.2052890723486205,0.0,0.0001256841962635817,0.001,16/89,4.61%,KCND2;KCNC2;KCNQ3;GRIK5;GRIK2;HCN1;KCNMA1;KCNA6;KCNH8;KCNQ5;KCNH7;KCNA5;KCNH4;KCNH5;KCNN2;KCNA2
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.753616925107391,2.177572425561108,0.0,0.000109973671730634,0.001,9/19,9.50%,GRID2;GRIK5;GRIK2;GRID1;GABRG3;GABRA2;GRIK1;GABRA3;GABRA1
prerank,ligand-gated anion channel activity (GO:0099095),0.7806589925107014,2.1747515898147585,0.0,9.775437487167468e-05,0.001,9/17,9.50%,GLRA3;GABRG3;GABRB1;GABRB3;GLRA1;GABRB2;GABRA2;GABRA3;GABRA1
prerank,voltage-gated potassium channel activity (GO:0005249),0.5431412306929027,2.1747229177498215,0.0,8.79789373845072e-05,0.001,15/80,4.61%,KCND2;KCNC2;KCNQ3;HCN1;KCNMA1;KCNA6;KCNH8;KCNQ5;KCNH7;KCNA5;KCNJ3;KCNH4;KCNH5;KCNN2;KCNA2
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.6802575644433388,2.15553313780453,0.0,0.0003199234086709353,0.004,9/28,9.50%,GRID2;GRIK5;GRIK2;GRID1;GABRG3;GABRA2;GRIK1;GABRA3;GABRA1
prerank,GABA receptor activity (GO:0016917),0.7163755133955643,2.1339169148056802,0.0,0.0005132104680762921,0.007,10/21,14.23%,GABRG3;GABRB1;GABRB3;GABRB2;GABRA2;GABBR2;GABRA3;GABRA1;GABBR1;GABRE
prerank,GABA-A receptor activity (GO:0004890),0.724025994626576,2.0510739930284756,0.0,0.002707044227215606,0.037,7/18,9.50%,GABRG3;GABRB1;GABRB3;GABRB2;GABRA2;GABRA3;GABRA1
prerank,neuropeptide receptor activity (GO:0008188),0.6319878655349589,1.9961640286326205,0.0,0.006032841420651923,0.083,9/29,11.23%,NPSR1;OPRM1;SORCS1;SORCS3;GPR37;NPY2R;KISS1R;TACR1;NMUR2
prerank,voltage-gated calcium channel activity (GO:0005245),0.5843437860023487,1.9835403279878938,0.0,0.007800799114759639,0.115,22/37,17.93%,OPRM1;CACNA1B;CATSPER4;CACNA2D1;CACNA1A;NCS1;CACNB3;CACNG8;TMC1;CACNA1D;CACNA2D3;CACNG3;CACNB4;CACNA1E;CACNG2;CACNG4;TMC2;CACNG5;CACNA2D4;CACNB1;CACNA1G;CACNA1I
prerank,cadherin binding (GO:0045296),-0.4229051207996204,-1.9806947222397238,0.0,0.05586574777089903,0.047,116/315,18.00%,PTPRB;SPTBN1;CLINT1;TJP1;DAB2IP;DOCK9;PTPRM;ESYT2;CTNNA1;ITGA6;SPTAN1;WASF2;CAST;COBLL1;LIMA1;ITGB1;BSG;MRTFB;ASAP1;ERC1;STXBP6;ABI1;BAIAP2L1;MPP7;CDH11;MYH9;CD2AP;PPFIBP1;BMPR2;PARVA;EPS15;IQGAP1;EIF4H;ANXA2;PROM1;PTPN1;TRIM25;F11R;ZC3HAV1;PKP4;FNBP1L;PAK2;EIF3E;DDX3X;RAB1A;AHNAK;KDR;YWHAE;PTPRJ;EGFR;GIGYF2;NOTCH3;EMD;EPS8L2;IDH1;PDLIM5;LARP1;CBL;PLCB3;AFDN;NCK1;DLG1;STK24;TRPC4;TMOD3;MACF1;EPS15L1;EZR;SNX9;CDH5;TJP2;MRE11;FXYD5;PDLIM1;CTNND1;CEMIP2;YWHAZ;CDH1;PICALM;CHMP4B;FLNA;PUF60;SERBP1;ARHGAP1;EHD1;PSEN1;EEF2;STK38;LASP1;LRRFIP1;CSNK1D;NDRG1;CHMP2B;PDXDC1;PKN2;RPL7A;NUMB;HCFC1;MARK2;SH3GL1;CLIC1;FMNL2;ABCF3;EHD4;CHMP5;SLK;GCN1;ANXA1;CTNNB1;SWAP70;CALD1;DBNL;VAPA;CAPZB;GIPC1;CCS
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.776568978068909,1.9733777156530725,0.0,0.008357999051528184,0.133,7/12,9.50%,GABRG3;GABRB1;GABRB3;GABRB2;GABRA2;GABRA3;GABRA1
prerank,clathrin adaptor activity (GO:0035615),-0.7333718274499337,-1.9599277670373128,0.0,0.041077755713896345,0.068,11/15,20.03%,HIP1;DAB2;STON1;LDLRAP1;AP2B1;AP2A2;AP2S1;AP1G1;HIP1R;STON2;AP2M1
prerank,sodium channel activity (GO:0005272),0.5725169823664368,1.9464535022029974,0.0021413276231263384,0.01133375722776887,0.184,11/37,8.20%,GRIK5;GRIK2;ASIC2;HCN1;SCN8A;SCN1B;SCN1A;SCN3A;SCN2A;GRIK1;SCN5A
prerank,delayed rectifier potassium channel activity (GO:0005251),0.5861508187820672,1.936074598655027,0.0,0.012365928421266848,0.211,6/32,4.61%,KCNC2;KCNQ3;KCNA6;KCNQ5;KCNA5;KCNA2
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.7275961101929016,1.910594236332732,0.004484304932735426,0.016114036952530792,0.271,7/13,14.23%,GLRA3;GABRG3;GLRA1;GABRA2;GABRA3;GABRA1;GABRE
prerank,ion channel activity (GO:0005216),0.4623563059553932,1.8424521054352605,0.0,0.03378391195565077,0.486,17/80,8.83%,TRPM3;GRID2;GRIA3;GRIK5;GRIK2;GRID1;GABRB1;GRIN2B;UNC80;GRIA4;GRIN2A;GRIA1;TMC1;TMEM63A;GRIK1;TRPM1;GRIA2
prerank,ligand-gated cation channel activity (GO:0099094),0.4737538881594586,1.8323654661495317,0.0,0.03581999593512079,0.518,19/75,14.60%,GRIA3;GRIK5;GRIK2;ASIC2;GRIN2B;GRIA4;HTR3A;KCNJ3;GRIN2A;KCNN2;GRIA1;GRIK1;KCNJ6;GRIA2;KCNN3;P2RX3;GRIN3A;P2RX5;ASIC1
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.638184829921483,-1.8050484222372454,0.003401360544217687,0.26034168732451646,0.479,9/18,15.62%,ENG;FERMT2;TGFBR3;TGFBR2;TGFB2;SMAD2;SMAD7;USP15;SMAD6
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.5614798272874912,-1.8027701702374013,0.0,0.20018559617905488,0.487,16/34,22.11%,CYTH3;PARD3;MYO10;FERMT2;IQGAP1;ARAP3;AKT1;ARAP1;FCHSD2;ZFYVE1;HIP1R;GAB2;ZFYVE16;OGT;PHLDA3;KIF16B
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.6502471684093709,-1.799908283054803,0.005385996409335727,0.16628275512985244,0.498,4/17,1.27%,ATP10A;PITPNC1;ATP8B1;PLTP
prerank,cell adhesion mediator activity (GO:0098631),0.588452815063464,1.7801300886147209,0.002150537634408602,0.05830604123027795,0.699,14/24,15.73%,LRRC4C;CNTN6;CNTN4;DSCAML1;DSCAM;NTNG1;MYPN;VSTM2L;EMB;CNTN2;JAM3;ROBO3;CD47;SIRPA
prerank,retinoic acid receptor binding (GO:0042974),-0.6367834452879366,-1.774617154767759,0.007312614259597806,0.1924264645442078,0.603,9/17,20.11%,TACC1;NSD1;ASXL1;NRIP1;RARG;MED1;ACTN4;NCOA6;PPARG
prerank,chloride channel activity (GO:0005254),0.47136325011156266,1.7730851225470856,0.0,0.059328405166682904,0.721,13/59,9.50%,GLRA3;GABRG3;GABRB1;GABRB3;CLCNKA;ANO3;GLRA1;GABRB2;GABRA2;ANO4;CLCN2;GABRA3;GABRA1
prerank,I-SMAD binding (GO:0070411),-0.6898544669483351,-1.7637459468991639,0.010526315789473684,0.18903591962814015,0.649,8/13,19.65%,SMURF1;SMAD1;SMAD2;SMAD4;SMAD7;SMAD6;CTNNB1;SMAD9
prerank,androgen receptor binding (GO:0050681),-0.5765085582342118,-1.7632459660681192,0.0018656716417910447,0.16595413308414125,0.649,6/25,10.79%,FOXP1;NSD1;ZBTB7A;PRPF6;WIPI1;KDM3A
prerank,high voltage-gated calcium channel activity (GO:0008331),0.7140729549636565,1.7534598222630893,0.013793103448275862,0.0663141240535723,0.781,5/10,7.76%,CACNA1B;CACNA1A;CACNB3;CACNA1D;CACNB4
prerank,tau-protein kinase activity (GO:0050321),-0.6035819797688572,-1.7441026966954079,0.007547169811320755,0.1828112269104365,0.725,11/20,16.69%,DYRK1A;GSK3B;MARK1;ROCK1;GSK3A;SIK3;PRKAA1;MARK2;ROCK2;FYN;MARK3
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.6296358447367739,-1.7401019311745358,0.0037735849056603774,0.17000713831457903,0.737,9/18,23.64%,STXBP6;BAIAP2L1;ANXA2;PDLIM5;TMOD3;PDLIM1;ANXA1;CDC42EP1;PPP1CA
prerank,thyroid hormone receptor binding (GO:0046966),-0.5513669953340415,-1.7192978671630121,0.007067137809187279,0.1933890947791193,0.809,16/28,29.30%,TACC1;NSD1;MED1;TRIP12;TAF11;MED13;JMJD1C;MED17;HMGN3;TAF7;NCOA6;ZNHIT3;THRAP3;GAS2L1;OASL;BRD8
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.4065047264404788,-1.718491049092291,0.0,0.17891644710941523,0.811,56/147,21.46%,RAPGEF5;PREX2;CYTH3;DOCK9;RAPGEF2;DOCK1;FGD5;AKAP13;BCR;RIN3;FGD6;RAB3GAP1;RCBTB2;ARHGEF28;DOCK4;ELMO1;FARP1;EPS8L2;RASGRF2;HPS4;ARHGEF15;MON1A;CYTH1;DENND5B;RAP1A;PLCE1;ITSN1;DENND3;SH3BP5L;RASGRP2;ARHGEF2;DENND6A;EIF2B2;RAB3GAP2;RAPGEF1;IQSEC2;ARHGEF11;ARFGEF1;RIN2;ARHGEF10;DENND4C;DENND2C;ABR;ARHGEF18;HERC2;PREX1;ALS2;ANKRD27;RGL1;WDR41;RGL2;SPATA13;ARHGEF5;NUCB2;RABIF;VAV2
prerank,histone-lysine N-methyltransferase activity (GO:0018024),-0.4990859565263997,-1.7149460383888573,0.0017730496453900709,0.1707149396438031,0.83,19/44,15.61%,MECOM;NSD1;ASH1L;SETD2;PRDM16;KMT2E;KMT5B;NSD3;SETD5;SUV39H1;SETD3;EHMT1;DOT1L;ASH2L;KMT5A;SMYD1;N6AMT1;PRDM9;KMT2C
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.7092758510891719,1.7129346496677806,0.02927927927927928,0.09153328645484131,0.878,6/10,18.60%,GABRG3;GABRA2;GABRA3;GABRA1;GABRE;GABRA5
prerank,GTPase binding (GO:0051020),-0.3876107336378191,-1.709195146139508,0.0,0.16900562350860213,0.846,56/194,15.56%,SPTBN1;UNC13B;GNB1;FGD5;AKAP13;RIN3;EPS8;ERC1;FGD6;CAV1;RUSC2;RAB3GAP1;SH3BP4;IQGAP1;DOCK4;DVL3;RALBP1;RANBP9;FNBP1L;PAK2;LRRK2;EXOC4;RANBP2;AFDN;RASIP1;STRN3;AMBRA1;HPS4;BNIP3;RAB11FIP3;PLCE1;USP6NL;TBC1D30;ARHGEF2;RAF1;EXOC2;PICALM;MTSS2;PDE6D;FLNA;RAB3GAP2;TNFAIP1;ARHGAP1;EHD1;BRAF;RASA1;ANKFY1;GOLGA4;LCP1;NDRG1;RTKN;AP1G1;MLPH;NCKAP1;EXOC8;TBC1D20
prerank,SH3 domain binding (GO:0017124),-0.45745205304738623,-1.687025986614893,0.0017825311942959,0.19834166136700887,0.907,16/62,6.07%,AFAP1L1;DAB2IP;WASF2;SHANK3;AFAP1L2;RUFY1;ABI1;CD2AP;ELMO1;CRK;PTPN12;ADAM9;CBL;CNTNAP1;ABL1;DNM2
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",-0.3893184726048365,-1.6863689624869849,0.0,0.1876568806863165,0.909,51/173,18.45%,FOXP1;KLF12;FOXP2;ETV6;ZBTB16;ZBTB20;ZEB1;ZFHX3;PRDM5;PRDM16;NFATC4;MITF;NR3C1;ZBTB37;SOX13;PLAGL1;ZNF148;ELK3;CTCF;NFKB1;HES1;PPARA;FOXO3;GTF2IRD1;MAX;SKIL;JUN;ZBTB4;ZFP90;TBX2;DACH1;ZBTB39;PRDM2;PPARD;ZNF25;ETS2;LRRFIP1;ZBTB6;MZF1;ZBTB25;ZBTB34;TCF3;TRPS1;HIC1;SKI;ZNF692;ZBTB14;PATZ1;HEY1;HEY2;ZBTB12
prerank,GTPase activator activity (GO:0005096),-0.363841323384971,-1.6850101239843018,0.0,0.17900236136973188,0.914,113/313,22.62%,RAPGEF5;PREX2;CYTH3;DOCK9;CHN2;ARHGAP31;TBC1D4;RAPGEF2;DOCK1;FGD5;AKAP13;BCR;RGS3;RIN3;ASAP1;RALGAPA1;FGD6;RAB3GAP1;RCBTB2;RGS5;ARHGEF28;STARD8;IQGAP1;DOCK4;RALBP1;ARHGAP10;ELMO1;FARP1;LRRK2;ARAP3;EPS8L2;RANBP2;TBC1D1;RASGRF2;CHN1;TBC1D2B;PLCB1;HPS4;ARHGEF15;MON1A;CYTH1;DENND5B;RAP1A;TBC1D8B;JUN;PLCE1;ITSN1;USP6NL;SIPA1L3;DENND3;SH3BP5L;RASGRP2;TBC1D30;BNIP2;ARHGEF2;TBC1D14;MTSS2;ARHGAP17;DENND6A;STARD13;EIF2B2;TBC1D22B;RASA4;RAB3GAP2;RAPGEF1;ARAP1;ARHGAP1;IQSEC2;TBC1D22A;ARHGEF11;ARFGEF1;RASA1;RIN2;ARHGAP28;WNT11;ARHGEF10;LARS1;DENND4C;SEC23B;TBC1D20;SMAP2;DENND2C;ARHGAP22;ABR;ARHGEF18;HERC2;PREX1;ALS2;ARHGAP29;ANKRD27;ARHGAP35;TBC1D8;RGL1;TBC1D17;ARHGAP26;TBC1D25;WDR41;RGL2;SPATA13;ARHGAP42;NF1;ARHGEF5;ASAP3;NUCB2;RABIF;VAV2;SYDE1;PREB;TBC1D12;ALDH1A1;EVI5;ARFGEF2;ARHGAP11A
prerank,R-SMAD binding (GO:0070412),-0.6022898549515358,-1.678237902204329,0.013084112149532711,0.1802552776660163,0.927,9/18,21.02%,SMURF1;LDLRAD4;JUN;SMAD2;SMAD4;RGCC;SMAD6;PMEPA1;DROSHA
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.6682133290844532,-1.6781000397275718,0.008818342151675485,0.17082581077933318,0.927,6/12,12.29%,ENG;ACVRL1;BMPR2;TGFBR3;TGFBR2;LTBP4
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",-0.36751888252651393,-1.6747609773985683,0.0,0.16688522888032292,0.934,62/254,15.00%,MECOM;LEF1;KLF7;NFIA;RREB1;ZBTB16;NFIB;ERG;FOXO1;MEF2A;NFAT5;ELF1;KLF4;ETS1;ESR1;TCF12;IRF2;PRRX1;NFATC1;PRDM16;FOSL2;ZSCAN21;MITF;NR3C1;PLAGL1;SOX17;SP1;ELK3;NFKB1;PPARA;MEOX2;SIX1;UBP1;FOXO3;STAT6;NFYC;E2F4;MEF2C;JUN;SMAD1;SMAD2;PRDM2;IRF1;SMAD4;GLIS2;TP53;KLF10;NFIC;GMEB1;FOXF2;FOXJ3;CREBRF;PLSCR1;TFCP2L1;SMARCD3;ZIC3;ATF4;MZF1;GRHL1;TCF3;FOXC1;MYBL2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.6818793519533588,1.6726925703059878,0.018018018018018018,0.12306899817978949,0.942,4/11,9.14%,DDAH2;PADI1;ARG2;PADI2
prerank,metallocarboxypeptidase activity (GO:0004181),0.5390160415916054,1.6702963418356507,0.007142857142857143,0.1204659746335271,0.945,9/26,14.23%,AGBL4;CPB2;CPA2;CPE;AGBL1;CPN1;AEBP1;CPA4;CPA3
prerank,retinoid X receptor binding (GO:0046965),-0.6725460513777982,-1.6650039911216294,0.0148975791433892,0.17427400868587645,0.946,4/11,5.58%,TACC1;NSD1;NRIP1;RARG
prerank,calcium:sodium antiporter activity (GO:0005432),0.6895671515643873,1.6509073761816075,0.025,0.13573893196466827,0.964,6/10,16.04%,SLC24A4;SLC24A2;SLC8A2;SLC8A3;SLC8A1;SLC8B1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),-0.32795204520378973,-1.630382686673026,0.0,0.23222624563589406,0.987,179/732,18.47%,FOXP1;MECOM;KLF12;LEF1;PBX1;KLF7;NFIA;RREB1;FOXP2;ZBTB16;NFIB;ZNF423;TEF;ERG;ZBTB20;FOXO1;MEF2A;NSD1;ZEB1;NFAT5;ELF1;KLF4;ETS1;NR3C2;DACH2;PKNOX2;ESR1;FOXN3;TCF12;HIVEP2;ZFHX3;TEAD4;NRIP1;PRDM5;ZNF260;KLF2;CHD2;IRF2;RXRA;PRRX1;KLF3;NFATC1;TBX15;PRDM16;FOSL2;TEAD1;NFATC4;ZSCAN21;TBX1;MITF;NR3C1;THRB;ZBTB37;SOX13;NFIX;PBX3;TIPARP;PLAGL1;SOX17;MKX;SP1;ZNF148;ELK3;CTCF;MGA;HDAC1;NFKB1;HES1;PPARA;MEOX2;RARG;SIX1;UBP1;ZBTB7A;FOXO3;ZIC4;IKZF2;HIVEP1;HOXB6;STAT6;NFYC;E2F4;GTF2IRD1;MEF2C;SKIL;ZNF182;JUN;ZBTB4;SMAD1;SMAD2;TBX2;KDM6A;DACH1;BACH2;ZBTB39;PPARD;EBF1;IRF1;GLI3;SMAD4;ZIC5;HSF5;HOXC6;SP3;TAL1;GLIS2;TP53;ZBTB40;KDM6B;KLF10;ETS2;STAT2;NFIC;PRRX2;GMEB1;SOX7;ZBTB7C;MAZ;ZSCAN25;FOXF2;FOXJ3;HDAC4;ZNF394;LRRFIP1;PROX2;ZBTB6;KLF9;TFCP2L1;ZIC3;ATF4;PGBD1;MZF1;GRHL1;ZBTB25;NR1D2;ZBTB34;HIF3A;H3-3A;TCF3;TCF7L1;FOXC1;MYBL2;ZKSCAN1;ZNF32;NR2C1;RUVBL2;ETV1;FOXO4;CC2D1B;ZFP1;HIC1;SKI;ZNF235;SIX4;RARA;ZNF692;HOXA2;HDAC6;ZNF691;ZBTB14;FOXQ1;TFAP4;ZNF250;ZNF83;NLRC5;ARNT;PATZ1;CEBPG;HEY1;ZFP28;HEY2;ZSCAN12;NRF1;WBP2;ELK4;HOXB9;ZIC1;ZBTB12;HLF
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.6814343180140061,-1.6269314485553934,0.010714285714285714,0.22908290432909154,0.988,6/10,8.26%,NSD1;ASH1L;SETD2;NSD3;SETD5;SETD3
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.6570386780728916,-1.6258931080820893,0.014571948998178506,0.22168295500266066,0.988,6/11,25.69%,MAP3K20;MAP3K5;EGFR;MAP3K6;MAP3K7;MAP3K15
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),-0.32680998361662983,-1.6255777814210015,0.0,0.21342906462121505,0.988,179/731,18.47%,FOXP1;MECOM;KLF12;LEF1;PBX1;KLF7;NFIA;RREB1;FOXP2;ZBTB16;NFIB;ZNF423;TEF;ERG;ZBTB20;FOXO1;MEF2A;NSD1;ZEB1;NFAT5;ELF1;KLF4;ETS1;NR3C2;DACH2;PKNOX2;ESR1;TCF12;HIVEP2;ZFHX3;TEAD4;NRIP1;PRDM5;ZNF260;KLF2;CHD2;IRF2;RXRA;PRRX1;KLF3;NFATC1;TBX15;PRDM16;FOSL2;TEAD1;NFATC4;ZSCAN21;TBX1;MITF;NR3C1;THRB;ZBTB37;SOX13;NFIX;PBX3;PLAGL1;SOX17;MKX;SP1;ZNF148;ELK3;CTCF;MGA;HDAC1;NFKB1;HES1;PPARA;MEOX2;RARG;SIX1;UBP1;ZBTB7A;FOXO3;ZIC4;IKZF2;HIVEP1;HOXB6;STAT6;NFYC;E2F4;GTF2IRD1;CREB3L2;MAX;MEF2C;SKIL;ZNF182;JUN;ZBTB4;SMAD1;SMAD2;TBX2;KDM6A;DACH1;BACH2;ZBTB39;PPARD;EBF1;IRF1;GLI3;SMAD4;ZIC5;HSF5;HOXC6;SP3;TAL1;GLIS2;TP53;ZBTB40;KDM6B;KLF10;ETS2;STAT2;NFIC;PRRX2;GMEB1;SOX7;ZBTB7C;MAZ;ZSCAN25;FOXF2;FOXJ3;HDAC4;ZNF394;LRRFIP1;PROX2;ZBTB6;KLF9;TFCP2L1;ZIC3;ATF4;PGBD1;MZF1;GRHL1;ZBTB25;NR1D2;ZBTB34;HIF3A;H3-3A;TCF3;TCF7L1;FOXC1;MYBL2;ZKSCAN1;ZNF32;NR2C1;RUVBL2;ETV1;FOXO4;CC2D1B;ZFP1;HIC1;SKI;ZNF235;SIX4;RARA;ZNF692;HOXA2;HDAC6;ZNF691;ZBTB14;FOXQ1;TFAP4;ZNF250;ZNF83;NLRC5;ARNT;PATZ1;CEBPG;HEY1;ZFP28;HEY2;ZSCAN12;NRF1;WBP2;ELK4;HOXB9;ZIC1;ZBTB12;HLF
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.6861992548069168,-1.623695956745145,0.017857142857142856,0.20812729561707485,0.988,6/10,10.19%,MECOM;ASH1L;PRDM16;SETD5;SUV39H1;EHMT1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.6868321512688236,-1.622001552814991,0.018796992481203006,0.2035022446033621,0.99,4/10,8.86%,SLCO2A1;SLCO1C1;SLCO3A1;SLCO2B1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.6214421161936464,1.6180254345047045,0.017316017316017316,0.16943529837671473,0.99,5/14,13.81%,SLC7A11;SLC25A13;SLC1A2;SLC17A6;SLC1A3
prerank,amino acid:sodium symporter activity (GO:0005283),0.6460401576030426,1.6077139830004266,0.0379746835443038,0.177218906204859,0.994,4/11,13.81%,SLC6A15;SLC6A11;SLC1A2;SLC1A3
prerank,protein phosphatase 1 binding (GO:0008157),-0.5540009625740482,-1.6037652491579282,0.015594541910331383,0.23179590724270083,0.996,6/21,8.96%,AKAP11;PPP1R3B;SHOC2;PHACTR4;KCNQ1;PPP1R3C
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.5667590921341745,-1.5988141903049764,0.0223463687150838,0.23347274305066054,0.996,7/18,12.29%,ENG;ACVRL1;BMPR2;TGFBR3;TGFBR2;ACVR2A;LTBP4
prerank,voltage-gated sodium channel activity (GO:0005248),0.5299097393886861,1.5979663128621282,0.019027484143763214,0.18506795183366823,0.996,7/22,8.20%,HCN1;SCN8A;SCN1B;SCN1A;SCN3A;SCN2A;SCN5A
prerank,small GTPase binding (GO:0031267),-0.367653868471558,-1.5953592782071055,0.0,0.2328469761666818,0.997,48/169,15.56%,UNC13B;FGD5;AKAP13;RIN3;EPS8;ERC1;FGD6;CAV1;RUSC2;RAB3GAP1;SH3BP4;IQGAP1;DOCK4;DVL3;RALBP1;RANBP9;PAK2;LRRK2;EXOC4;RANBP2;AFDN;STRN3;HPS4;RAB11FIP3;PLCE1;USP6NL;TBC1D30;ARHGEF2;RAF1;EXOC2;PICALM;MTSS2;PDE6D;FLNA;RAB3GAP2;TNFAIP1;ARHGAP1;EHD1;BRAF;ANKFY1;GOLGA4;NDRG1;RTKN;AP1G1;MLPH;NCKAP1;EXOC8;TBC1D20
prerank,transcription regulatory region nucleic acid binding (GO:0001067),-0.36637401331595854,-1.5939004185612313,0.0,0.22862200384422313,0.997,70/188,24.95%,PBX1;SMARCA2;FLI1;ZBTB20;BNC2;KLF4;ETS1;TCF12;PRDM5;RXRA;PRDM16;SOX13;SOX17;PSPC1;SP1;VSX1;CTCF;NFKB1;SIX1;FOXO3;NFYC;GABPB2;CREB3L2;MEF2C;JUN;SUV39H1;YAP1;IRF1;SMAD4;TAL1;GLIS2;TP53;PER3;SOX7;CHD3;HDAC4;SFPQ;GABPB1;ASH2L;ATF4;MZF1;GRHL1;FOXC1;BCOR;PRDM9;SMAD6;TAF7;ARID5B;ZBTB14;TFAP4;CARM1;RNF10;SOX4;TCF7L2;NONO;TBL1X;PPARG;BRCA1;NFE2L2;GABPA;RELA;KCNH2;YY1;ATF6;RBBP5;CEBPA;ATF5;TAF9;HMGB1;DHX9
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.4814797675496578,-1.5904445207764175,0.013207547169811321,0.2276049981180807,0.997,18/38,26.64%,HIP1;DAB2IP;PARD3;SH3PXD2B;PLA2G4A;ZFYVE26;TECPR1;WIPI1;SNX12;PLEKHA4;ZFYVE1;WDR45B;PHLDA3;SNX13;KIF16B;ATG2A;PLEKHF1;ATG2B
prerank,glycine binding (GO:0016594),0.6192766551011257,1.5840578006587176,0.03017241379310345,0.1983650103841311,0.999,4/11,5.34%,GLRA3;GRIN2B;GLRA1;GNMT
prerank,vinculin binding (GO:0017166),-0.6523572947644835,-1.5821466032535414,0.03690036900369004,0.23674064949616871,0.999,7/11,23.66%,UTRN;CTNNA1;PXN;ACTN1;SORBS3;RTCB;TLN1
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),-0.36068864027832004,-1.5809607327980308,0.0017543859649122807,0.23206515639780034,0.999,62/181,23.06%,TACC1;MEF2A;CREBBP;RB1;KLF4;MIER1;NRIP1;GSK3B;RXRA;PRRX1;NFATC1;LMO2;DTX3L;SP1;TACC2;HDAC1;HES1;PPARA;NFKBIA;MED1;SPEN;JUN;MDFIC;ANXA4;SMARCE1;LDB1;PPARD;RBBP8;TAL1;TP53;RNF25;SIN3A;RERE;ZFPM1;BCAS3;MTDH;HDAC4;ACTB;ACTN4;PIAS2;SMARCD3;ATF4;TCF3;TADA3;MIER2;MAD2L2;GTF2I;CTNNB1;ARNT;CDK5RAP3;HEY2;MIER3;PIAS4;TCF7L2;PPARG;WWP2;CREB1;TAF4B;NFE2L2;RELA;MYOCD;TBX3
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.5354794377855921,1.5804117849851314,0.04608294930875576,0.18651534725515528,0.999,8/22,17.27%,CHRM2;HTR2C;CHRM3;HTR4;HTR1D;HTR1F;HRH1;HRH2
prerank,G protein-coupled amine receptor activity (GO:0008227),0.5354794377855921,1.5804117849851314,0.04608294930875576,0.18651534725515528,0.999,8/22,17.27%,CHRM2;HTR2C;CHRM3;HTR4;HTR1D;HTR1F;HRH1;HRH2
prerank,serotonin receptor activity (GO:0099589),0.5354794377855921,1.5804117849851314,0.04608294930875576,0.18651534725515528,0.999,8/22,17.27%,CHRM2;HTR2C;CHRM3;HTR4;HTR1D;HTR1F;HRH1;HRH2
prerank,UDP-galactosyltransferase activity (GO:0035250),0.6413654603002605,1.5740795794558553,0.04421052631578947,0.19049883803117604,0.999,4/10,7.56%,B3GALT1;B3GALT4;B3GALT5;B4GALT7
prerank,nuclear localization sequence binding (GO:0008139),-0.562524102737308,-1.5721033784659941,0.02737226277372263,0.24321161116395318,1.0,7/18,17.86%,BRAP;KPNA4;NFKBIA;KPNA3;NUP153;KPNA1;NUP214
prerank,sialyltransferase activity (GO:0008373),-0.5515529329246718,-1.5709616286493215,0.02524271844660194,0.23846397891096716,1.0,7/20,9.03%,ST3GAL6;ST3GAL4;ST3GAL1;ST8SIA4;ST6GAL1;ST6GALNAC3;ST3GAL2
prerank,anion channel activity (GO:0005253),0.4128660598851452,1.5695113568587933,0.011682242990654205,0.19136607785689566,0.999,13/61,10.56%,GLRA3;GABRG3;GABRB1;GABRB3;ANO3;GLRA1;GABRB2;GABRA2;LRRC8E;ANO4;GABRA3;GABRA1;VDAC2
prerank,calcium channel activity (GO:0005262),0.3937067439409624,1.5642300845401473,0.006535947712418301,0.19325268167065304,0.999,24/84,11.72%,SLC24A4;SLC24A2;OPRM1;CACNA1B;CATSPER4;CACNA2D1;CACNA1A;PKD1L2;NCS1;CACNB3;CACNG8;TMC1;CACNA1D;CACNA2D3;RYR2;TMCO1;CACNG3;CACNB4;CACNA1E;TRPM1;PKD1L1;CACNG2;CACNG4;TMC2
prerank,protein tyrosine kinase activator activity (GO:0030296),0.5422912828198132,1.5568752013374878,0.040865384615384616,0.19813307873028893,1.0,4/19,1.83%,GRM5;NRG3;NRG1;DGKQ
prerank,calcium ion binding (GO:0005509),0.32813707418329957,1.5523639540613934,0.0,0.1997561773315236,1.0,69/323,12.82%,KCNIP4;NRXN1;CDH18;BGLAP;SYT1;PCLO;SYT5;KCNIP1;CDH8;CDH20;CDH9;CDH10;ENPP2;ADGRL3;CABP4;SLC25A23;MMP12;RYR3;SLC25A13;SPOCK1;DNER;ASTN2;SYT12;SYT11;TKT;HPCA;CLEC3B;DCHS1;CDH19;PCDHA4;NCS1;PITPNM1;CALM2;CDH12;GSN;PADI1;RYR2;RPH3A;CDH7;GJB2;ENPP3;PPP3CA;S100A6;CDH17;PLA2G4E;PADI2;PGS1;CDH24;TESC;CPNE1;SLIT3;SLIT1;ANXA8;ANXA8L1;CDHR3;C2CD5;MCTP2;TNNC1;CIB2;SYT4;CDH2;PPP3R1;SLC8A1;TCHH;SRI;HRC;RASGRP1;MYL2;CASQ1
prerank,phosphatidic acid binding (GO:0070300),-0.5489333540631571,-1.5507403207640302,0.030035335689045935,0.2747990836298277,1.0,4/19,3.26%,PITPNC1;RAPGEF2;PLTP;MARK1
prerank,phosphatidylinositol binding (GO:0035091),-0.388773016077721,-1.5489261921082516,0.008880994671403197,0.2720068090640884,1.0,25/91,15.96%,PARD3B;PITPNC1;HIP1;ESYT2;PARD3;ITPR1;FCHO2;MCF2L;WDFY1;ITPR2;SNX9;SCARB1;PICALM;WDFY3;SNX12;BCAS3;PLEKHF2;ANKFY1;SNX24;ZFYVE1;EXOC8;HIP1R;MITD1;SNX8;TNFAIP8L3
prerank,insulin-like growth factor I binding (GO:0031994),-0.6068256207272859,-1.5470919109898857,0.04107142857142857,0.26868363156180003,1.0,5/13,4.35%,IGF1R;ITGA6;INSR;IGFBP4;ITGB4
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.5203168105809631,-1.5462032603957545,0.019538188277087035,0.2639108878765461,1.0,4/24,4.31%,DAB2IP;CERT1;PLA2G4A;GOLPH3L
prerank,diacylglycerol kinase activity (GO:0004143),0.6075546741484558,1.545362773494068,0.049773755656108594,0.20419696784170016,1.0,3/11,1.83%,DGKK;DGKI;DGKQ
prerank,phosphatidate phosphatase activity (GO:0008195),0.6001975612555933,1.5451401330183343,0.06167400881057269,0.1996074510326117,1.0,6/13,8.91%,LPIN1;PLPPR4;PLPPR1;PLPP2;PLPP4;PLPPR5
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.6320266746160719,-1.54222366278821,0.04036697247706422,0.2656495122362741,1.0,5/11,13.40%,UBR5;UBE2K;RBX1;UBE4B;UBE4A
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.568666716169365,1.5407323957667292,0.03547671840354767,0.20126716443055753,1.0,6/15,7.93%,HS6ST3;HS3ST6;HS3ST5;NDST4;HS6ST2;HS3ST2
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.3841592439136113,-1.5325692737197494,0.01206896551724138,0.279563468887146,1.0,25/100,15.42%,HIP1;CYTH3;DAB2IP;PARD3;MYO10;CERT1;FERMT2;IQGAP1;SH3PXD2B;PLA2G4A;ARAP3;GOLPH3L;ZFYVE26;TECPR1;AKT1;WIPI1;SNX12;ARAP1;FCHSD2;ANKFY1;PLEKHA4;SNX24;ZFYVE1;HIP1R;GAB2
prerank,lipid phosphatase activity (GO:0042577),0.5832635665894998,1.53213335309661,0.03655913978494624,0.20789022999698212,1.0,5/14,8.91%,PLPPR4;PLPPR1;PLPP2;SGPP1;PLPPR5
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),-0.30423719758545975,-1.529026263812205,0.0,0.2813667050294482,1.0,195/831,18.47%,FOXP1;MECOM;KLF12;LEF1;PBX1;KLF7;NFIA;RREB1;FOXP2;ETV6;ZBTB16;NFIB;ZNF423;TEF;ERG;ZBTB20;FOXO1;MEF2A;NSD1;RB1;ZEB1;NFAT5;ELF1;KLF4;ETS1;NR3C2;DACH2;PKNOX2;ESR1;CUX1;TCF12;HIVEP2;ZFHX3;TEAD4;NRIP1;PRDM5;ZNF260;KLF2;CHD2;IRF2;RXRA;PRRX1;KLF3;NFATC1;TBX15;PRDM16;FOSL2;TEAD1;NFATC4;ZSCAN21;TBX1;MITF;NR3C1;THRB;ZBTB37;SOX13;NFIX;PBX3;PLAGL1;SOX17;MKX;ZBTB46;SP1;ZNF148;ELK3;CTCF;MGA;HDAC1;NFKB1;HES1;LHX6;PPARA;MEOX2;RARG;SIX1;UBP1;ZBTB7A;FOXO3;ZIC4;IKZF2;HIVEP1;HOXB6;BBX;STAT6;NFYC;E2F4;GTF2IRD1;MAX;MEF2C;SKIL;ZNF182;JUN;ZBTB4;SMAD1;SMAD2;ZFP90;TBX2;KDM6A;DACH1;BACH2;ZBTB39;PRDM2;PPARD;EBF1;IRF1;GLI3;ZNF25;SMAD4;ZIC5;HSF5;HOXC6;SP3;TAL1;GLIS2;TP53;ZBTB40;KDM6B;KLF10;ETS2;STAT2;NFIC;PRRX2;GMEB1;SOX7;ZBTB7C;MAZ;TWIST2;ZSCAN25;FOXF2;FOXJ3;HDAC4;ZNF394;LRRFIP1;ACTN4;PROX2;ZBTB6;KLF9;CREBRF;CIC;TFCP2L1;ZIC3;ATF4;PGBD1;MZF1;GRHL1;ZBTB25;NR1D2;ZBTB34;HIF3A;H3-3A;TCF3;TCF7L1;FOXC1;MYBL2;ZKSCAN1;ZNF32;NR2C1;RUVBL2;ETV1;FOXO4;CC2D1B;ZFP1;TRPS1;HIC1;SKI;ZNF235;SIX4;RARA;ZNF692;HOXA2;HDAC6;ZNF691;ZBTB14;FOXQ1;ZBTB8A;TFAP4;ZNF250;ZNF83;NLRC5;ARNT;PATZ1;CEBPG;HEY1;ZFP28;HEY2;ZSCAN12;RPS3;NRF1;WBP2;ELK4;HOXB9;ZIC1;ZBTB12;EPAS1;HLF
prerank,GTPase regulator activity (GO:0030695),-0.3415348293902183,-1.5256532978208133,0.0,0.28266475053065404,1.0,74/212,22.62%,PREX2;CHN2;ARHGAP31;TBC1D4;RAPGEF2;DOCK1;BCR;RGS3;ASAP1;RALGAPA1;RAB3GAP1;RGS5;SH3BP4;STARD8;IQGAP1;RALBP1;ARHGAP10;LRRK2;ARAP3;RANBP2;TBC1D1;RGS12;CHN1;TBC1D2B;SLIT2;PLCB1;TBC1D8B;JUN;WASL;USP6NL;SIPA1L3;TBC1D30;BNIP2;TBC1D14;MTSS2;ARHGAP17;STARD13;PDE6D;TBC1D22B;RASA4;RAB3GAP2;ARAP1;ARHGAP1;TBC1D22A;ARFGEF1;GDI1;RASA1;RIN2;ARHGAP28;RTKN;WNT11;LARS1;SEC23B;TBC1D20;SMAP2;ARHGAP22;ABR;PREX1;ALS2;ARHGAP29;ARHGAP35;TBC1D8;TBC1D17;ARHGAP26;TBC1D25;ARHGAP42;NF1;ASAP3;SYDE1;PREB;TBC1D12;ALDH1A1;EVI5;ARHGAP11A
prerank,5'-nucleotidase activity (GO:0008253),-0.5993551125373133,-1.5201190820638146,0.04355400696864112,0.28814067815430583,1.0,7/13,26.79%,NT5C2;NT5E;NT5C1A;NT5C3B;ACP3;NT5DC1;NT5C
prerank,5'-3' exonuclease activity (GO:0008409),-0.5756456411317523,-1.51550813328996,0.04570383912248629,0.29233074153263283,1.0,10/14,36.58%,XRN1;MRE11;XRN2;EXOG;DCLRE1B;DCLRE1A;DXO;EXO1;FAN1;DCP2
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.5199829243553472,1.5029051653042291,0.04103671706263499,0.24690800005087585,1.0,3/18,7.18%,AKR1C1;HSD17B7;HSD17B14
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.5025589226537193,1.5020530385649167,0.05106382978723404,0.24289837060505248,1.0,3/21,6.92%,GRM5;GRIA1;GRM1
prerank,protein serine/threonine kinase activity (GO:0004674),-0.3202406459172936,-1.501989179934314,0.0,0.31608313361240414,1.0,96/334,17.01%,GRK5;PRKCH;SNRK;MAP3K20;ACVRL1;BCR;DYRK1A;CSNK1A1;NEK7;DAPK1;FAM20A;PRKCE;BMPR2;TLK2;GSK3B;CDK13;ATM;MARK1;RPS6KA5;LIMK2;PAK2;SIK1;LRRK2;MAP3K5;MAP4K3;PRKD3;NEK6;MTOR;PRKD2;CAMK2G;CDK12;EGFR;TLK1;CSNK1G3;TGFBR2;STK3;STK24;MAST4;MAST2;STK35;PRKCD;BRD2;CDK10;ERN1;MAPKAPK2;CDC42BPA;AAK1;PLK2;MAPK1;ROCK1;PRKD1;AKT3;RAF1;GSK3A;ACVR2A;ALPK1;LATS2;MYLK;AKT1;SIK3;TAOK3;PRKAA1;WNK4;GAK;STK10;ILK;STK32C;IKBKE;BRAF;STK38;IRAK1;RPS6KA1;CSNK1G1;CSNK1D;CLK3;ULK2;MAP3K8;CDK6;MKNK2;MAPK8;PKN2;TRIO;RPS6KA3;MAP4K4;MARK2;PKN3;ROCK2;NUAK1;MAPK12;SRPK2;SLK;MARK3;RPS6KC1;HIPK1;IRAK2;CDC42BPB
prerank,histone demethylase activity (GO:0032452),-0.49126943373571563,-1.499800067874753,0.044169611307420496,0.31465560876844606,1.0,10/27,16.87%,KDM2A;KDM6A;KDM6B;KDM3A;JMJD1C;HR;RIOX2;KDM7A;JMJD6;KDM5B
prerank,AMP binding (GO:0016208),0.6009098650812105,1.4968059740761255,0.07259953161592506,0.2457981759140349,1.0,2/11,2.28%,MPPED2;ACSS2
prerank,tau protein binding (GO:0048156),-0.4391578442715455,-1.4967120713393018,0.035849056603773584,0.3157677820183869,1.0,18/40,19.24%,DYRK1A;GSK3B;MARK1;SMAD2;ROCK1;GSK3A;PICALM;PRKAA1;DCTN1;ACTB;MARK2;ROCK2;LGMN;PPP2CB;FYN;MARK3;HDAC6;PPP2CA
prerank,acetyltransferase activity (GO:0016407),-0.46545672722297077,-1.4944269344451433,0.03710575139146568,0.31400931874521404,1.0,9/31,11.31%,CREBBP;KAT6B;KAT2B;KAT6A;NAA16;NAA80;SMARCE1;NAA15;GNPNAT1
prerank,neuropeptide binding (GO:0042923),0.5131097607560381,1.4943241594215588,0.05555555555555555,0.24430651174960347,1.0,5/18,16.85%,OPRM1;GPR37;SORL1;NMUR2;GPR149
prerank,sequence-specific double-stranded DNA binding (GO:1990837),-0.3038441894149397,-1.4913900821343833,0.0,0.3148972426255866,1.0,177/597,25.03%,FOXP1;KLF12;LEF1;PBX1;SMARCA2;FLI1;MBNL2;NFIB;TEF;ERG;ZBTB20;BNC2;NFAT5;ELF1;KLF4;ETS1;NR3C2;PKNOX2;ESR1;CUX1;TCF12;PRDM5;KLF2;IRF2;RXRA;KLF3;NFATC1;TBX15;PRDM16;TEAD1;NFATC4;TBX1;NR3C1;THRB;ZBTB37;SOX13;NFIX;SOX17;PSPC1;SP1;VSX1;ELK3;CTCF;NFKB1;HES1;LHX6;MEOX2;RARG;SIX1;UBP1;ABL1;ZBTB7A;FOXO3;ZIC4;HIVEP1;HOXB6;BBX;NFYC;E2F4;GABPB2;CREB3L2;MAX;MEF2C;JUN;TBX2;SUV39H1;MCM9;BACH2;YAP1;PPARD;IRF1;GLI3;SMAD4;ZIC5;HSF5;SP3;TAL1;MCM4;GLIS2;ELF2;TP53;KLF10;HMBOX1;PER3;ETS2;NFIC;ORC5;PRRX2;GMEB1;SOX7;CHD3;FOXJ3;HDAC4;SFPQ;GABPB1;ASH2L;TFCP2L1;ZIC3;ATF4;MZF1;GRHL1;NR1D2;TCF7L1;FOXC1;MYBL2;BCOR;ZNF32;NR2C1;PRDM9;SMAD6;ETV1;FOXO4;ZFP1;TAF7;HIC1;ORC2;KDM5B;SIX4;RARA;HOXA2;ARID5B;ZBTB14;FOXQ1;TFAP4;ZNF250;ARNT;CEBPG;HEY1;HEY2;CARM1;ELK4;HOXB9;ZIC1;ZBTB12;HLF;ORC4;RNF10;GATA2;SOX4;TCF4;TCF7L2;NONO;TBL1X;PPARG;PRDM1;BCL6;RARB;BRCA1;FOXL2;GLIS1;HSF4;CREB1;ELF4;NFE2L2;GABPA;RELA;KCNH2;YY1;MCM3;TBX3;ATF6;MSX1;RXRG;RBBP5;CEBPA;BEND3;KLF16;ATF5;E2F7;GMEB2;E2F3;TAF9;ZNF276;HMGB1;EGR3;DHX9;IRF7
prerank,potassium ion antiporter activity (GO:0022821),0.5459028540377499,1.489982330132421,0.04602510460251046,0.24610761116927352,1.0,4/15,5.25%,SLC24A4;SLC24A2;SLC9A7;SLC9A9
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.5347620592425183,-1.4779147614323171,0.053703703703703705,0.34094537242533973,1.0,6/18,14.44%,XIAP;TNFAIP8;BIRC3;GAS6;RPS6KA1;RPS6KA3
prerank,vitamin D receptor binding (GO:0042809),-0.5611600641748786,-1.4757582778872005,0.05698529411764706,0.33953477779516444,1.0,6/14,16.25%,RXRA;MED1;TAF11;MED13;MED17;TAF7
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.3822455767622921,-1.4729911703468415,0.01192504258943782,0.3403672410486257,1.0,20/71,12.96%,PTPRG;PTPRB;PTPRM;PTPN14;PTP4A2;EYA4;MTMR3;PTPN1;PTPN9;PTPRJ;PTPN12;PTPDC1;CDC14A;PTPRK;PALD1;MTMR6;PTPN3;DUSP23;DUSP3;PTPN13
prerank,DNA-binding transcription factor binding (GO:0140297),-0.33783444967421605,-1.472061541617494,0.0017667844522968198,0.3365288912958577,1.0,66/189,24.95%,MEF2A;CREBBP;RB1;KLF4;MIER1;TCF12;PRDM5;GSK3B;PRRX1;NFATC1;PRDM16;LMO2;SIK1;NEK6;SP1;HDAC1;HES1;PPARA;ZBTB7A;SPEN;MEF2C;JUN;SMAD2;YAP1;YWHAZ;LDB1;PPARD;RBBP8;TAL1;TP53;ZMYND8;SIN3A;RERE;ZFPM1;MTDH;HDAC4;KAT5;PIAS2;ATF4;HCFC1;TCF3;MIER2;FOXO4;MAD2L2;SKI;GTF2I;CTNNB1;HEY2;MIER3;PIAS4;TCF7L2;PPARG;WWP2;HDAC7;CREB1;PTMA;NFE2L2;GABPA;RELA;MYOCD;TBX3;CRTC1;TAF9;TLE6;HMGB1;DHX9
prerank,ephrin receptor activity (GO:0005003),0.5211353907066187,1.4713754808268256,0.06132075471698113,0.2650236107918008,1.0,5/17,5.49%,EPHA6;EPHB1;EPHA5;EFNA3;EFNB3
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.5211353907066187,1.4713754808268256,0.06132075471698113,0.2650236107918008,1.0,5/17,5.49%,EPHA6;EPHB1;EPHA5;EFNA3;EFNB3
prerank,neurexin family protein binding (GO:0042043),0.6139875504472151,1.4671000481382965,0.09110169491525423,0.2666607754071573,1.0,6/10,19.35%,NLGN1;SYTL2;CPE;NLGN2;SYTL1;NLGN3
prerank,kinase binding (GO:0019900),-0.30471349259362346,-1.4670972087893521,0.0,0.3419429750641057,1.0,139/434,24.36%,UTRN;DAB2IP;TTC28;GHR;SLC12A7;SP100;ACVRL1;RB1;FERMT2;PPP2R5A;CAV1;RAC1;ESR1;RHOBTB1;LIMS1;GSK3B;IQGAP1;KIF13B;PTPN1;KAT2B;RND3;CRK;PAK2;WWC2;SPRED2;SIK1;NR3C1;NBEAL1;NEK6;PLCG1;LRBA;PTPRJ;EGFR;SLC12A2;TFRC;CDKN1B;NISCH;TAX1BP1;MSN;HNRNPA0;RICTOR;AP2A2;DLG1;FOXO3;FAS;CCND3;CEP250;PTK2;IRGM;PRKCD;PTPRK;CNTLN;ZBTB4;SMAD1;ACTA2;MAML1;PRKRIP1;TBC1D14;YWHAZ;EXOC2;PLCG2;NBEAL2;CSPG4;CTBP2;BCAR1;ADAM10;MYOM1;TP53;FLNA;PPP1R12A;RGCC;ILK;PEBP1;TRIM14;EEF2;JAK2;DCTN1;FRMD5;RPTOR;RHOA;IRAK1;ACTB;CEACAM1;DUSP3;MTCP1;CHP1;GYS1;RHOC;RHOG;ATF4;PARN;PIK3IP1;GRB2;KIF11;SKI;CTNNB1;TNS2;CDK5RAP3;MAVS;CACUL1;SASH1;RPS3;RAD23A;TRPV4;CEP152;IKBKB;NOD2;CCND1;PRKAB1;PTPRC;VRK2;TCF7L2;PRC1;ERCC6L2;PTPN11;WARS1;CDKN2C;SIKE1;PDGFRB;HDAC7;MAP2K3;TOM1L2;CDC25A;IFNAR2;RPS7;GADD45A;RELA;PTN;PARP16;PIP5K1A;BECN1;CASP1;TPCN2;CEBPA;FZD5;TRIM68;TRIB3;ATF5;CCNK
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.4528656569857463,-1.4649081788604794,0.04203152364273205,0.34067152072058043,1.0,15/35,24.56%,FOXP1;NR3C1;HDAC1;TP53;KLF10;TAF1B;TAF1C;AGO2;H3-3A;DR1;RUVBL2;UBTF;RELA;SNAPC3;SMARCB1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.475416007364281,1.4647904388992794,0.05591397849462366,0.2651817971165099,1.0,7/24,10.34%,AK9;ITPKA;AK7;AK5;AK3;NME2;IP6K2
prerank,death receptor binding (GO:0005123),-0.5550403181922867,-1.4618960785019801,0.0686106346483705,0.3415969506194222,1.0,6/15,23.21%,DAB2IP;EDA;NGF;FEM1B;CASP8AP2;RIPK1
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.49393896772233126,-1.4595281165526233,0.060550458715596334,0.3417112288878022,1.0,7/23,8.99%,PLCB4;EDNRA;PLCG1;PLCB3;PLCB1;PLCE1;PLCG2
prerank,transaminase activity (GO:0008483),0.5666424915287358,1.4558940941850436,0.08333333333333333,0.27473867057684165,1.0,2/11,3.11%,GOT1L1;OAT
prerank,protein kinase C activity (GO:0004697),-0.5668500714307386,-1.4532229851355456,0.08468468468468468,0.3508588041376267,1.0,5/14,8.54%,PRKCH;PRKCE;PRKD3;PRKCD;PRKD1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.471133067089926,-1.4509503876261765,0.057971014492753624,0.3506738420026089,1.0,7/26,10.66%,ABCG2;SLC6A6;SLC16A12;SLC5A6;SLC16A9;SLC16A1;SLC16A6
prerank,protein kinase binding (GO:0019901),-0.30117744491249476,-1.4504678616079942,0.0,0.3462722297792063,1.0,150/479,22.67%,UTRN;GRK5;DAB2IP;GHR;SLC12A7;ITGB1;ACVRL1;FERMT2;CAV1;RAC1;ESR1;CAVIN2;BMPR2;RHOBTB1;LIMS1;GSK3B;IQGAP1;KIF13B;PTPN1;KAT2B;RND3;CRK;PAK2;SPRED2;SIK1;NR3C1;NBEAL1;NEK6;PLCG1;PRKD2;LRBA;PTPRJ;ACE;SLC12A2;TFRC;CDKN1B;NISCH;MSN;ADAM9;PDLIM5;HNRNPA0;RICTOR;AP2A2;IRS1;DLG1;ABL1;FOXO3;PPEF2;PARD6G;CCND3;CEP250;GCH1;PTK2;KCNQ1;IRGM;PRKCD;PTPRK;CNTLN;EZR;MAPKAPK2;CDH5;TJP2;ZBTB4;SMAD1;ACTA2;ADCY4;MAML1;EPHA4;PRKRIP1;TBC1D14;YWHAZ;EXOC2;PLCG2;NBEAL2;GSK3A;CSPG4;CTBP2;BCAR1;ADAM10;TP53;PPP1R12A;RGCC;ILK;PEBP1;TRIM14;EEF2;JAK2;DCTN1;FRMD5;RPTOR;STK38;RHOA;IRAK1;ACTB;CEACAM1;PRKCSH;DUSP3;MTCP1;NEDD9;GYS1;RHOC;CSK;RHOG;ATF4;PARN;GRB2;TCF3;KIF11;TPR;MAD2L2;SKI;NOX4;RARA;HINT1;CDK5RAP3;MAVS;CACUL1;SASH1;RPS3;TRPV4;CEP152;IKBKB;NOD2;PPM1D;DUSP16;CCND1;DUSP22;PRKAB1;PTPRC;VRK2;TCF7L2;PRC1;ERCC6L2;PTPN11;WARS1;CDKN2C;ROR2;SIKE1;PDGFRB;HDAC7;SPAG9;MAP2K3;TOM1L2;CDC25A;MAPK7;IFNAR2;RPS7;HSP90AA1;RELA;PTN
prerank,transcription cis-regulatory region binding (GO:0000976),-0.3060530755339688,-1.4499748378969677,0.0,0.3418886394083996,1.0,124/406,24.69%,FOXP1;LEF1;PBX1;RREB1;SMARCA2;FLI1;ETV6;ZBTB20;MEF2A;RB1;BNC2;KLF4;ETS1;CUX1;FOXN3;TCF12;PRDM5;IRF2;RXRA;PRDM16;FOSL2;TEAD1;NR3C1;SOX13;TIPARP;PLAGL1;SOX17;PSPC1;ZBTB46;SP1;VSX1;ELK3;CTCF;HDAC1;NFKB1;LHX6;SIX1;FOXO3;BBX;STAT6;NFYC;GABPB2;CREB3L2;MAX;MEF2C;JUN;ZBTB4;SMAD2;ZFP90;SUV39H1;DACH1;YAP1;PRDM2;IRF1;GLI3;ZNF25;SMAD4;SP3;TAL1;GLIS2;TP53;KLF10;PER3;SOX7;CHD3;TWIST2;XRN2;FOXF2;HDAC4;SFPQ;GABPB1;ACTN4;CREBRF;ASH2L;CIC;ATF4;MZF1;AGO2;GRHL1;HIF3A;TCF3;FOXC1;BCOR;PRDM9;SMAD6;DR1;TAF7;TRPS1;RARA;ARID5B;ZBTB14;ZBTB8A;TFAP4;ARNT;CARM1;RPS3;EPAS1;RNF10;SOX4;TCF7L2;NONO;TBL1X;PPARG;BRCA1;PBX2;NFE2L2;GABPA;RELA;KCNH2;YY1;SNAPC3;ATF6;MSX1;RFXANK;RBBP5;CEBPA;ATF5;ZFP3;E2F7;E2F3;TAF9;TFDP1;HMGB1;RBAK
prerank,histone deacetylase binding (GO:0042826),-0.3668379850052891,-1.448308333142691,0.025597269624573378,0.3400895858479669,1.0,32/88,23.08%,LEF1;MEF2A;MIER1;KAT2B;YWHAE;SP1;NIPBL;HDAC1;HES1;MEF2C;GLI3;TAL1;TP53;HDAC4;SFPQ;MAPK8;PKN2;PHF6;BCOR;MIER2;HIC1;HDAC6;TFAP4;HDAC10;HEY2;MIER3;CCND1;PRDM1;NACC1;HSP90AA1;RELA;SUDS3
prerank,peptide hormone receptor binding (GO:0051428),0.577756375593484,1.446816924717581,0.07621247113163972,0.2838680405137209,1.0,2/11,10.27%,PSMC5;CCK
prerank,insulin-like growth factor binding (GO:0005520),-0.5579441518793167,-1.4444411051648203,0.06133828996282528,0.3436712501634824,1.0,6/15,9.44%,IGF1R;ITGA6;INSR;IGFBP4;ITGB4;IGF2R
prerank,organic cation transmembrane transporter activity (GO:0015101),0.5137752807898277,1.442576889839984,0.06073752711496746,0.28627717803937325,1.0,4/16,8.27%,SLC22A4;SLC22A1;SLC7A8;SLC29A4
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.4424203923484885,-1.4378728309449946,0.05818181818181818,0.35232266597761286,1.0,13/34,16.06%,SETD2;KMT2E;KMT5B;NSD3;SUV39H1;SETD3;EHMT1;DOT1L;KMT5A;SMYD1;N6AMT1;PRDM9;ANTKMT
prerank,sodium channel regulator activity (GO:0017080),0.4139564771398854,1.4333954758957896,0.05924170616113744,0.29648901898578933,1.0,12/37,17.91%,FGF14;FGF12;SCN1B;ATP2B4;PKP2;GPD1L;GPLD1;SGK1;FXYD4;SCN2B;SGK3;SGK2
prerank,protein phosphatase binding (GO:0019903),-0.3439429036316801,-1.4329405201506502,0.01282051282051282,0.3585086675798285,1.0,28/117,12.97%,DAB2IP;FOXO1;MFHAS1;IQGAP1;MTMR3;JAK1;ITGA1;MAP3K5;EGFR;AKAP11;CDKN1B;PPP1R3B;PXN;STRN3;PIK3R1;SHOC2;PHACTR4;PTK2;KCNQ1;STAT6;CDH5;FLT4;PPP1R3C;TP53;IKBKE;CEACAM1;PPP6R3;CTTNBP2NL
prerank,transcription coregulator binding (GO:0001221),-0.4064114225726285,-1.4262557591058156,0.04044117647058824,0.3685721767584112,1.0,14/50,10.52%,ZBTB16;ESR1;LMO2;THRB;NEK6;VGLL4;CTCF;ZBTB7A;SUZ12;PPARD;SMAD4;CTBP2;EHMT1;PER3
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.5696963315243646,1.4225469960855373,0.09069767441860466,0.30950383420577326,1.0,3/11,8.86%,SLC22A4;SLC22A1;SLC25A45
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.431662951913316,-1.4204932830956984,0.04537521815008726,0.3776137188060826,1.0,16/34,27.03%,PAN3;ERI3;EXOSC2;EXOSC3;XRN2;PARN;PDE12;USB1;EXOSC5;ANGEL2;DIS3L2;CNOT2;EXOSC7;TOE1;CNOT8;CNOT1
prerank,ubiquitin protein ligase activity (GO:0061630),-0.31474480358726126,-1.4200378526450976,0.0034542314335060447,0.37334594126557685,1.0,86/228,29.34%,WWP1;PELI1;XIAP;UBR5;KCMF1;BRAP;NEDD4L;CBLL1;ZNRF1;SMURF2;UBE2K;TRIM25;TRIM56;RNF139;RNF111;DTX3L;ZNRF3;SMURF1;RNF125;BIRC3;RBX1;CBL;RNF43;UBE4B;CUL3;NEDD4;LTN1;RNF115;RNF144B;UHRF2;PDZRN3;HECTD1;SH3RF1;TRIP12;ZNRF2;UBE2D3;UBR2;RNF25;AREL1;TRIM14;UBR4;UBE4A;ASB1;RC3H1;RNF167;TRIM59;MYLIP;DTX3;PELI2;HERC2;TRIM13;RFWD3;RNF10;UBR1;SIAH1;RNF152;RNF2;TRIM3;RNFT2;WWP2;HUWE1;FANCL;MDM2;SH3RF2;RNF216;HACE1;TRIM39;TRIM68;RCHY1;TRIM7;RNF38;FBXL22;FBXO17;TRIM44;ARIH2;RNF122;NEURL3;NEURL1B;RNF34;TRIM6;RNF114;NEURL2;TRIM35;RNF14;RNF187;ANAPC11
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.5543165898010296,-1.415371330078826,0.08241758241758242,0.37881019194114446,1.0,8/13,25.35%,PIP4K2A;PIP4K2B;PIP5K1B;PIK3C2A;PIK3CD;PIK3CB;PIP5K1A;PIK3CA
prerank,peptide N-acetyltransferase activity (GO:0034212),-0.585689362135537,-1.4114659590755967,0.09074410163339383,0.38214484000801796,1.0,3/10,10.04%,NAA16;NAA80;NAA15
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.5458677903875817,-1.4064789480697912,0.0897887323943662,0.38949965481848675,1.0,7/13,27.33%,BMP5;BMP6;BMP4;CDH5;BMP7;BMP2;BMP3
prerank,histone acetyltransferase activity (GO:0004402),-0.43545594416191824,-1.3972180844147755,0.07047619047619047,0.4074617310921481,1.0,9/30,15.40%,CREBBP;KAT6B;KAT2B;KAT6A;BAZ1A;SRCAP;KAT5;MCM3AP;TADA3
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.4043094074234764,-1.3949676317224855,0.04634581105169341,0.4074475204090903,1.0,16/42,16.18%,CRK;SHE;LDLRAP1;YWHAE;YES1;PIK3R1;IRS1;ABL1;NEDD4;SHB;PLCG2;NCK2;PTPN3;RASA1;GRB2;PIK3R3
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.4455454267491956,-1.393719962787121,0.06445672191528545,0.4049978448437802,1.0,8/30,14.44%,CAST;XIAP;TNFAIP8;BIRC3;GAS6;BIRC6;RPS6KA1;RPS6KA3
prerank,histone methyltransferase activity (GO:0042054),-0.4361284637136825,-1.3925224906866953,0.06716417910447761,0.4026117972152314,1.0,14/32,18.01%,SETD2;KMT2E;KMT5B;NSD3;SUZ12;SUV39H1;EHMT1;DOT1L;KMT5A;SMYD1;N6AMT1;PRDM9;KMT2C;CARM1
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.5178424987555806,-1.3911788913002605,0.09497206703910614,0.4007644153187898,1.0,7/15,16.18%,ATM;PI4KB;PIK3C2A;PIK3CD;PIK3CB;PI4K2B;PIK3R3
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.5483356256369639,1.3905201075897236,0.10070257611241218,0.36438191761488437,1.0,4/11,10.43%,FBXO11;PRMT9;PRMT6;PRMT5
prerank,syntaxin-1 binding (GO:0017075),0.45876318814786365,1.3890211227579536,0.09312638580931264,0.3613441589944018,1.0,7/22,7.80%,SYT1;SNAP25;SNPH;SYNPR;PRRT2;SYP;STXBP2
prerank,phospholipase C activity (GO:0004629),-0.4589545528566427,-1.3860483807241715,0.08671586715867159,0.40811530259143003,1.0,8/25,13.13%,PLCB4;EDNRA;PLCG1;PLCB3;PLCB1;PLCE1;PLCG2;PDIA3
prerank,death receptor activity (GO:0005035),-0.5796406366666695,-1.3785582368556566,0.10126582278481013,0.42212871030123694,1.0,5/11,20.18%,TNFRSF1B;FAS;TNFRSF19;TNFRSF1A;TNFRSF25
prerank,transforming growth factor beta binding (GO:0050431),-0.4594251053617794,-1.3776062986020838,0.0974264705882353,0.4192568173307702,1.0,5/23,5.09%,ENG;ACVRL1;THBS1;TGFBR3;TGFBR2
prerank,voltage-gated ion channel activity (GO:0005244),0.5316501769999183,1.3771698386247717,0.1308411214953271,0.37931902511680976,1.0,4/14,10.56%,KCND2;HCN1;CACNA1E;VDAC2
prerank,bHLH transcription factor binding (GO:0043425),-0.47818716605285616,-1.375450670365304,0.09057301293900184,0.4195140944517727,1.0,4/19,4.96%,CREBBP;TCF12;LMO2;SP1
prerank,sequence-specific DNA binding (GO:0043565),-0.27971919459333383,-1.3725662648441348,0.0,0.42154685791407653,1.0,125/590,18.47%,FOXP1;KLF12;LEF1;PBX1;FOXP2;FLI1;MBNL2;NFIB;ZNF423;TEF;ERG;ZBTB20;FOXO1;MEF2A;CBFB;NFAT5;ELF1;KLF4;NR3C2;PKNOX2;ESR1;CUX1;TCF12;PRDM5;KLF2;IRF2;RXRA;STN1;KLF3;NFATC1;TBX15;PRDM16;TEAD1;NFATC4;TBX1;NR3C1;THRB;KDM2A;ZBTB37;SOX13;NFIX;SP1;ZNF148;VSX1;ELK3;CTCF;HES1;LHX6;PPARA;MEOX2;RARG;SIX1;UBP1;ABL1;ZBTB7A;FOXO3;ZIC4;HIVEP1;HOXB6;BBX;E2F4;MAX;MEF2C;UPF2;JUN;ZBTB4;TBX2;BACH2;PRDM2;PPARD;GLI3;SMAD4;ZIC5;HSF5;SP3;GLIS2;ELF2;KLF10;HMBOX1;ETS2;NFIC;PRRX2;GMEB1;SOX7;FOXF2;FOXJ3;SNAPC1;HDAC4;SIRT3;CTC1;TFCP2L1;MECP2;ZIC3;ATF4;GRHL1;NR1D2;TCF7L1;FOXC1;MYBL2;ZNF32;NR2C1;PRDM9;ETV1;FOXO4;TERF2;ZFP1;HIC1;KDM5B;SIX4;RARA;HOXA2;ZBTB14;FOXQ1;TFAP4;ZNF250;ARNT;CEBPG;HEY1;HEY2;ELK4;HOXB9;ZIC1;ZBTB12;EPAS1;HLF
prerank,BMP receptor binding (GO:0070700),-0.5458849311621626,-1.3696980874476128,0.11418685121107267,0.42401372286899675,1.0,7/12,27.33%,BMP5;BMP6;BMP4;CDH5;BMP7;BMP2;BMP3
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.5267222347720596,-1.365375419564765,0.10452961672473868,0.4300696042930664,1.0,6/14,19.46%,USP9X;MINDY1;USP13;USP15;ATXN3;USP7
prerank,dipeptidyl-peptidase activity (GO:0008239),0.5516705037588086,1.3642159650737598,0.13574660633484162,0.399779129505439,1.0,2/10,1.82%,DPP10;DPP6
prerank,G protein-coupled receptor activity (GO:0004930),0.29597916266495994,1.3618447125644337,0.022222222222222223,0.3985864810839055,1.0,38/239,12.02%,GRM5;ADGRB3;HCRTR1;PROKR1;OPRM1;ADGRL3;GRM8;NPFFR2;GPR101;ADGRG4;GABBR2;CNR1;GPR135;MTNR1B;GPR37;ELOVL4;MTNR1A;GPR22;GRM1;NPY;KISS1R;TRHR;ADRA2C;C3AR1;GIPR;ADRB3;ADRA2A;GPR83;GPR65;TSHR;LGR5;VIPR2;ADRA1D;ADRA1A;NMUR2;GPR45;CELSR2;GABBR1
prerank,methyl-CpG binding (GO:0008327),0.45400821879744413,1.3615703080983748,0.1146067415730337,0.39296342251148797,1.0,11/22,24.37%,ZCWPW1;CXXC4;UHRF1;ZBTB21;PRMT5;TET1;CXXC5;CHTOP;ERH;WDR77;LHX4
prerank,calcium-activated potassium channel activity (GO:0015269),0.5345091885536041,1.3615362000869722,0.13189448441247004,0.38701257794387917,1.0,3/11,11.48%,KCNMA1;KCNN2;KCNN3
prerank,ubiquitin-like protein ligase activity (GO:0061659),-0.3020360520608085,-1.3608639580570079,0.008710801393728223,0.43635403263462363,1.0,86/232,29.34%,WWP1;PELI1;XIAP;UBR5;KCMF1;BRAP;NEDD4L;CBLL1;ZNRF1;SMURF2;TRIM25;TRIM56;RNF139;RNF111;DTX3L;ZNRF3;SMURF1;RNF125;BIRC3;RBX1;CBL;RNF43;CUL3;NEDD4;LTN1;RNF115;RNF144B;UHRF2;PDZRN3;HECTD1;SH3RF1;TRIP12;ZNRF2;UBE2D3;UBR2;RNF25;AREL1;TRIM14;NSMCE2;PIAS2;UBR4;ASB1;RC3H1;RNF167;TRIM59;MYLIP;DTX3;PELI2;HERC2;TRIM13;RFWD3;RNF10;UBR1;SIAH1;RNF152;RNF2;TRIM3;RNFT2;PIAS4;WWP2;HUWE1;FANCL;MDM2;SH3RF2;RNF216;HACE1;TRIM39;TRIM68;RCHY1;TRIM7;RNF38;FBXL22;FBXO17;TRIM44;ARIH2;RNF122;NEURL3;NEURL1B;RNF34;TRIM6;RNF114;NEURL2;TRIM35;RNF14;RNF187;ANAPC11
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.37139401194670335,-1.3568020781467394,0.06043956043956044,0.4415622660188031,1.0,14/60,9.44%,FLT1;TEK;IGF1R;NRP2;TIE1;ROR1;INSR;CRIM1;KDR;MERTK;EGFR;EPHA4;FLT4;IGF2R
prerank,transcription coactivator binding (GO:0001223),-0.47751785950530184,-1.3561472505513361,0.10288808664259928,0.4378639803006116,1.0,5/20,9.29%,ESR1;THRB;VGLL4;PPARD;SMAD4
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.3684650218139388,-1.354713544493249,0.057971014492753624,0.43664885077510135,1.0,14/60,9.17%,FLT1;TEK;IGF1R;ACVRL1;TIE1;ROR1;INSR;KDR;MERTK;EGFR;TGFBR2;EPHA4;FLT4;ACVR2A
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.5502394936115227,-1.3518901085051764,0.14548802946593,0.4391729361257843,1.0,7/12,31.74%,KDM3A;JMJD1C;HR;KDM7A;KDM3B;KDM4D;KDM4A
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.4511946750358277,-1.3515180474353916,0.09773123909249563,0.4351172559092194,1.0,10/25,22.11%,HIP1;ARAP3;AKT1;FCHSD2;PLEKHA4;ZFYVE1;HIP1R;GAB2;PHLDA3;KIF16B
prerank,estrogen receptor binding (GO:0030331),-0.4265181775315816,-1.3512263250772036,0.09540636042402827,0.43122118222903894,1.0,12/32,19.09%,LEF1;TACC1;NSD1;ESR1;NRIP1;MED1;WIPI1;RERG;DCAF13;CTNNB1;WBP2;NCOA6
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.42659299209661383,-1.347769160237065,0.09090909090909091,0.43568922834610063,1.0,10/30,20.72%,SLC39A10;SLC40A1;SLC31A1;SLC30A10;SLC39A8;SLC39A11;SLC30A5;SLC25A28;SLC39A6;SLC30A1
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.4842822833327954,1.347280406618453,0.12293144208037825,0.4050839163245765,1.0,8/16,22.88%,ATP6V1B2;ATP6V0C;ATP6V0D2;ATP6V0A2;ATP6V0D1;ATP6V1C1;ATP6V1A;ATP6V0E1
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.4842822833327954,1.347280406618453,0.12293144208037825,0.4050839163245765,1.0,8/16,22.88%,ATP6V1B2;ATP6V0C;ATP6V0D2;ATP6V0A2;ATP6V0D1;ATP6V1C1;ATP6V1A;ATP6V0E1
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.3994052073765091,-1.3466389424113345,0.08672566371681416,0.43396755256326247,1.0,13/37,21.49%,YARS1;WARS2;NARS2;CARS2;FARS2;TARS3;LARS1;HARS2;DARS2;VARS2;FARSA;IARS2;WARS1
prerank,nuclear receptor binding (GO:0016922),-0.3318671415599809,-1.3455828882486527,0.0285204991087344,0.43203998002638105,1.0,29/111,17.12%,FOXP1;LEF1;TACC1;NSD1;ESR1;ASXL1;NRIP1;RXRA;TACC2;ZBTB7A;MED1;PRPF6;SMARCE1;TRIP12;TAF11;MED13;WIPI1;KDM3A;JMJD1C;BCAS3;MED17;ACTN4;HMGN3;SMARCD3;TADA3;RERG;TAF7;DCAF13;CTNNB1
prerank,actin monomer binding (GO:0003785),-0.4652759364912165,-1.345455214569336,0.1051693404634581,0.4278362362479288,1.0,5/22,5.93%,LIMA1;NOS3;PRKCE;TMSB4X;ABL1
prerank,phosphatase activity (GO:0016791),0.3496700935966356,1.3453993761608063,0.05203619909502263,0.40280121435174454,1.0,20/73,15.84%,ATP1A2;BPNT2;LPIN1;PLPPR4;PPP5C;PLPPR1;PLPP2;DUSP4;SBF1;PLPP4;PLPPR5;HDHD2;OCRL;APTX;DUSP8;NUDT16;DUSP15;PSPH;PTPRO;FRA10AC1
prerank,SH2 domain binding (GO:0042169),-0.41778806420143644,-1.343981621757121,0.11552346570397112,0.4272312451321311,1.0,8/31,6.61%,AFAP1L2;RUFY1;CRK;SH3PXD2B;ARHGAP5;IRS1;ABL1;PTK2
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.4400256845574072,1.3425423383131276,0.11036036036036036,0.40289253093850125,1.0,7/23,10.03%,PDE4B;PDE3B;PDE1B;PDE10A;CNP;PDE1A;PDE11A
prerank,Wnt-activated receptor activity (GO:0042813),-0.5021434593949676,-1.3418467364397095,0.12007168458781362,0.42775636283404067,1.0,9/15,26.46%,ROR1;LRP5;FZD6;FZD4;FZD7;FZD5;FZD10;TSPAN12;FZD1
prerank,filamin binding (GO:0031005),-0.5466329343773669,-1.3418036310828148,0.12686567164179105,0.42352410921503314,1.0,8/11,36.40%,NEBL;CEACAM1;SYNPO2;CRMP1;RFLNB;RFLNA;DPYSL4;FBLIM1
prerank,double-stranded DNA binding (GO:0003690),-0.27484711056938144,-1.3408443366559513,0.0,0.42156731430648026,1.0,113/531,18.47%,FOXP1;KLF12;LEF1;PBX1;FLI1;MBNL2;NFIB;TEF;ERG;ZBTB20;NFAT5;ELF1;KLF4;NR3C2;PKNOX2;ESR1;CUX1;TCF12;KLF2;IRF2;RXRA;KLF3;RBMS1;NFATC1;TBX15;TEAD1;NFATC4;TBX1;NR3C1;THRB;ZBTB37;NFIX;EGFR;SP1;DMC1;VSX1;ELK3;HES1;LHX6;MEOX2;RARG;SIX1;UBP1;ABL1;ZBTB7A;FOXO3;ZIC4;HIVEP1;HOXB6;BBX;E2F4;MAX;MEF2C;JUN;SMAD2;MRE11;TBX2;BACH2;PPARD;GLI3;RBBP8;ZIC5;HSF5;SP3;GLIS2;ELF2;KLF10;HMBOX1;ETS2;NFIC;DDX60;PRRX2;GMEB1;SOX7;FOXJ3;ZNF638;PNKP;TFCP2L1;MECP2;ZIC3;ATF4;GRHL1;NR1D2;TCF7L1;POLR3F;MYBL2;CGAS;ZNF32;NR2C1;ETV1;FOXO4;TERF2;ZFP1;HIC1;KDM5B;SIX4;RARA;HOXA2;ZBTB14;FOXQ1;TFAP4;ZNF250;ARNT;CEBPG;HEY1;ZMYND11;HEY2;RPS3;ELK4;HOXB9;ZIC1;ZBTB12;HLF
prerank,store-operated calcium channel activity (GO:0015279),-0.5578207757559732,-1.3389347854343345,0.12404580152671756,0.42166655165691785,1.0,4/10,16.74%,STIM2;TRPC4;TRPC6;TRPC3
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.4322420609506211,-1.3371024690799764,0.08561020036429873,0.4217101467642567,1.0,21/29,40.43%,NFATC1;PTPRJ;ACE;ABL1;GCH1;MAPKAPK2;TPR;CDK5RAP3;PPM1D;DUSP16;MAPK7;TNIP1;DUSP1;MAPK14;DUSP6;DIRAS1;ATF7;DUSP5;MAPKAPK5;DUSP2;SIRT1
prerank,DNA binding (GO:0003677),-0.27051970780686124,-1.3370848853072446,0.0,0.41766904858300363,1.0,204/694,25.19%,MECOM;KLF12;LEF1;PBX1;FOXP2;SMARCA2;FLI1;ZBTB16;NFIB;ZNF423;ERG;FOXO1;MEF2A;CREBBP;CBFB;ETS1;CUX1;HIVEP2;PDS5B;PRDM5;KLF2;CHD2;IRF2;RXRA;STN1;APP;RBMS1;PRDM16;TEAD1;TBX1;THRB;DDX3X;SOX13;KAT6A;PLAGL1;PARP4;EGFR;SP1;DMC1;ZNF148;CRLF3;CTCF;TOP3A;ZMYM6;HES1;PPARA;MEOX2;RARG;SIX1;RBM5;RYBP;ABL1;ZBTB7A;SAMHD1;FOXO3;ZIC4;XRCC4;NFYC;E2F4;XRN1;MAX;JUN;ZBTB4;SMAD2;MRE11;TSHZ2;TBX2;POLR2G;NABP1;MCM9;PRDM2;PPARD;IRF1;SMAD4;ERCC2;RBBP8;SPTY2D1;CLSPN;MCM4;TP53;BCLAF3;WDR76;HMBOX1;ETS2;RTF2;DDX60;ENDOV;CHD3;YAF2;FOXF2;FOXJ3;RAD18;SNAPC1;RTF1;HDAC4;SFPQ;ZNF638;OGG1;ZMYM4;LRRFIP1;RPA3;DNA2;JRKL;ZBTB6;RPA1;SIRT3;CTC1;PNKP;XPC;MECP2;ZIC3;ATF4;NHEJ1;ARID3B;GRHL1;ERCC3;HNRNPA1;TCF3;TCF7L1;POLR3F;FOXC1;CGAS;NR2C1;PRDM9;TRIM16;PALB2;FOXO4;HIC1;DNMT1;KDM5B;RPS27;ARID5B;ZBTB14;TFAP4;FANCG;ARNT;PATZ1;FUBP1;CEBPG;ZMYND11;HEY2;TSHZ1;WRN;RPS3;RAD23A;ELK4;SDE2;EPAS1;HLF;RPA2;ZDHHC1;RNF4;SMARCAD1;PRKDC;TCF4;TCF7L2;TIMELESS;PPARG;BCL6;RARB;HUWE1;LIG4;BRCA1;RAD51AP2;NR2F2;TRIM28;FOXL2;DCLRE1B;TERT;BLM;RBM6;TSHZ3;TAF4B;NFE2L2;RELA;RPS15;YY1;MBD6;MCM3;TOP1;NTHL1;SNAPC3;TBX3;ATF6;RFC1;PCBP1;GTF3C4;CEBPA;MSH3;THRAP3;ATF5;MAU2;ARID3A;E2F3;TAF9;SMARCB1;HMGB1;KHDRBS1;DHX9;INO80;IRF7;DCLRE1A;HIC2;FOXF1
prerank,growth factor activity (GO:0008083),0.34677613365243565,1.3360349751599447,0.04295942720763723,0.41071081655013236,1.0,13/74,13.40%,NRG3;NRG1;OSGIN1;CLEC11A;FGF6;GRN;FGF5;VEGFA;PDGFA;IL12A;THPO;BDNF;FGF20
prerank,metallopeptidase activity (GO:0008237),0.3147856030336881,1.3358969985068772,0.03398058252427184,0.4050748539576817,1.0,21/113,9.76%,ADAM12;OMA1;ADAM23;ADAM29;MMP12;MME;ADAM11;MMP16;MMP24;MMP28;MMP25;PAPPA2;ADAMTS15;METAP2;ADAMTSL4;ADAM2;DPEP1;MPND;PSMD14;ADAM19;ADAMTS16
prerank,histone acetyltransferase binding (GO:0035035),-0.4558299006588501,-1.335603720950977,0.11604095563139932,0.4172552032323087,1.0,10/21,23.92%,MEF2A;ZBTB7A;GLI3;TP53;BCAS3;TAF7;EPAS1;CITED2;KANSL1L;TRIM68
prerank,acylglycerol lipase activity (GO:0047372),-0.543263863142104,-1.3352438527241393,0.15399239543726237,0.41399075047480605,1.0,3/11,14.81%,ABHD2;MGLL;LIPE
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.5395099263444569,1.3351391407370123,0.13863636363636364,0.4006829633021356,1.0,1/11,0.61%,HCN1
prerank,E-box binding (GO:0070888),-0.40961699067850466,-1.3348114227079,0.07733812949640288,0.4111082459899937,1.0,9/34,20.11%,ZEB1;MITF;HES1;MAX;TAL1;TCF3;TFAP4;TCF4;PPARG
prerank,nucleotide diphosphatase activity (GO:0004551),-0.512716625650977,-1.3337787890555595,0.1014760147601476,0.4101940226652708,1.0,5/14,18.95%,FHIT;NUDT13;ENPP4;NUDT6;NUDT12
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.5375484842743686,-1.3337739562810673,0.11904761904761904,0.4064263578300101,1.0,6/12,16.18%,ATM;PIK3C2A;PIK3CD;PIK3R6;PIK3CB;PIK3R3
prerank,syntaxin binding (GO:0019905),0.3536270858332824,1.3317952078180844,0.06502242152466367,0.4028109622195047,1.0,11/61,7.80%,STXBP5L;SYT1;SYT5;SNAP25;SNPH;SYNPR;SYT12;CACNA1A;PRRT2;SYP;STXBP2
prerank,metalloexopeptidase activity (GO:0008235),0.3658153652097614,1.3301612931509208,0.06569343065693431,0.4003992774642478,1.0,14/51,14.23%,AGBL4;CPB2;TRHDE;MMP16;CPA2;CPE;METAP2;AGBL1;DPEP1;CPN1;AEBP1;NUDT16;CPA4;CPA3
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.37452679688041435,-1.329621560629634,0.08576642335766424,0.41247594018866346,1.0,18/49,20.36%,TAB3;EPS15;UIMC1;RNF169;MINDY1;IKBKE;RAD18;BABAM2;RNF168;ZFAND6;TNFAIP3;AGAP3;TAB2;HDAC6;BRCC3;RAD23A;IKBKG;PSMD4
prerank,ubiquitin-protein transferase activity (GO:0004842),-0.28157823844073554,-1.3269562977954246,0.008361204013377926,0.4142430259846449,1.0,126/346,29.34%,WWP1;PELI1;XIAP;UBR5;KCMF1;BRAP;NEDD4L;CBLL1;ZNRF1;SMURF2;TRAF5;UBE2K;TRIM25;TRIM56;CNOT4;RNF139;RNF111;DTX3L;ZNRF3;SMURF1;RNF125;FBXL3;BIRC3;RNF213;RBX1;CBL;RNF43;LMO7;CUL3;NEDD4;LTN1;RNF40;RNF115;RNF144B;CUL2;BIRC6;UHRF2;PDZRN3;HECTD1;SH3RF1;TRIP12;UBE2J2;ZNRF2;UBE2D3;MIB1;UBA7;UBR2;RNF25;FBXW8;AREL1;TNFAIP1;KLHL13;TRIM14;RMND5A;TSPAN17;UBE2E2;OBI1;UBR4;ASB1;FBXW11;RNF168;RC3H1;RNF167;TRIM59;MYLIP;DTX3;TNFAIP3;BCOR;UBE2M;ERCC8;UBE2L3;PELI2;HERC2;TRIM13;MIB2;RFWD3;KCTD10;RNF10;UBR1;SIAH1;RNF152;AKTIP;RNF2;TRIM3;RNF4;RNFT2;TRIM47;WWP2;HUWE1;FANCL;BRCA1;TRIM28;UBE2R2;MDM2;SH3RF2;RNF216;HACE1;TRIM39;TRIM68;RCHY1;TRIM7;RNF146;MAEA;RNF38;FBXL22;FBXO17;DTL;TRIM44;ARIH2;RNF122;TRIM45;RNF103-CHMP3;NEURL3;NEURL1B;RNF34;RNF103;TRIM6;RNF114;ASB4;NEURL2;RNF214;TRIM35;RNF31;RNF14;RNF187;ANAPC11
prerank,RNA binding (GO:0003723),-0.2556127404796557,-1.326784789663067,0.0,0.4109058480276796,1.0,460/1321,29.27%,SPTBN1;MBNL1;TNS1;CTNNA1;RBPMS;MBNL2;CAST;MAP3K20;MSI2;SRSF11;EIF3H;FNDC3B;ANKHD1;MYH9;FNDC3A;ZCCHC7;ANKRD17;YARS1;ZNFX1;TNRC6B;TUT7;HADHB;ERI3;RBFOX2;SUGP2;CHD2;TMSB4X;EIF4H;IFIH1;ZNF326;ANXA2;CDK13;TENT4B;PTPN1;TRIM25;RBMS1;TRIM56;RRBP1;PRPF3;NUP42;DEK;CNOT4;ZC3HAV1;ANXA11;RPS21;DAP3;EIF3E;METTL14;ARCN1;SYNE1;UTP11;DDX3X;DIAPH1;MAP4;RPL37;AHNAK;YWHAE;RAE1;FBRSL1;SARNP;RPL31;GIGYF2;PSPC1;TFRC;ZC3H4;SUCLG1;MSN;RTRAF;HNRNPA0;EIF3C;LARP1;THOC2;RPL9;PPIG;RBM5;RPS14;PRRC2B;WDR75;SAMHD1;NOVA2;HNRNPR;HOXB6;KHNYN;FARS2;SORBS2;RPF1;MACF1;UPF3B;FUS;NOL10;AATF;PRPF6;DDX10;SNTB2;RBM33;ACIN1;NUP98;SF3B6;EIF3B;SPEN;XRN1;ZCCHC9;RPSA;TCP1;RBMS2;SAMD4A;PUM1;EZR;JUN;TOP3B;MYO18A;RBM19;HNRNPM;ZC3H7B;FAM120C;S100A16;AGFG1;SECISBP2;ZGRF1;DDX50;POLR2G;PRKRIP1;HNRNPAB;NOP2;YWHAZ;EXOSC2;PHF5A;EXOSC1;ADK;CELF1;PTCD3;DDX39B;ZNF106;RPL3;SF3B1;MRPL32;GTF2E2;SRPRA;GPATCH8;RPL26;ESF1;NAA15;TASOR;DNTTIP2;FLNA;PUF60;PPP1R10;PRPF31;CPSF7;RPS11;SNIP1;NDUFV3;SRP9;HNRNPA3;SLC25A11;DICER1;FAM120A;HNRNPUL1;HELZ2;EXOSC3;TDRD3;SERBP1;EFTUD2;PRRC2C;DDX60;RBM39;PEBP1;DHX38;DBR1;EEF2;ENDOV;MAZ;MRPS23;OTUD4;HNRNPF;CHD3;XRN2;TUT4;SON;RPL13;MTCL1;ACTN1;ALDH18A1;MTDH;SPATS2L;RTF1;SFPQ;ZNF638;PA2G4;STRBP;LLPH;LRRFIP1;KCTD12;UTP3;ACTN4;TIAL1;DNA2;RPL38;CLK3;PDIA3;EIF5A;RRP1;RPL27;NIP7;RPS16;LARP4B;APOBEC1;XPOT;RPS4X;MECP2;PKN2;MRPL2;PARN;GSPT1;NUFIP2;AGO2;RPL10;MRPS24;RBM20;RPL7A;RPUSD4;RC3H1;FAM98A;GRB2;SF3A1;FAU;MARK2;HNRNPA1;LARP1B;CCDC9;N4BP1;PHF6;MRPS27;MRPL12;SYNCRIP;CCDC9B;ROCK2;ZC3H14;PABPC4L;HARS2;JMJD6;KMT2C;USP10;DARS2;TPR;RPL5;UBE2L3;PUS10;ALG13;CAVIN1;TEP1;SRSF12;LBR;PSTK;DCAF13;SRP14;UTP14A;MOV10;SRPK2;SUMO1;GCN1;RPS27;CCDC86;API5;ADARB1;RPL27A;TRMT9B;EDC3;FUBP1;PPHLN1;DIDO1;LSM10;RPL7L1;RPS3;ATP5F1C;RBM4B;DHX57;NCOA5;STAU1;TES;BUD13;HMGN2;RPL36A;COA6;RPL35A;TNRC6A;FIP1L1;DDX31;UTP4;PRKDC;SRRM1;FARSA;BOP1;MRPS14;TXN;NONO;DCP1A;CAPRIN1;RNPS1;CDK11B;RPL37A;SRSF3;NQO1;PSMD4;HUWE1;BRCA1;PTBP3;DUSP14;PES1;RTCB;MRPS21;TRIM28;STRAP;RRS1;DROSHA;BZW1;RBM3;SRSF10;TERT;RPL32;TRA2B;FASTKD5;NKAP;MEX3A;SLC3A2;PRPF38B;ARHGEF1;LSM3;RBM6;MEX3B;EBNA1BP2;CWC22;METTL16;UBTF;RPS7;MRPL54;HSP90AA1;TPD52L2;KTN1;RPS15;RBM25;YY1;TOP1;RPS8;ALKBH5;RPL28;RPL22;AKAP1;RPL13A;MRPL13;NPM3;MRPL9;RPL36;EIF3A;RPL30;ZCCHC24;RBM15;NOP16;PCBP1;RPS23;TRMT1;THRAP3;POLDIP3;SMG6;SF3B5;HSPA1B;NXF1;TAF15;HMGB1;NEMF;SRBD1;ELAC2;GLRX3;IMMT;NOA1;RPS17;EIF3I;PINX1;KHDRBS1;DHX9;MRPS28;MRPS35;NOL8;EXOSC7;UBAP2;WDR46;FXR1;NCBP3;RPS2;MRPL43;PRPF40B;RBM28;FAM32A;IGF2BP2;TOE1;PEF1;EIF2AK4;TUFM;ZFP36L1;ENDOU;RPP30;LRP1;RTCA;TRNT1;RBM47;RPL39;MRPL11;RPS26;NAF1;RPS15A;HNRNPL;HNRNPD;DXO;RAN;RBPMS2;MRPS31;NANOS1;BYSL;SELENOH;LARP6;RPL15;RPL34;CNOT1;EIF5B;EMG1;PABPC1;BAG4;NMD3;HNRNPU;SCAF11;SLTM;RPL22L1;SMG1;HDLBP;PCDH20;POP4;RDX;HTATSF1;LSM2;TDRD7;SCG3;OASL;BST2;DMGDH;NUFIP1;DHX40;UTP23;UBE2I;DDX28;KHDC4;NUDT7;UBA1;UTP20;MTIF2;RPUSD2;SPATS2;PPIE;RAD51AP1;ZFR;EIF4G3
prerank,protein serine/threonine phosphatase activity (GO:0004722),-0.3608184378899263,-1.3229898699478975,0.0728476821192053,0.4162741520702039,1.0,15/60,11.07%,PPM1H;MTMR3;LRRK2;CAMK2G;PPEF2;LRRK1;PPM1L;CDC14A;ILKAP;MTMR6;PPM1F;CTDSPL2;PPP1R3C;PPM1B;UBLCP1
prerank,signal sequence binding (GO:0005048),-0.40371761162868625,-1.320246634630811,0.0852575488454707,0.41824183369346507,1.0,19/35,32.00%,BRAP;KPNA4;AP2B1;NFKBIA;KPNA3;KDELR3;NUP153;CAT;BABAM2;KPNA1;NUP214;AP2M1;RANBP6;TOMM20;SEC61A1;TOMM70;KDELR1;TNPO2;CEMIP
prerank,actin binding (GO:0003779),-0.304018248061598,-1.3177844048110012,0.022108843537414966,0.4198771208023693,1.0,38/170,13.34%,UTRN;ABLIM1;MYRIP;SORBS1;LIMA1;ITGB1;FERMT2;NOS3;EPS8;PARVB;PHACTR2;MYH9;PRKCE;PARVA;TMSB4X;MICAL2;LRRK2;SYNE1;SYNE2;EMD;EPS8L2;PDLIM5;ABL1;PHACTR4;MACF1;PTK2;EZR;MYO1F;FXYD5;PDLIM1;SHROOM2;PHACTR1;CEACAM1;SYNPO2;LCP1;TPM1;ACTN4;PDLIM3
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.5193548726877719,-1.3173075950619713,0.13736263736263737,0.4174071497133106,1.0,4/13,7.34%,IL1R1;PDGFD;PTPRJ;ERN1
prerank,amino acid binding (GO:0016597),0.3991577349231612,1.3163993040244164,0.11206896551724138,0.42301446146969524,1.0,6/31,8.89%,GLRA3;GRIN2B;DDAH2;GLRA1;GNMT;GRM7
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.5100078190915143,-1.312873899642487,0.16353383458646617,0.42397909794080885,1.0,5/13,13.35%,GSK3B;KCNQ1;EZR;GSK3A;CSK
prerank,triglyceride lipase activity (GO:0004806),-0.45394805433113117,-1.309409847760272,0.13686131386861314,0.4278640310256555,1.0,7/20,29.49%,LPL;LIPE;DAGLB;DDHD2;LCAT;PNPLA2;LIPH
prerank,organic anion transmembrane transporter activity (GO:0008514),-0.3108325141526357,-1.3089838801863587,0.02982456140350877,0.4252963390455249,1.0,24/134,9.97%,ABCC4;ABCG2;SLC6A6;SLC26A7;SLCO2A1;SLCO1C1;SLC7A1;SLC7A5;SLC26A2;SLCO3A1;SLC16A12;SLC25A32;SLC5A6;SLC19A2;SLC38A5;SLC16A1;SLC25A25;SLC39A8;SLC1A5;SLCO2B1;SLC13A3;SLC35A3;MFSD2A;SLC52A1
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.5437046623094476,-1.3077583485575535,0.14762741652021089,0.4246680520123012,1.0,6/11,18.94%,STN1;RPA1;CTC1;HNRNPA1;TERF2;RPA2
prerank,glycerophospholipid flippase activity (GO:0140333),-0.5416764952498326,-1.3058229410794933,0.16206261510128914,0.4254833936845384,1.0,2/11,0.63%,ATP10A;ATP8B1
prerank,metal ion binding (GO:0046872),0.26384668303509345,1.3015531283367892,0.0027247956403269754,0.4484379047896105,1.0,111/477,17.26%,KCNIP4;NRXN1;CDH18;BGLAP;SYT1;PCLO;SYT5;KCNIP1;CDH8;CDH20;CDH9;CDH10;ENPP2;ADGRL3;CABP4;SLC25A23;IGFBP3;MMP12;GEM;RYR3;SLC25A13;SPOCK1;RP2;DNER;ASTN2;GNAI1;SYT12;SYT11;TKT;OXSR1;HPCA;CLEC3B;DCHS1;CDH19;PCDHA4;NCS1;PITPNM1;STK11;CALM2;MAP2K7;CDH12;SPHK1;GSN;PADI1;TRIM27;NUDT18;RYR2;SRPK1;RPH3A;CDH7;GJB2;ENPP3;STK26;ATP4A;PPP3CA;S100A6;CDH17;PLA2G4E;PADI2;PGS1;HMGCLL1;CDH24;TESC;CPNE1;SLIT3;SLIT1;ANXA8;ANXA8L1;CDHR3;C2CD5;MCTP2;TNNC1;CIB2;SYT4;CDH2;PPP3R1;SLC8A1;TCHH;HMGCL;SRI;HRC;RASGRP1;IDH3A;MYL2;TPPP;CASQ1;NUDT16;CISD3;BRSK2;SYT3;RCN3;APOE;ACVR1C;NDUFAB1;TESMIN;AASDHPPT;PSPH;CDH22;GALNT3;POSTN;ADAM8;ASAH2;CETN3;PCP4;CABYR;CDH13;EFCAB11;SYT9;MSH2;PGP;DHX36
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.44042818623310875,1.2996752753178402,0.13053097345132744,0.4462817292599308,1.0,5/20,5.53%,DLG2;AK9;AK7;AK3;AK6
prerank,cytokine receptor binding (GO:0005126),-0.33882230437367744,-1.2985675113367292,0.07142857142857142,0.43937582276986126,1.0,16/83,11.75%,KITLG;OSMR;JAK1;SPRED2;CCL25;IL6ST;TGFBR3;IL6R;IL34;TGFB2;SMAD2;LIFR;VEGFC;SOCS2;JAK2;USP15
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.540671955103708,-1.295593080724396,0.16081330868761554,0.443065122067307,1.0,5/10,16.18%,ATM;PIK3C2A;PIK3CD;PIK3CB;PIK3R3
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.46326248596436875,1.2952203464910832,0.1407563025210084,0.450113778880275,1.0,7/17,17.00%,AK9;AK7;AK5;AK3;NME2;CLP1;AK1
prerank,death domain binding (GO:0070513),-0.5257016440299237,-1.2950087659285963,0.15575221238938053,0.4407899228312845,1.0,5/11,15.10%,MCL1;IRGM;DAPL1;CRADD;DAP
prerank,zinc ion binding (GO:0008270),-0.28006008792919235,-1.2948902253999437,0.01001669449081803,0.43759735635345587,1.0,103/293,26.38%,MYRIP;KLF7;SHANK3;MNAT1;NSD1;SEC24B;ZEB1;KLF4;CLIP1;TAB3;MSRB3;LIMS1;IFIH1;RXRA;PTPN1;KDM2A;TNFSF10;KAT6A;WDFY1;RNF125;ACE;CTCF;TET2;SAMHD1;SEC24A;PDE2A;GCH1;SIRT5;PAM;ECE1;NAPEPLD;SEC24D;PDXK;ARHGEF2;CRIP2;PRDM2;PHF5A;RASSF1;TP53;ENPEP;ZCCHC4;ZMYND8;ACER3;CHD3;HDAC4;SLU7;ADAM33;SIRT3;PLSCR1;KDM7A;ZFYVE1;RC3H1;SLC30A5;TAB2;SKI;KDM5B;RPS27;HDAC10;HPF1;GDA;ZMYND11;ERAP1;SOD1;KDM1B;CZIB;TES;SIAH1;NUDT12;RNF2;NPEPPS;PIAS4;PPARG;BAZ1B;TRIM28;MDM2;BLM;RABIF;CALB1;TET3;APIP;SEC24C;BBOX1;PGGT1B;USP16;MSRB2;RCHY1;ACE2;RBAK;POLR2L;ADA;MT1G;MT1A;MT1B;MT1F;MT1E;MT1M;MT1X;MT1H;TIMM10;RABGGTB;QPCTL;ARIH2;CDADC1
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.4400117380265592,-1.2946372456069337,0.11986301369863013,0.4348064011213643,1.0,11/25,26.17%,ZC3HAV1;TIPARP;PARP4;SIRT5;PARP14;SIRT3;PARP11;ART3;PARP16;PARP6;PARP9
prerank,Notch binding (GO:0005112),-0.4342971268212494,-1.291638201356488,0.14928057553956833,0.43839745764754534,1.0,10/22,21.16%,JAG2;CUL3;AAK1;NOTCH4;GALNT11;TCIM;JAG1;CCN3;KCTD10;DLL4
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.4187718420973219,-1.287806599063204,0.14625228519195613,0.4438640182242142,1.0,7/27,8.42%,ITPR1;CNNM2;SLC12A2;ITPR2;SLC9B2;CNNM4;ATP2A3
prerank,protein kinase activator activity (GO:0030295),-0.34939739243952356,-1.2825920397440855,0.09747292418772563,0.45271965729600644,1.0,17/60,14.78%,AFAP1L2;ABI1;FAM20A;IQGAP1;PAK2;DDX3X;GPRC5C;RICTOR;GAS6;STK3;IRGM;RPLP1;RGCC;RPTOR;MTCP1;WNT11;MARK2
prerank,calcium-dependent phospholipid binding (GO:0005544),0.35614898113249477,1.2786536919692695,0.14908256880733944,0.4816457041699433,1.0,13/49,11.31%,SYT1;PCLO;SYT5;SYT12;SYT11;RPH3A;CPNE9;PLA2G4E;CPNE1;ANXA8;C2CD5;MCTP2;SYT4
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.4815742073783802,1.2771031514782782,0.16129032258064516,0.4789793298556033,1.0,4/14,9.70%,AK9;AK7;AK5;NME2
prerank,CoA-ligase activity (GO:0016405),0.48181340906059306,1.2768674164996725,0.17090069284064666,0.4735764998644319,1.0,3/14,7.59%,ACSS2;ACSBG1;ACSS1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.41332420824960575,1.276836712541129,0.14446952595936793,0.4678548223888806,1.0,7/26,12.27%,B3GALT1;B3GALT4;B3GALT5;B4GALNT3;CHSY3;EXTL2;CHSY1
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.5238279143742021,-1.2755554265788054,0.19156414762741653,0.4656752709767599,1.0,2/11,3.11%,SGMS1;SGMS2
prerank,carboxypeptidase activity (GO:0004180),0.3797674891792346,1.2737520034081835,0.13908872901678657,0.4688641370275792,1.0,9/35,14.23%,AGBL4;CPB2;CPA2;CPE;AGBL1;CPN1;AEBP1;CPA4;CPA3
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",-0.3971747378802672,-1.2709650365874485,0.13443830570902393,0.4724405348444596,1.0,14/33,25.97%,ERI3;XRN1;EXOSC2;EXOSC3;XRN2;PARN;PDE12;USB1;EXOSC5;ANGEL2;DIS3L2;EXOSC7;TOE1;CNOT8
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.42728180288150236,1.2703279852020477,0.1681614349775785,0.4709282097166187,1.0,6/21,10.03%,PDE4B;PDE3B;PDE1B;PDE10A;PDE1A;PDE11A
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.503576324886363,1.269945533544282,0.185589519650655,0.46610205979989744,1.0,2/12,3.86%,B3GALT1;B3GALT5
prerank,peptidase activator activity (GO:0016504),-0.4335123398309748,-1.2692838782248035,0.14102564102564102,0.47281437538657617,1.0,12/22,35.90%,CAV1;PSME2;VSIR;APH1A;CASP8AP2;PSME1;ADRM1;NLRC4;PCOLCE2;MAL;CLPX;VCP
prerank,miRNA binding (GO:0035198),-0.3988995128739973,-1.2677904766852837,0.1386481802426343,0.47262654973202806,1.0,7/30,14.80%,TUT7;PUM1;ZC3H7B;TUT4;AGO2;RC3H1;HNRNPA1
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.5079096657729287,1.2663450006262402,0.18949771689497716,0.46900957713140906,1.0,5/12,16.83%,AKR1C1;DCXR;CBR1;NDUFS7;CRYZL1
prerank,mRNA 5'-UTR binding (GO:0048027),-0.4195958321698754,-1.2648855658279687,0.17086330935251798,0.47624664589480553,1.0,14/24,32.77%,DDX3X;LARP1;RPS14;RPL26;SYNCRIP;RPL5;RPS7;CCT5;IGF2BP2;LARP6;UTP23;SHMT1;RPS13;RPL41
prerank,1-phosphatidylinositol binding (GO:0005545),-0.47925997145097804,-1.2636663773499919,0.18761061946902655,0.4756599744725348,1.0,7/15,17.53%,WDFY1;SNX9;SCARB1;PICALM;WDFY3;ZFYVE1;ZFYVE16
prerank,ubiquitin protein ligase binding (GO:0031625),-0.27763245000560266,-1.262975297644361,0.03820598006644518,0.47381619104341016,1.0,84/254,24.52%,FOXO1;RB1;SNCAIP;MFHAS1;FZD6;TRAF5;GSK3B;PRKACB;UBE2K;JAK1;NEK6;YWHAE;FHIT;MID1;EGFR;MAP1LC3B;FZD4;RBX1;TNFRSF1B;NFKBIA;AMBRA1;CUL3;RNF40;TCP1;SNX9;JUN;SMAD2;CUL2;ARRDC1;YWHAZ;USP2;UBE2J2;DET1;CASP8;USP13;TP53;AXIN2;GABARAP;IKBKE;TXNIP;SMAD7;SPOPL;RAD18;PA2G4;ATXN3;CD40;ERLIN2;SLF2;MAGEC2;UQCRC1;SMAD6;RPL5;UBE2L3;HERC2;SKI;SUMO1;HDAC6;PATZ1;SPOP;NDUFS2;IKBKG;WASHC1;RPA2;USP7;PIAS4;UCHL1;FANCL;BRCA1;TRIM28;VCL;MDM2;DBT;DIO2;LTBR;HSP90AA1;RELA;KCNH2;BECN1;RIPK1;RALB;FZD5;ARRB1;TRIB3;HSPA1B
prerank,damaged DNA binding (GO:0003684),-0.3765680522521071,-1.2611527736283727,0.1456140350877193,0.47429504371931386,1.0,19/44,26.66%,CREBBP;ERCC2;RBBP8;RAD18;OGG1;RPA3;RPA1;PNKP;XPC;ERCC3;FANCG;RPS3;SDE2;RPA2;DCLRE1B;NTHL1;HMGB1;DCLRE1A;CRY2
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.5126629996058962,-1.2607436720891607,0.19818181818181818,0.47181650353699456,1.0,6/11,21.60%,DAB2IP;PPEF2;STK38;TCF3;SASH1;ROR2
prerank,transcription corepressor binding (GO:0001222),-0.4113658731468388,-1.259298026228388,0.1773308957952468,0.4718980825490122,1.0,8/27,10.52%,ZBTB16;ESR1;NEK6;ZBTB7A;SUZ12;CTBP2;EHMT1;PER3
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.2753816684028806,-1.2592553093132441,0.02689075630252101,0.468550416062431,1.0,87/269,24.52%,FOXO1;RB1;SNCAIP;MFHAS1;FZD6;TRAF5;GSK3B;PRKACB;UBE2K;JAK1;DTX3L;NEK6;YWHAE;FHIT;MID1;EGFR;MAP1LC3B;FZD4;RBX1;TNFRSF1B;NFKBIA;AMBRA1;CUL3;RNF40;TCP1;SNX9;JUN;SMAD2;CUL2;ARRDC1;YWHAZ;USP2;UBE2J2;DET1;CASP8;USP13;TP53;AXIN2;GABARAP;STAT2;IKBKE;TXNIP;SMAD7;SPOPL;RAD18;PA2G4;ATXN3;CD40;ERLIN2;SLF2;MAGEC2;UQCRC1;SMAD6;RPL5;UBE2L3;HERC2;SKI;SUMO1;HDAC6;PATZ1;SPOP;CDK5RAP3;NDUFS2;IKBKG;WASHC1;RPA2;USP7;PIAS4;UCHL1;FANCL;BRCA1;TRIM28;VCL;MDM2;DBT;DIO2;LTBR;HSP90AA1;RELA;KCNH2;BECN1;RIPK1;RALB;FZD5;ARRB1;TRIB3;HSPA1B
prerank,phosphotyrosine residue binding (GO:0001784),-0.37627575271036606,-1.2580867695289173,0.1387900355871886,0.4678326037419602,1.0,14/37,16.18%,CRK;SHE;LDLRAP1;YES1;PIK3R1;IRS1;ABL1;SHB;PLCG2;NCK2;PTPN3;RASA1;GRB2;PIK3R3
prerank,potassium channel regulator activity (GO:0015459),0.347213609815198,1.2579222342739471,0.1358313817330211,0.48218525199633017,1.0,6/49,6.37%,KCNIP4;DPP10;KCNIP1;DPP6;WNK2;WNK3
prerank,symporter activity (GO:0015293),0.5063198493169848,1.2553115134755173,0.20286396181384247,0.4824744930953333,1.0,4/10,9.49%,SLC5A12;SLC4A4;SLC46A2;SLC28A2
prerank,cell-cell adhesion mediator activity (GO:0098632),0.36207823157706565,1.2552679621237715,0.1352549889135255,0.47710285774447814,1.0,10/42,8.42%,LRRC4C;CNTN6;CNTN4;DSCAML1;DSCAM;NTNG1;MYPN;VSTM2L;EMB;CNTN2
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.3790040920284841,-1.2550769342927184,0.159369527145359,0.4714289120057983,1.0,10/35,16.68%,DYRK1A;LYN;YES1;BMX;ABL1;PTK2;FRK;PKDCC;CSK;FYN
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.516082889710501,-1.254651822367168,0.1694290976058932,0.4692198251743587,1.0,5/11,23.26%,CASP12;CASP8;CFLAR;CASP2;CASP1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.5291301623625315,-1.254635856728694,0.1906474820143885,0.4659921889684768,1.0,5/10,23.26%,CASP12;CASP8;CFLAR;CASP2;CASP1
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.4820097383083105,1.2543524167755384,0.17359413202933985,0.4738643321904429,1.0,8/13,25.66%,TRMT10B;TRMT10A;TRMT11;FTSJ1;TRMT5;THUMPD3;TRMT1L;THUMPD2
prerank,ATP hydrolysis activity (GO:0140603),-0.3678602826478041,-1.253938135439015,0.15817223198594024,0.46431556541940844,1.0,18/41,30.65%,DDX3X;RNF213;TOR1B;MYO18A;ABCB10;CHD3;DNA2;RUVBL2;KIF26A;TOR3A;HSP90AA1;HSPA1B;DHX9;ABCG4;KIF14;CHD1L;TDRD9;DDX4
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.5115898298839999,-1.2533796651573748,0.20848708487084872,0.4625714133549586,1.0,6/12,25.01%,CDK13;CDK12;MAPK1;CDK6;CCNK;BRD4
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.4892475172456729,-1.253230225114525,0.19607843137254902,0.45976324975193683,1.0,5/13,19.85%,LPCAT1;AGPAT4;AGPAT3;AGPAT1;LCLAT1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.5111485933026473,-1.2514452519579404,0.18968692449355432,0.4608682009319452,1.0,4/11,7.87%,ITPR1;ITPR2;TRPC4;TRPC6
prerank,platelet-derived growth factor binding (GO:0048407),0.5116468145318412,1.2496555864936232,0.19821826280623608,0.47908882012657916,1.0,6/11,15.32%,COL2A1;COL1A1;PDGFA;COL1A2;COL3A1;PDGFRA
prerank,calcium channel regulator activity (GO:0005246),0.37055198709391396,1.2481375140980968,0.14601769911504425,0.47724748359904523,1.0,11/37,12.78%,NRXN1;GEM;NPY2R;CALM2;CACNB3;CACNG8;NPY;INAFM2;CACNG4;SRI;SGK1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.503969388649164,-1.2458642700583258,0.2,0.47041801759708546,1.0,3/11,10.04%,NAA16;NAA80;NAA15
prerank,phosphatidylglycerol binding (GO:1901611),-0.4968050611084489,-1.2418304667665687,0.18198874296435272,0.4766490007535517,1.0,6/13,24.24%,PITPNC1;PLTP;GSDME;UQCC3;PITPNA;STOML2
prerank,MAP-kinase scaffold activity (GO:0005078),-0.5182323263871258,-1.2405414415438214,0.20707964601769913,0.4765019662811977,1.0,4/11,13.80%,AKAP13;IQGAP1;SH3RF1;KSR1
prerank,lipase activity (GO:0016298),-0.3626520070568119,-1.2393955049104468,0.1561938958707361,0.47598690744575634,1.0,18/43,36.22%,ABHD2;LIPA;MGLL;LPL;LIPE;SMPD2;DAGLB;DDHD2;LCAT;PNPLA8;PNPLA2;LYPLA1;ABHD15;LIPH;SEC23IP;PLBD1;ABHD12;PLB1
prerank,carboxylic acid binding (GO:0031406),0.3654214160652941,1.2385084166256357,0.15938864628820962,0.4928050306635628,1.0,10/38,13.89%,GLRA3;GRIN2B;AKR1C1;GLRA1;EPDR1;GNMT;GRM7;MAG;GLUD1;GRIN3A
prerank,exopeptidase activity (GO:0008238),0.34119620079131374,1.2376112826238272,0.15180722891566265,0.4895279108533915,1.0,10/50,9.98%,DPP10;DPP6;MME;TRHDE;CPA2;CPE;METAP2;KDM8;DPEP1;JMJD7
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.3837123250168221,-1.2375670021252247,0.1631578947368421,0.4769703968288123,1.0,11/32,23.45%,SLC6A6;SLC7A5;SLC38A5;SLC1A5;SLC36A4;SLC43A1;SLC1A1;SLC6A7;SLC1A4;SLC3A2;SLC38A6
prerank,outward rectifier potassium channel activity (GO:0015271),0.5004216727727453,1.2359782134688229,0.21123595505617979,0.48795896955680884,1.0,2/11,2.42%,KCND2;KCNA5
prerank,ephrin receptor binding (GO:0046875),-0.4221241564377024,-1.2299099612759916,0.17921146953405018,0.49238178539639105,1.0,7/21,6.21%,ANKS1A;LYN;PTPN1;CRK;CBL;ABL1;CHN1
prerank,nuclease activity (GO:0004518),-0.3403171045834971,-1.2297728611401664,0.15151515151515152,0.4894619092960408,1.0,20/52,23.04%,RNASE7;SAMHD1;MRE11;N4BP2;RNASE3;XRN2;OGG1;DNA2;RNASE12;PNKP;PLSCR1;PARN;PDE12;N4BP1;WRN;REXO1;EXOG;REXO5;DIS3L2;NTHL1
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.3163364119041648,1.22896841013172,0.11504424778761062,0.49801577243217615,1.0,10/73,10.44%,NPSR1;HCRTR1;SORCS1;SORCS3;GPR37;KISS1R;GIPR;TSHR;LGR5;VIPR2
prerank,cyclic nucleotide binding (GO:0030551),0.41596660681956565,1.2276482428296849,0.18764302059496568,0.4958928270680977,1.0,8/21,19.07%,PDE4B;HCN1;PDE10A;SLC19A1;PDE11A;POPDC2;POPDC3;PDE4D
prerank,semaphorin receptor activity (GO:0017154),-0.5046165769631448,-1.2239075420819516,0.24452554744525548,0.5002899621062257,1.0,3/11,8.44%,NRP2;PLXND1;PLXNA4
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.4866080920386535,1.2238963732464716,0.21852731591448932,0.49918171778858555,1.0,2/11,2.73%,AKR1D1;AKR1C1
prerank,SUMO binding (GO:0032183),-0.4732790595216583,-1.2233294904495722,0.2158671586715867,0.4982837095674381,1.0,7/13,19.43%,RNF111;UBA2;SERBP1;SIMC1;HERC2;CASP8AP2;RNF4
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.32068029038433754,-1.2227929921893796,0.1438721136767318,0.4962820830453413,1.0,24/72,24.25%,HIP1;PARD3;FCHO2;STXBP6;KCNJ2;SVIL;ANXA2;MARK1;LDLRAP1;PLCB1;KCNQ1;PICALM;PLEKHA4;CGAS;HIP1R;GSDME;TULP1;ANXA9;OSBPL2;PHLDA3;AMER1;TULP3;FZD7;SNX18
prerank,neuropeptide receptor binding (GO:0071855),0.46457791499521656,1.2183652979281108,0.20093457943925233,0.5065453970623142,1.0,5/14,23.48%,SHANK1;NPY;NTS;GAL;AGRP
prerank,regulatory RNA binding (GO:0061980),-0.3641184493396541,-1.2178442534584197,0.16928446771378708,0.5045319015303594,1.0,8/38,14.80%,TUT7;PUM1;ZC3H7B;DICER1;TUT4;AGO2;RC3H1;HNRNPA1
prerank,amyloid-beta binding (GO:0001540),0.3120607490486925,1.216920638718144,0.1566265060240964,0.5044624290690259,1.0,14/79,8.83%,GRIA3;NLGN1;GRIN2B;GRIA4;CACNA1B;GRIN2A;APBA2;CACNA1A;ITM2C;GRIA1;SORL1;BACE1;PGRMC1;GRIA2
prerank,water transmembrane transporter activity (GO:0005372),0.487586075563603,1.2160222956848725,0.2071269487750557,0.5014799430916911,1.0,2/11,4.58%,PDPN;AQP4
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.4098327306004194,1.2156343599455008,0.20092378752886836,0.49746051320726165,1.0,5/22,10.51%,CPSF1;EXOSC9;CPEB1;ELAVL4;CPEB3
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.32790713992593007,1.2137571101997133,0.1645021645021645,0.49702120471162187,1.0,11/55,8.91%,SLC24A4;SLC24A2;ATP2B4;ATP2B2;PKD1L2;CACNA1D;SLC8A2;RYR2;TMCO1;TRPM1;PKD1L1
prerank,phosphatase binding (GO:0019902),-0.29848457920799876,-1.212187575324392,0.13381555153707053,0.5146896392241121,1.0,26/105,12.73%,CTSC;IQGAP1;MTMR3;JAK1;ITGA1;MAP3K5;EGFR;CDKN1B;PXN;PIK3R1;DLG1;MAST2;SHOC2;CHCHD3;PTK2;STAT6;CDH5;SMAD2;MAPK1;CNST;FLT4;PPP1R3C;TP53;IKBKE;CEACAM1;PPP6R3
prerank,phospholipase inhibitor activity (GO:0004859),-0.5091262949178559,-1.210632888769038,0.23774954627949182,0.514841204947501,1.0,4/10,20.02%,ANXA2;ANXA4;ANXA1;ANXA9
prerank,phospholipid transfer activity (GO:0120014),-0.41964111417898986,-1.2080628251050833,0.20864661654135339,0.5179709387161787,1.0,3/21,1.27%,PITPNC1;CERT1;PLTP
prerank,transition metal ion binding (GO:0046914),-0.2526393392912103,-1.2076644154699918,0.04276315789473684,0.5157743292748289,1.0,131/397,26.38%,MYRIP;KLF7;SHANK3;MNAT1;NSD1;SEC24B;ZEB1;NOS3;KLF4;CLIP1;TAB3;MSRB3;LIMS1;IFIH1;XPNPEP3;RXRA;PTPN1;ATOX1;KDM2A;TNFSF10;KAT6A;WDFY1;RNF125;ACE;LOXL3;CTCF;TET2;ABL1;SAMHD1;SEC24A;PDE2A;GCH1;SIRT5;PAM;ECE1;NAPEPLD;SEC24D;PDXK;ARHGEF2;CRIP2;PRDM2;PHF5A;AOX1;RASSF1;TP53;ENPEP;ZCCHC4;ZMYND8;FDX1;KDM3A;ACER3;CHD3;HDAC4;SLU7;ADAM33;SIRT3;PLSCR1;KDM7A;CYP2R1;ZFYVE1;RC3H1;SLC30A5;XPNPEP1;JMJD6;TAB2;SKI;COX17;KDM5B;RPS27;MGAT2;HDAC10;HPF1;AOC3;GDA;ZMYND11;CCS;ERAP1;SOD1;WRN;KDM1B;LARGE1;CZIB;TES;SIAH1;NUDT12;COA6;RNF2;GALNT1;NPEPPS;B4GALT1;PIAS4;PPARG;GYG1;BAZ1B;ABCE1;TRIM28;DOHH;MDM2;BLM;RABIF;CALB1;TET3;NOS1;APIP;SEC24C;BBOX1;PGGT1B;USP16;PIM1;XYLT2;MSRB2;RCHY1;ACE2;RBAK;POLR2L;ADA;MT1G;MT1A;MT1B;MT1F;MT1E;MT1M;MT1X;MT1H;LCN2;TIMM10;RABGGTB;ENDOU;QPCTL;ARIH2;CDADC1
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.3698439320458501,-1.2072825245899705,0.19133574007220217,0.51363827353273,1.0,11/33,28.73%,ZNF326;RTRAF;RPRD2;SPTY2D1;CDC73;AGO2;ELOF1;SUPT4H1;DHX9;HNRNPU;ELP2
prerank,endodeoxyribonuclease activity (GO:0004520),-0.4225232732909929,-1.205938918525855,0.20955882352941177,0.5136255705507644,1.0,10/20,33.33%,MRE11;RBBP8;ENDOV;DNA2;RPS3;EXOG;EXO1;APLF;RAD50;ENDOG
prerank,NAD-retinol dehydrogenase activity (GO:0004745),-0.4607319982421998,-1.2058837625118783,0.22003577817531306,0.5106189095723029,1.0,13/14,53.97%,RDH10;RDH12;ADH1A;RDH11;AKR1A1;DHRS9;DHRS3;RDH16;HSD17B6;SDR9C7;ADH4;ADH7;RDH5
prerank,nuclear export signal receptor activity (GO:0005049),-0.4883795310438372,-1.2036222398322458,0.2302158273381295,0.5131189086838339,1.0,5/11,17.86%,NUP42;CSE1L;XPO7;XPO4;NUP214
prerank,phosphoric ester hydrolase activity (GO:0042578),0.3346719272088066,1.2022920145512608,0.18791946308724833,0.5183397529193182,1.0,17/49,19.23%,ATP1A2;MPPED2;PPP5C;PLCXD3;DUSP4;SBF1;SMPDL3B;HDHD2;DUSP8;DUSP15;PTPRO;FRA10AC1;PGP;SMPD1;ENPP6;ACP2;APEX1
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.48456555573417137,1.1973696822755537,0.2288888888888889,0.5250415404179039,1.0,3/11,8.43%,SLC25A23;SLC35B2;SLC19A1
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.4471048323124682,-1.1936252896960946,0.2558139534883721,0.5344929344674744,1.0,7/15,23.81%,SETD3;ASH2L;PRDM9;KMT2C;WDR82;WDR5;RBBP5
prerank,histone deacetylase activity (GO:0004407),-0.42653141440638714,-1.1916972361888678,0.23392857142857143,0.5359864687221304,1.0,10/19,26.59%,MIER1;HDAC1;HDAC4;SIRT3;MIER2;HDAC6;HDAC10;MIER3;SUDS3;HDAC5
prerank,protein tyrosine kinase activity (GO:0004713),-0.29254890870850125,-1.1914606977737887,0.15104166666666666,0.5333075601394364,1.0,21/108,12.16%,FLT1;TEK;IGF1R;TIE1;DYRK1A;ROR1;INSR;LYN;JAK1;KDR;MERTK;EGFR;YES1;BMX;ABL1;PTK2;EPHA4;FLT4;FRK;JAK2;PKDCC
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.44629045991318317,-1.1897041741750243,0.24545454545454545,0.5346809555111224,1.0,5/15,19.85%,LPCAT1;AGPAT4;AGPAT3;AGPAT1;LCLAT1
prerank,low-density lipoprotein particle binding (GO:0030169),-0.44254537954581363,-1.189649370569406,0.25539568345323743,0.5317079076055421,1.0,5/16,11.23%,PLTP;THBS1;SCARF1;SCARB1;STAB1
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.41117279511619,-1.1882246182732892,0.2351851851851852,0.5321065996359309,1.0,7/20,20.72%,SLC39A10;SLC30A10;SLC39A8;SLC39A11;SLC30A5;SLC39A6;SLC30A1
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.36707821050942596,-1.187617355336573,0.20670391061452514,0.5306137967753723,1.0,13/34,25.25%,FAM20A;IQGAP1;DDX3X;RICTOR;STK3;IRGM;MTCP1;ALS2;IGF2;PARP16;CAB39L;CCNK;CAB39
prerank,ligand-gated calcium channel activity (GO:0099604),0.4007451951666966,1.181018486355214,0.23319327731092437,0.5589235492839717,1.0,4/19,7.41%,GRIN2B;RYR3;GRIN2A;RYR2
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.45880591803163845,1.1808978364787261,0.2625,0.5540124132738982,1.0,3/12,3.71%,PDE4B;PDE3B;PDE1B
prerank,protein homodimerization activity (GO:0042803),-0.23947477153149554,-1.180123962566341,0.044444444444444446,0.5455503685294759,1.0,131/589,18.89%,HIP1;ABCG2;DAB2IP;FOXP2;CPQ;RBPMS;ZBTB16;GHR;PECAM1;ZHX3;SRR;EXT1;PKD2;MCL1;MYH9;NOD1;ST6GAL1;XPNPEP3;ATG7;F11R;TBX1;LRRK2;SYNE1;MAP3K5;ZDHHC3;MID1;CAMK2G;TFRC;ZHX2;PIP4K2A;SP1;FZD4;IDH1;ANO1;CEP57;IL6R;HES1;RASIP1;PDE2A;LRP6;SLIT2;TGFB2;GCH1;RABEP1;HPS4;PIP4K2B;RNF40;SPPL3;BNIP3;ECE1;ERN1;ABCB9;SNX9;ABCD3;ZBTB4;RAB11FIP3;TRPC6;S100A16;PDXK;PEX7;ABCB10;TPST2;FLT4;LDB1;AOX1;ST3GAL2;TPD52;STARD3;SMAD4;ADAM10;AKT1;CHMP4B;CHMP4A;MYOM1;FLNA;GSTM2;TPD52L1;FBLN5;SYT6;STK10;TRIM14;TBC1D22A;TMEM266;TMEM192;MTCL1;IRAK1;MGLL;ACTN1;SFPQ;S100A1;CEACAM1;LPL;LRRFIP1;TPM1;ACTN4;CAT;GBP4;CYP2R1;MZF1;ABCB7;GRHL1;TCF3;XPNPEP1;STARD3NL;HIP1R;ACOX1;PRDM9;DARS2;TPR;TERF2;COQ9;DGAT2;HOGA1;SLK;IRAK2;MGAT2;ALS2;TFAP4;ARNT;GBP5;HPGDS;CASQ2;PEX11A;WRN;NRF1;PLN;IKBKG;MKLN1;MTHFD1L;IKBKB;DEFA6
prerank,peptidoglycan binding (GO:0042834),-0.4946033789232183,-1.1800087429932171,0.27522935779816515,0.5426770570861215,1.0,7/10,35.99%,NOD1;RNASE7;PGLYRP1;NOD2;JCHAIN;NLRP3;TLR2
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.46280359017711603,-1.178819801727028,0.2558139534883721,0.5424753315186676,1.0,4/13,12.88%,ZGRF1;DICER1;ENDOV;DNA2
prerank,glucuronosyltransferase activity (GO:0015020),-0.415025129763482,-1.1752130360658408,0.23603603603603604,0.5483594158622223,1.0,2/19,3.70%,EXT1;CSGALNACT1
prerank,PDZ domain binding (GO:0030165),0.30748768962227746,1.1742680548598252,0.21296296296296297,0.5650039943624676,1.0,9/61,4.85%,GRID2;NLGN1;SLC22A4;ATP2B4;ATP2B2;KIDINS220;CXXC4;GRIA1;CXADR
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.47266355578949354,-1.1731023805990113,0.2766355140186916,0.5502019217013658,1.0,5/12,23.26%,NOD1;ATP2A3;CTSH;CASP8AP2;CASP1
prerank,phospholipase binding (GO:0043274),0.4567343004667821,1.1729592445031414,0.25287356321839083,0.5631620568065905,1.0,2/13,1.83%,BLNK;DGKQ
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.4662524151507951,-1.1725967468796117,0.2783882783882784,0.5484194016852513,1.0,2/12,6.02%,ENTPD1;ENTPD6
prerank,cation channel activity (GO:0005261),0.2880754559074336,1.1721154922852957,0.1565217391304348,0.5602338770941083,1.0,14/94,8.91%,TRPM3;HCN1;SLC24A4;SLC24A2;UNC80;KCNA2;PKD1L2;TMEM63A;CACNA1D;RYR2;TMCO1;CACNA1E;TRPM1;PKD1L1
prerank,lipoprotein particle binding (GO:0071813),-0.4047921358000557,-1.1658216796023366,0.2425828970331588,0.5617002744285383,1.0,6/20,12.71%,PLTP;THBS1;SCARF1;SCARB1;STAB1;LPL
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.4653803923700537,-1.1655097511358052,0.2737030411449016,0.5592687268179559,1.0,6/12,27.03%,PAN3;PARN;CNOT2;TOE1;CNOT8;CNOT1
prerank,nucleosomal DNA binding (GO:0031492),-0.3981191196997571,-1.1645500150159112,0.2518248175182482,0.5584347851139113,1.0,6/21,14.82%,HDAC1;SMARCC1;SMARCE1;SMARCC2;ACTB;H3-3A
prerank,dynactin binding (GO:0034452),0.4618523729389323,1.1643924197088613,0.28662420382165604,0.5747560940934721,1.0,7/12,19.85%,BICD1;BBS4;MAPT;HTT;BICDL1;HOOK3;SNX5
prerank,cAMP binding (GO:0030552),0.46059442559980085,1.1611875216210388,0.24835164835164836,0.5775974344538227,1.0,3/11,5.18%,PDE4B;HCN1;PDE10A
prerank,nucleotidyltransferase activity (GO:0016779),-0.4110011084753134,-1.161126643856375,0.2816399286987522,0.5637933195162798,1.0,9/19,22.10%,TUT7;TENT4B;TENT4A;TUT4;REV1;TENT2;CGAS;TERT;MOCS3
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.35877649757528446,-1.160614460981797,0.24736842105263157,0.5620389509329748,1.0,11/33,28.73%,ZNF326;RTRAF;RPRD2;CDC73;LLPH;AGO2;ELOF1;SUPT4H1;DHX9;HNRNPU;ELP2
prerank,phosphatase activator activity (GO:0019211),-0.43823437700677087,-1.1579156173977958,0.26195028680688337,0.5659759794837473,1.0,7/14,27.45%,PPP2R5A;PHACTR4;FRS2;PPP2R5E;BMP2;PPP2R5D;PPP2R5C
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.45385475639429396,1.1503239806949472,0.2775330396475771,0.5993312072552739,1.0,3/12,8.43%,SLC25A23;SLC35B2;SLC19A1
prerank,FMN binding (GO:0010181),-0.4683708261011818,-1.1498810040357232,0.31365313653136534,0.5828801026912493,1.0,6/11,23.94%,NOS3;POR;MTRR;NOS1;PNPO;PPCDC
prerank,neuropeptide hormone activity (GO:0005184),0.3865778885394413,1.1482109515001033,0.2694063926940639,0.5991288461378463,1.0,4/22,10.27%,PNOC;NPY;PENK;CCK
prerank,double-stranded RNA binding (GO:0003725),-0.3035593381078228,-1.1426439882227541,0.23591549295774647,0.5982151367943297,1.0,15/70,14.58%,MBNL1;EIF4H;IFIH1;DDX3X;TFRC;MSN;PRKRIP1;DICER1;DDX60;ACTN1;MTDH;STRBP;LRRFIP1;AGO2;RC3H1
prerank,NF-kappaB binding (GO:0051059),-0.3809505939984228,-1.142503236644796,0.2702702702702703,0.5954526588910124,1.0,9/24,22.61%,GSK3B;HDAC1;NFKBIA;ANXA4;RNF25;MTDH;CDK5RAP3;TAF4B;RELA
prerank,protein kinase C binding (GO:0005080),-0.32886187714232373,-1.1397851873705476,0.25045045045045045,0.5992860586690487,1.0,9/43,8.02%,GRK5;CAVIN2;PRKD2;ADAM9;PDLIM5;IRS1;ABL1;PARD6G;ADCY4
prerank,mannose binding (GO:0005537),0.4486837592318763,1.1384208033954522,0.3006535947712418,0.6189050483016737,1.0,5/12,19.90%,CD207;MBL2;LMAN1;ACR;COLEC11
prerank,adenylate cyclase binding (GO:0008179),0.47191073454617116,1.1370418196222618,0.31065759637188206,0.6171570769700103,1.0,2/10,5.75%,AKAP6;CALM2
prerank,BMP binding (GO:0036122),-0.46408762407147675,-1.1347756743650947,0.30918727915194344,0.6092883339447009,1.0,3/11,8.98%,ENG;BMPR2;GREM2
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.36310719782974565,-1.1341595816817627,0.2918825561312608,0.6076984395392909,1.0,3/28,2.64%,DAB2IP;EDA;TRAF5
prerank,actinin binding (GO:0042805),-0.3935237405816527,-1.1322571474766678,0.2996389891696751,0.6095539580872777,1.0,11/21,22.61%,PKD2;PROM1;PDLIM5;NFKB1;CSRP2;SYNPO2;RARA;MAGI1;PPARG;PKD2L1;RELA
prerank,SUMO transferase activity (GO:0019789),-0.4205324361678759,-1.1318573225440396,0.2965641952983725,0.6072015944096405,1.0,7/16,21.28%,RANBP2;NSMCE2;HDAC4;PIAS2;PIAS4;TRIM28;MDM2
prerank,muscle alpha-actinin binding (GO:0051371),-0.42113513923614965,-1.131426093476984,0.29963235294117646,0.6050598139917122,1.0,5/15,13.34%,PKD2;PDLIM5;PDLIM1;SYNPO2;PDLIM3
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.4377100524320621,-1.1303185006629468,0.3275862068965517,0.60463647675422,1.0,7/14,32.92%,NOD1;ATP2A3;CTSH;CASP8AP2;CASP1;RPS27L;MAL
prerank,semaphorin receptor binding (GO:0030215),-0.37771740977548174,-1.129333368597002,0.26508226691042047,0.6040274397342164,1.0,12/23,24.83%,SEMA6A;SEMA3C;SEMA7A;SEMA3G;SEMA6B;SEMA4C;SEMA5B;SEMA4A;SEMA3E;SEMA4G;SEMA5A;PLXNB1
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.2940670236985309,-1.1249706777067254,0.2351851851851852,0.6117541260084145,1.0,29/78,26.15%,USP9X;CTSC;CASP12;USP24;USP2;CASP8;USP13;CAPN2;CFLAR;USP40;USP15;USP18;PDIA3;USP34;CTSZ;USP10;LGMN;CTSH;USP7;UCHL1;USP1;CTSF;CASP2;CTSO;USP16;CASP1;USP12;GPAA1;CAPN15
prerank,nucleotidase activity (GO:0008252),-0.43087874598587683,-1.1245003681238477,0.2982142857142857,0.6097377360936914,1.0,8/15,26.79%,NT5C2;NT5E;NT5C1A;BPNT1;NT5C3B;ACP3;NT5DC1;NT5C
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.4238173313556141,1.1241685393890146,0.32175925925925924,0.6455999699217309,1.0,6/14,20.45%,ISCA2;ACO1;NFU1;CIAO3;EXO5;ACO2
prerank,kinase inhibitor activity (GO:0019210),-0.34491824599474785,-1.122531078735029,0.2717391304347826,0.6116278285612282,1.0,9/33,15.03%,PARVA;CDKN1B;NCK1;LRP6;SH3BP5L;PRKRIP1;TAOK3;SPRY4;GMFB
prerank,alanine transmembrane transporter activity (GO:0022858),-0.4503294277709744,-1.121546415059619,0.33088235294117646,0.6110781710340173,1.0,5/12,21.38%,SLC6A6;SLC38A5;SLC36A4;SLC1A4;SLC3A2
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.40760141781643744,-1.121295166999288,0.32304900181488205,0.605613555164651,1.0,3/16,0.33%,PTPRG;PTPRB;PTPRM
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.40760141781643744,-1.121295166999288,0.32304900181488205,0.605613555164651,1.0,3/16,0.33%,PTPRG;PTPRB;PTPRM
prerank,ATP binding (GO:0005524),-0.2467615695459969,-1.1212450300458219,0.1791304347826087,0.6027651394765291,1.0,57/266,17.01%,SNRK;MAP3K20;ACVRL1;SRR;INSR;MYH9;PEX1;DAPK1;TLK2;PRKACB;MARK1;RPS6KA5;SIK1;MAP3K5;MAP4K3;NEK6;TLK1;UBA2;CARS2;STK3;ABL1;MAST2;PIP4K2B;ABCC6;ERN1;ABCB9;PRAG1;CDC42BPA;ABCD3;MYO18A;MYO1F;TAP2;PDXK;N4BP2;AKT3;PXK;LATS2;SMC4;AKT1;NOL9;EIF2B2;SIK3;WNK4;STK38;CDK6;PNKP;MKNK2;KSR1;KCNJ8;MAP4K4;MARK2;ABCF2;DARS2;ABCF3;SRPK2;GALK1;CDC42BPB
prerank,poly(U) RNA binding (GO:0008266),-0.3943984568192599,-1.119029708297747,0.30943396226415093,0.605593512048228,1.0,11/20,33.36%,RBMS1;RBMS2;PABPC4L;DIS3L2;KHDRBS1;ATXN1;PABPC1;SSB;RBM11;PABPC5;PABPC1L
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.47427302054706544,-1.1124237740453906,0.35611510791366907,0.619369732723142,1.0,4/10,14.90%,STAMBP;OTUD4;ATXN3;TNFAIP3
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.4450313302882848,-1.1111274511784441,0.35283363802559414,0.6195801763774836,1.0,3/12,11.33%,DDI2;SPPL3;PSEN1
prerank,calcium-release channel activity (GO:0015278),-0.399892448771687,-1.1100320577234255,0.3132969034608379,0.619301739284675,1.0,8/17,26.11%,ITPR1;PKD2;ITPR2;MCOLN1;TRPA1;MCOLN2;TPCN2;TPCN1
prerank,protein kinase inhibitor activity (GO:0004860),-0.32412496353909065,-1.1098162254294548,0.2813067150635209,0.6168667641071566,1.0,10/42,15.03%,PARVA;SPRED2;CDKN1B;NCK1;SH3BP5L;PRKRIP1;TAOK3;RPTOR;SPRY4;GMFB
prerank,acid-thiol ligase activity (GO:0016878),0.41818371929941744,1.1088962619528877,0.30839002267573695,0.6810389896197492,1.0,3/13,11.79%,ACSS2;ACSS1;AASDH
prerank,MHC class II protein complex binding (GO:0023026),0.4418204877291967,1.0982997268176162,0.36504424778761063,0.7046373565697477,1.0,4/11,9.22%,MS4A1;ATP1B1;CD81;PKM
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.27665753162530693,-1.0978937893089298,0.2867132867132867,0.6439367329843726,1.0,28/91,24.25%,HIP1;PARD3;FCHO2;STXBP6;KCNJ2;SVIL;ANXA2;MARK1;SH3PXD2B;LDLRAP1;PLCB1;KCNQ1;PICALM;WIPI1;PLEKHA4;CGAS;HIP1R;GSDME;TULP1;ANXA9;WDR45B;OSBPL2;PHLDA3;KIF16B;AMER1;TULP3;FZD7;SNX18
prerank,purine ribonucleoside triphosphate binding (GO:0035639),-0.2300095377161789,-1.097457390621836,0.19008264462809918,0.6419344770705593,1.0,142/431,28.59%,SNRK;MAP3K20;ACVRL1;SRR;INSR;MYH9;RAC1;PEX1;RHOJ;DAPK1;MFHAS1;RHOBTB1;TLK2;PRKACB;MARK1;RPS6KA5;ARF3;RND3;RAB7A;SIK1;LRRK2;MAP3K5;MAP4K3;NEK6;TLK1;RAB2A;RASL12;UBA2;CARS2;STK3;ABL1;DNM2;MAST2;ATL2;RHOQ;GCH1;PIP4K2B;ABCC6;RAP1A;GBP6;ERN1;ABCB9;PRAG1;CDC42BPA;ABCD3;MYO18A;MYO1F;TGM2;TAP2;RAP1B;PDXK;RAB27A;RAB5A;N4BP2;AKT3;PXK;LATS2;RRAS;SMC4;AKT1;NOL9;EIF2B2;SIK3;WNK4;STK38;RHOA;ARL4A;DRG1;GBP4;RHOC;RHOG;CDK6;PNKP;MKNK2;KSR1;KCNJ8;MAP4K4;MARK2;RAB32;ABCF2;DARS2;RERG;ABCF3;SRPK2;GALK1;CDC42BPB;LSG1;GBP5;RAP2A;MTHFD1L;RRAS2;RAP2C;KRAS;NRAS;CDK11B;HSPA14;LIG4;ARL5C;ABCE1;ARHGEF5;BLM;P2RY1;TUBD1;MAP3K6;PMVK;PNPLA8;HSP90AA1;ARL4C;TOP1;PRPS2;TUBE1;HSPA13;MTG2;RALB;PIM1;ARL2;GBP3;RHEB;HSPA1B;NOA1;DHX9;REM1;PEX6;ARF5;ERCC6;DMPK;TRNT1;MKNK1;RAN;RND1;KIF14;TRIP13;RAB38;TUBG2;HNRNPU;RAP2B;RAB22A;ATP1A1;GNL1;RHOT2;PFKL;TGFBR1
prerank,ribosomal small subunit binding (GO:0043024),-0.40352306479630484,-1.0953944734607037,0.32082551594746717,0.6442134226271593,1.0,4/17,9.11%,EIF4H;DDX3X;LARP1;PTCD3
prerank,protein phosphatase 2A binding (GO:0051721),-0.3681004806910784,-1.094357978957731,0.3541284403669725,0.6438873620487037,1.0,6/23,12.97%,DAB2IP;FOXO1;MFHAS1;STRN3;TP53;CTTNBP2NL
prerank,N-acetyltransferase activity (GO:0008080),-0.3853295770661131,-1.0922986784729516,0.3382352941176471,0.6460740275211732,1.0,4/19,11.31%,KAT2B;NAA80;SMARCE1;GNPNAT1
prerank,cGMP binding (GO:0030553),-0.449426249622319,-1.0909405341267426,0.33629893238434166,0.6464845347232002,1.0,2/11,6.05%,RAPGEF2;PDE2A
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.33437819122339,-1.0893419290092408,0.30642201834862387,0.6476299859920008,1.0,10/33,20.91%,DCUN1D3;RNF125;UBA2;PPARA;RNF144B;DCUN1D2;RPS3;SIAH1;DCUN1D5;FOXL2
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.24071906376230684,-1.087961143775028,0.22852233676975944,0.6480954159522344,1.0,100/248,30.65%,GNB1;MYH9;RAC1;RHOJ;DNM3;RHOBTB1;GNAI3;RND3;RAB7A;LRRK2;DDX3X;RAB1A;RNF213;RAB2A;RASL12;GNA12;RAB5B;DNM2;ATL2;TOR1B;RHOQ;GCH1;IRGM;RAP1A;GBP6;MYO18A;RAP1B;ABCB10;RAB27A;RAB5A;RRAS;SRPRA;EFTUD2;EEF2;GNA14;CHD3;RAB8B;RHOA;DNA2;DRG1;GBP4;RHOC;RHOG;GSPT1;RAB23;RAB24;RAB32;RUVBL2;RERG;AGAP3;KIF15;RAB11A;KIF26A;LSG1;GBP5;TOR3A;MYL6;RAP2A;GPN2;RRAS2;RAP2C;KRAS;NRAS;GFM2;NKIRAS2;HSP90AA1;SAR1A;MTG2;RALB;GNB2;KIF18B;ARL2;GBP3;RAB19;RHEB;GNG3;HSPA1B;DHX9;GNGT2;RAB6B;ABCG4;GNA11;RAN;GPN3;RND1;KIF14;RAB38;RAP2B;RAB22A;GNL1;RHOT2;RAB21;RAB18;CHD1L;GNG8;TDRD9;ARL8B;RAP1GAP;RAB31;DDX4
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.40685062627709156,-1.0864077852708178,0.354014598540146,0.6493339417198929,1.0,3/15,7.50%,SLC26A7;SLC26A2;SLC39A8
prerank,Hsp70 protein binding (GO:0030544),0.3314734641299939,1.0859979073142338,0.3094262295081967,0.7333044430998675,1.0,12/31,20.18%,PACRG;GPR37;DNAJC8;RNF207;METTL21A;PPID;CYP1A1;HIKESHI;DNAJB2;IQCG;DNAJB1;DNAJC18
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.4372859324938677,-1.0852574814832368,0.3664259927797834,0.6491541603276171,1.0,7/12,24.03%,INSR;PIK3R1;IRS1;SOCS2;IGF1;IGF2;ARRB1
prerank,RNA polymerase II complex binding (GO:0000993),-0.33814094744197404,-1.0836711581090077,0.3406193078324226,0.6502715018984243,1.0,11/32,28.73%,ZNF326;RTRAF;RPRD2;CDC73;AGO2;ELOF1;SUPT4H1;DHX9;BRD4;HNRNPU;ELP2
prerank,cytokine receptor activity (GO:0004896),-0.2798798203881792,-1.0826468424608586,0.30526315789473685,0.6499098448566968,1.0,21/83,22.37%,IL1R1;OSMR;GHR;IL17RD;IFNAR1;IL6ST;FZD4;IL6R;CCR9;LIFR;IL4R;IL17RA;IL17RE;IL10RB;CMKLR1;IL20RB;IFNGR2;F3;IL13RA1;IFNAR2;IL3RA
prerank,G protein-coupled receptor binding (GO:0001664),0.25184632124444495,1.0808032528447833,0.26730310262529833,0.7420332624659915,1.0,25/132,15.83%,GNAO1;BICD1;WNT7B;PACRG;GNAI2;GIP;TAFA5;PSMC5;PNOC;GNAI1;CALCA;GNAL;GNAT3;NPY;HOMER1;PENK;ARR3;WNT6;CCL5;RSPO1;BBS1;NTS;WNT4;GPRASP2;DVL2
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.30950159319145987,-1.0806282735897934,0.3392857142857143,0.652118975354991,1.0,9/48,7.87%,SLC12A7;PIEZO2;PKD2;TRPM6;TRPM7;SLC12A2;ABCC9;TRPM4;TRPC6
prerank,translation initiation factor activity (GO:0003743),-0.3331614714519637,-1.0803401007156976,0.33584905660377357,0.6499315107655256,1.0,15/36,33.43%,EIF3H;EIF3E;EIF3C;EIF3B;EIF2B2;AGO2;EIF3F;EIF3A;EIF3I;EIF5B;EIF4G3;COPS5;EIF4A2;EIF2B4;EIF2B5
prerank,endopeptidase activator activity (GO:0061133),-0.45648716719190546,-1.0791051517725068,0.3770197486535009,0.6500674575092772,1.0,5/10,19.70%,PSME2;VSIR;APH1A;PSME1;ADRM1
prerank,protein heterodimerization activity (GO:0046982),0.24005292233792402,1.0790779919132052,0.27007299270072993,0.7409052463788242,1.0,34/178,14.41%,TENM4;ATP1A2;TENM1;NPAS3;QTRT2;NPAS1;PHB2;TENM3;ADCY8;RRAGA;BCL2;GABBR2;TENM2;ATP1B1;NAE1;ADD2;HSF1;ADRA2C;NOLC1;PIK3R2;ADRA2A;PDGFA;IL12A;FXR2;PRMT5;BUD23;ADRA1A;ARNT2;SRI;FZD9;MIGA2;BDKRB2;TAF1;PSMF1
prerank,hormone activity (GO:0005179),0.29860716353571654,1.0786386051739743,0.3028169014084507,0.7361905814116276,1.0,8/54,12.80%,PNOC;CHGB;NPPC;TRH;NPY;PENK;CCK;METRNL
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.30061217299387366,-1.0768195519971664,0.30824372759856633,0.6529407074904096,1.0,12/55,10.66%,SLC6A6;SLC7A1;SLC7A5;SLC16A12;SLC25A32;SLC38A11;SLC19A2;SLC38A5;SLC16A9;SLC16A1;SLC13A3;SLC16A6
prerank,acetylcholine receptor activity (GO:0015464),0.35937766088337664,1.0752590033950256,0.3585746102449889,0.739853197874537,1.0,2/22,5.19%,CHRM2;CHRM3
prerank,tubulin binding (GO:0015631),0.2260071025855118,1.074164246738384,0.2375296912114014,0.7370030776275123,1.0,76/295,19.14%,AGBL4;NAV3;TRIM36;KIF21A;SNPH;EML2;PACRG;NEFM;KIF17;APC2;CCDC88A;CDK5;TTLL12;UNC5C;MTUS2;SYBU;KIF26B;RCC2;DNM1;ARHGEF7;MAP2;TERF1;MAP1S;AGBL1;EML5;PAK1;BBS4;MAPT;ARL3;NEFH;TPGS1;DCX;GAS2L3;STMN2;SGIP1;KIF5A;MAP1B;KIF3A;DYNC1I1;TPPP3;GJB6;TTLL5;MAPRE3;TPPP;KIF1C;TUBGCP2;GOLGA2;HDGFL3;RACGAP1;HOOK1;STMN4;GAS8;TOGARAM2;KIF3C;KIF21B;CLASP2;HTT;PPP1R42;IFT81;KATNA1;CETN3;DLGAP5;KRIT1;NUMA1;MAP1A;KIF22;MAP6;PDCD5;CDK5RAP2;WHAMM;MAP6D1;SUN2;HOOK3;FSD1;REEP4;GJA1
prerank,GTP binding (GO:0005525),-0.24692557797436052,-1.0724800315116765,0.2825342465753425,0.660963606132317,1.0,60/172,28.46%,INSR;RAC1;RHOJ;MFHAS1;RHOBTB1;ARF3;RND3;RAB7A;LRRK2;RAB2A;RASL12;DNM2;ATL2;RHOQ;GCH1;PIP4K2B;RAP1A;GBP6;TGM2;RAP1B;RAB27A;RAB5A;RRAS;EIF2B2;RHOA;ARL4A;DRG1;GBP4;RHOC;RHOG;RAB32;RERG;LSG1;GBP5;RAP2A;RRAS2;RAP2C;KRAS;NRAS;ARL5C;ARHGEF5;TUBD1;ARL4C;TUBE1;MTG2;RALB;ARL2;GBP3;RHEB;NOA1;REM1;ARF5;RAN;RND1;RAB38;TUBG2;RAP2B;RAB22A;GNL1;RHOT2
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.37128494526916417,-1.0703526179179945,0.3805309734513274,0.6634627062401504,1.0,6/20,19.85%,LPCAT1;AGPAT4;AGPAT3;AGPAT1;DGAT2;LCLAT1
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.34485219016348456,-1.0703171982982131,0.3505338078291815,0.6606219979127649,1.0,12/27,31.12%,SLC26A7;SLC26A2;ANO1;SLC39A8;SLC25A11;SLC26A11;ANKH;SLC5A5;LRRC8A;SLC22A8;SLC26A6;SLC25A10
prerank,calcium channel inhibitor activity (GO:0019855),-0.4453324125535153,-1.0695957960754787,0.3912248628884826,0.6596126684477159,1.0,2/11,6.40%,ITPR1;MCUB
prerank,protein tyrosine kinase binding (GO:1990782),-0.28122315074378434,-1.0664880861009258,0.3288135593220339,0.6645292642843229,1.0,33/71,29.08%,ITGB1;PTPN14;BMPR2;DOCK4;PTPN1;CRK;CBL;GAS6;NCK1;CDH5;TJP2;EPHA4;GRB14;TP53;CEACAM1;DUSP3;NEDD9;ELMO2;ANGPT1;NOX4;HYAL2;DUSP22;TOB1;PTPN11;HSP90AA1;CD247;MAP3K7;KHDRBS1;PTPN2;TRIM6;TREM2;ANGPT4;PHYHIP
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.36399509852199385,-1.065863397257293,0.37153419593345655,0.6630830860316445,1.0,8/23,22.11%,HIP1;SH3PXD2B;WIPI1;PLEKHA4;HIP1R;WDR45B;PHLDA3;KIF16B
prerank,chemokine activity (GO:0008009),0.3296005066040705,1.0658028852056767,0.35730337078651686,0.7552642651692545,1.0,7/31,14.71%,CXCL16;CCL28;PF4;CCL13;CCL5;CCL2;CCL7
prerank,guanyl ribonucleotide binding (GO:0032561),-0.24133732365888627,-1.0649100979107438,0.2948073701842546,0.6626073170168486,1.0,67/196,28.46%,RAPGEF2;INSR;RAC1;RHOJ;MFHAS1;RHOBTB1;GNAI3;ARF3;RND3;RAB7A;LRRK2;RAB2A;RASL12;MIEF1;RAB5B;PDE2A;DNM2;ATL2;RHOQ;GCH1;PIP4K2B;RAP1A;GBP6;TGM2;RAP1B;RAB27A;RAB5A;RRAS;EIF2B2;RAB8B;RHOA;ARL4A;DRG1;GBP4;RHOC;RHOG;RAB32;RERG;LSG1;GBP5;RAP2A;RRAS2;RAP2C;KRAS;NRAS;ARL5C;ARHGEF5;TUBD1;ARL4C;TUBE1;MTG2;RALB;ARL2;GBP3;RHEB;NOA1;RAB9B;REM1;ARF5;RAN;RND1;RAB38;TUBG2;RAP2B;RAB22A;GNL1;RHOT2
prerank,RNA stem-loop binding (GO:0035613),-0.41494292948841793,-1.0644053168483274,0.38733705772811916,0.6609883052477576,1.0,5/12,26.86%,DDX3X;RC3H1;METTL16;DHX9;LARP6
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.4367027771679801,1.063367496335885,0.37448559670781895,0.7567297011129156,1.0,4/10,23.45%,ANKRD13B;FAAP20;DNAJB2;IDE
prerank,GTPase inhibitor activity (GO:0005095),-0.4079032952493285,-1.0624998365177376,0.370242214532872,0.6627164242007079,1.0,6/13,24.79%,IQGAP1;SLIT2;PDE6D;RTKN;ARL2;GPS2
prerank,ion channel inhibitor activity (GO:0008200),-0.317850491663362,-1.0592745407917818,0.36048526863084923,0.6679079236179264,1.0,9/35,17.41%,ITPR1;NEDD4L;MCUB;NEDD4;STX8;WNK4;RASA1;SCN3B;KCNMB2
prerank,pentosyltransferase activity (GO:0016763),-0.32666028188314133,-1.0575930264415934,0.3838383838383838,0.6694753573506552,1.0,19/36,36.20%,ZC3HAV1;TIPARP;PARP4;SIRT5;PARP14;SIRT3;PARP11;ART3;LARGE1;PARP16;PARP6;PARP9;PNP;TNKS2;UPP1;PARP3;TNKS;LARGE2;LACC1
prerank,magnesium ion binding (GO:0000287),-0.25045250931702756,-1.0575613186064474,0.3321492007104796,0.6667035791223327,1.0,35/135,21.93%,SNRK;MAP3K20;SRR;PRKACB;MARK1;SIK1;LRRK2;MAP3K5;NEK6;IDH1;UBA2;STK3;ABL1;PDE2A;MAST2;ERN1;CDC42BPA;PDXK;SIK3;ENDOV;STK38;PLSCR1;MARK2;MAPK12;SRPK2;CDC42BPB;HPRT1;HPGDS;RAP2A;WRN;NUDT12;CLYBL;GCLC;MAP3K6;DIS3L2
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",-0.28682949087065995,-1.0574872910890378,0.3578154425612053,0.6640568747609952,1.0,11/69,10.04%,CREBBP;KAT6B;KAT2B;ZDHHC6;PLA2G4A;KAT6A;ZDHHC3;NAA16;CERS4;NMT1;NAA15
prerank,DNA secondary structure binding (GO:0000217),-0.323234289825047,-1.056847359181847,0.35221238938053095,0.6628131765107242,1.0,14/31,30.50%,ABL1;MEF2C;RBBP8;CLSPN;RAD18;XPC;FANCM;WRN;BLM;YY1;HMGB1;XRCC2;RAD51AP1;RAD51D
prerank,signaling receptor complex adaptor activity (GO:0030159),0.30908632814944764,1.056390650978761,0.3664302600472813,0.7710460325669245,1.0,5/38,3.95%,MAGI2;GRIP1;BLNK;SHANK1;CD3G
prerank,solute:anion antiporter activity (GO:0140323),0.39497226290491644,1.0531116733267454,0.3741648106904232,0.7740373270943613,1.0,3/14,5.56%,SLC7A11;SLC26A5;SLC4A2
prerank,GTPase activity (GO:0003924),-0.24016687356898964,-1.0529762668426494,0.3222416812609457,0.6700727260938278,1.0,73/192,28.46%,GNB1;RAC1;RHOJ;DNM3;RHOBTB1;GNAI3;RND3;RAB7A;LRRK2;DDX3X;RAB1A;RAB2A;RASL12;GNA12;RAB5B;DNM2;ATL2;RHOQ;GCH1;IRGM;RAP1A;GBP6;RAP1B;RAB27A;RAB5A;RRAS;SRPRA;EFTUD2;EEF2;GNA14;RAB8B;RHOA;DRG1;GBP4;RHOC;RHOG;GSPT1;RAB23;RAB24;RAB32;RERG;AGAP3;RAB11A;LSG1;GBP5;RAP2A;GPN2;RRAS2;RAP2C;KRAS;NRAS;GFM2;NKIRAS2;SAR1A;MTG2;RALB;GNB2;ARL2;GBP3;RAB19;RHEB;GNG3;GNGT2;RAB6B;GNA11;RAN;GPN3;RND1;RAB38;RAP2B;RAB22A;GNL1;RHOT2
prerank,thioesterase binding (GO:0031996),-0.43595920337607214,-1.0511245771455182,0.4024604569420035,0.6716213059222054,1.0,2/11,2.64%,RAC1;TRAF5
prerank,anion transmembrane transporter activity (GO:0008509),-0.4262456367555528,-1.0488946752372428,0.4223385689354276,0.6744342515451583,1.0,3/12,8.86%,ABCG2;SLC39A8;SLCO2B1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.4286483810294743,1.046646113214995,0.39260969976905313,0.786985130125553,1.0,2/10,4.82%,ADARB2;CDA
prerank,galactosyltransferase activity (GO:0008378),-0.42807726504294363,-1.0462359227719764,0.41495327102803736,0.6786633685615325,1.0,4/11,19.41%,A4GALT;B4GALT4;B4GALT5;B4GALT1
prerank,Toll-like receptor binding (GO:0035325),-0.42732809600505595,-1.0457140470509558,0.42385321100917434,0.6771642672796484,1.0,1/11,0.25%,DAB2IP
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.40481737252223304,-1.0448703856092671,0.4076086956521739,0.676350859544565,1.0,7/13,26.09%,SLC7A1;SLC38A5;SLC7A7;SLC7A2;SLC66A1;SLC3A1;SLC7A3
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.38596588319428704,1.0409070051729155,0.40425531914893614,0.797814495240851,1.0,4/15,13.81%,SLC25A13;SLC1A2;SLC17A6;SLC1A3
prerank,3'-5' DNA helicase activity (GO:0043138),-0.383606575240818,-1.0404809686731094,0.3993231810490694,0.6845085435957663,1.0,9/16,31.28%,NAV2;ERCC3;FANCM;WRN;BLM;DHX9;MCM7;MCM5;MCM2
prerank,3'-5' exonuclease activity (GO:0008408),-0.3008270846329479,-1.03763014399293,0.40070921985815605,0.6888327742444966,1.0,15/45,25.97%,ERI3;MRE11;EXOSC2;EXOSC3;XRN2;PARN;PDE12;USB1;WRN;EXOSC5;ANGEL2;DIS3L2;EXOSC7;TOE1;CNOT8
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.41240222047436687,-1.0333716559916706,0.43037974683544306,0.696762998970685,1.0,3/12,10.05%,DAB2IP;CDH5;VEGFC
prerank,microtubule binding (GO:0008017),0.22463972607867974,1.0326350123472268,0.34823529411764703,0.8169110938992052,1.0,61/222,19.09%,NAV3;KIF21A;SNPH;EML2;NEFM;KIF17;APC2;CCDC88A;CDK5;MTUS2;SYBU;KIF26B;RCC2;DNM1;MAP2;TERF1;MAP1S;EML5;MAPT;ARL3;NEFH;TPGS1;DCX;GAS2L3;SGIP1;KIF5A;MAP1B;KIF3A;DYNC1I1;GJB6;MAPRE3;TPPP;KIF1C;TUBGCP2;CLIP4;GOLGA2;HDGFL3;RACGAP1;HOOK1;MAPRE1;GAS8;TOGARAM2;KIF3C;KIF21B;CLASP2;KATNA1;CETN3;DLGAP5;KRIT1;CAMSAP3;NUMA1;MAP1A;KIF22;MAP6;CDK5RAP2;WHAMM;MAP6D1;SUN2;HOOK3;FSD1;REEP4
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.36137276147816916,-1.0324064988204034,0.4130052724077329,0.6961663692020035,1.0,3/20,1.63%,SENP1;EIF3H;USP9X
prerank,ankyrin binding (GO:0030506),0.35712898116929526,1.0299385841538449,0.3982494529540481,0.8190839070497621,1.0,6/19,11.92%,NRCAM;FLNC;CACNA1D;SCN5A;SPTBN4;SLC8A1
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.33082598258049056,-1.0298913090852995,0.411231884057971,0.6995558295167196,1.0,8/27,20.91%,DCUN1D3;RNF125;PPARA;RNF144B;DCUN1D2;SIAH1;DCUN1D5;FOXL2
prerank,adenyl ribonucleotide binding (GO:0032559),-0.22465036040376837,-1.0288483312017158,0.35664335664335667,0.6992507521187815,1.0,56/291,14.97%,RAPGEF2;SNRK;MAP3K20;ACVRL1;SRR;INSR;MYH9;PEX1;DAPK1;TLK2;PRKACB;MARK1;RPS6KA5;SIK1;MAP3K5;MAP4K3;NEK6;TLK1;UBA2;MIEF1;CARS2;STK3;ABL1;PDE2A;MAST2;PIP4K2B;ABCC6;ERN1;ABCB9;PRAG1;CDC42BPA;ABCD3;MYO18A;MYO1F;TAP2;PDXK;N4BP2;AKT3;PXK;LATS2;SMC4;AKT1;NOL9;EIF2B2;SIK3;WNK4;STK38;CDK6;PNKP;MKNK2;KSR1;KCNJ8;CNBD2;MAP4K4;MARK2;ABCF2
prerank,NAD+ binding (GO:0070403),-0.42235998539836894,-1.0269548775082677,0.43872113676731794,0.701234931007582,1.0,3/12,13.45%,ZC3HAV1;SIRT5;SIRT3
prerank,poly-pyrimidine tract binding (GO:0008187),-0.35083689965321674,-1.0255727801448304,0.4230769230769231,0.7018732255931961,1.0,12/23,33.36%,RBMS1;RBMS2;PABPC4L;DIS3L2;KHDRBS1;ATXN1;PABPC1;HNRNPU;SSB;RBM11;PABPC5;PABPC1L
prerank,H4 histone acetyltransferase activity (GO:0010485),0.4190045816858095,1.0254848033709454,0.43956043956043955,0.8261681811869175,1.0,10/10,58.13%,USP22;NAA40;BRCA2;EP300;NAA50;KAT8;MSL3;HAT1;ATF2;NAA60
prerank,retinoic acid binding (GO:0001972),-0.41148112420823557,-1.0243086605947676,0.43726937269372695,0.7022033973863047,1.0,3/12,20.86%,RXRA;RARA;NR2F2
prerank,TBP-class protein binding (GO:0017025),-0.35201054185878067,-1.0240267401586283,0.43137254901960786,0.7001892138789274,1.0,6/21,15.76%,ESR1;TAF11;TAF1B;PSMC2;DR1;RUVBL2
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.4233861648783112,-1.022297703324349,0.4430379746835443,0.7019581682041401,1.0,8/11,52.63%,CHRNB1;CHRNA4;CHRNB2;CHRNA9;CHRNA5;CHRNA3;CHRNB4;CHRNA1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.3899562110283433,1.0222409140443274,0.4188034188034188,0.8301692531602101,1.0,4/14,12.71%,SPOCK3;SPOCK1;TIMP1;FETUB
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.28724294429673364,1.0190815872346186,0.3986636971046771,0.8338397861802078,1.0,8/46,11.60%,MGAT4C;B3GALT1;B3GALT4;B3GALT5;PIGP;MGAT5B;HEXB;EXTL2
prerank,chloride channel regulator activity (GO:0017081),0.3802683758621404,1.018383384530528,0.4520547945205479,0.8299175178065259,1.0,5/14,17.91%,WNK2;WNK3;VTI1B;SGK1;SGK3
prerank,voltage-gated anion channel activity (GO:0008308),0.37421157191903165,1.0163531853284125,0.42857142857142855,0.830023896654966,1.0,7/15,24.68%,CLCNKA;CLCN2;VDAC2;VDAC1;CLCN5;CLCN1;CLCN6
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.4328627886374274,-1.015350935261697,0.42992424242424243,0.7166656324222248,1.0,2/10,4.72%,KAT2B;CDKN1B
prerank,snoRNA binding (GO:0030515),0.313664904747889,1.014778687194226,0.4307692307692308,0.828666648862722,1.0,10/30,25.11%,NOP56;XRCC5;TBL3;NUDT16;TSR1;UTP6;NOP10;ISG20;WDR3;RRP9
prerank,epidermal growth factor receptor binding (GO:0005154),0.33448878689707046,1.0139944531113783,0.4279661016949153,0.8251418853096666,1.0,4/25,8.96%,ERBB4;CCDC88A;EFEMP1;SHC1
prerank,single-stranded DNA binding (GO:0003697),-0.26066929295588237,-1.0135610002091142,0.43309859154929575,0.7184931030548906,1.0,41/93,32.33%,STN1;RBMS1;DMC1;TOP3A;SAMHD1;POLR2G;NABP1;MCM9;RBBP8;MCM4;RTF1;RPA3;RPA1;CTC1;XPC;HNRNPA1;FUBP1;RAD23A;RPA2;RAD51AP2;BLM;MCM3;TOP1;PCBP1;MSH3;HMGB1;DHX9;POLR2H;MCM7;CRY2;MCM5;MCM10;HNRNPU;RAD51AP1;TDP1;SUB1;RAD51D;MCM2;NUP35;JCHAIN;MEIOB
prerank,Tat protein binding (GO:0030957),-0.4216156359165242,-1.0127919170389685,0.4634146341463415,0.7174362715521514,1.0,4/10,30.90%,MDFIC;ACTB;SMARCB1;TRIM32
prerank,single-stranded RNA binding (GO:0003727),-0.29472522325083883,-1.0114743987400425,0.4343065693430657,0.7178340454359612,1.0,11/43,15.54%,EIF4H;IFIH1;DDX3X;POLR2G;DDX60;ENDOV;HNRNPF;STRBP;AGO2;HNRNPA1;JMJD6
prerank,histone methyltransferase binding (GO:1990226),0.4097800999330936,1.009945828107746,0.4095022624434389,0.8313073636693542,1.0,8/11,30.78%,NOP56;LCOR;HSP90AB1;LCORL;PRDM4;CBX3;PHF1;WIZ
prerank,sterol binding (GO:0032934),0.27054578880884445,1.0072075836153396,0.40774487471526194,0.8338730425101013,1.0,18/56,21.41%,INSIG1;SULT2B1;CD81;SYP;ERLIN1;OSBPL6;OSBPL5;VDAC2;SIDT1;OSBPL9;GRAMD1B;OSBPL11;GPR183;SOAT2;VDAC1;GRAMD1C;SOAT1;SCARB2
prerank,solute:sodium symporter activity (GO:0015370),0.31427653278859147,1.005341873821342,0.4484304932735426,0.8332405178834509,1.0,5/27,13.97%,SLC34A1;SLC4A4;SLC4A5;SLC28A2;SLC13A5
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.2979689019318871,-1.004294799511938,0.44216417910447764,0.7332568984572254,1.0,24/42,40.60%,KAT2B;CDKN1B;CCND3;CCNY;CCNC;CCND1;CNPPD1;CDKN2C;CCNYL1;CCNG1;CCNK;CCNE2;CCNJ;CDKN2B;CCNH;CCND2;CCNL1;CDK5R1;CCNE1;CCNA2;CKS1B;CDKN1A;CCNB1;CDKN2D
prerank,glutamate receptor binding (GO:0035254),-0.3654443233780564,-1.0036243154369497,0.4581818181818182,0.7321976177870388,1.0,2/17,0.77%,HIP1;SHANK3
prerank,exoribonuclease activity (GO:0004532),-0.39643071079832537,-1.000360546987268,0.4750889679715303,0.7374721885616757,1.0,6/12,25.27%,EXOSC2;EXOSC1;EXOSC3;EXOSC8;EXOSC5;EXOSC7
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.38081440079989637,-0.99680465339986,0.4408014571948998,0.743764569946526,1.0,4/14,16.49%,SLC26A7;SLC26A2;SLC25A11;SLC26A11
prerank,chemokine receptor binding (GO:0042379),0.2997598067496088,0.9967828051230689,0.4792626728110599,0.8534506794655853,1.0,7/35,14.71%,CXCL16;CCL28;PF4;CCL13;CCL5;CCL2;CCL7
prerank,nuclear receptor coactivator activity (GO:0030374),-0.2742513965262655,-0.993922107058109,0.4802158273381295,0.7482084993532254,1.0,14/52,19.91%,TACC1;ZMIZ1;ETS1;MED1;MED13;HELZ2;MED17;FGF2;ACTN1;ACTN4;CARM1;NCOA6;RNF4;SS18
prerank,myosin V binding (GO:0031489),0.36815670045404153,0.9928693115245907,0.4638949671772429,0.8594389355010971,1.0,6/15,21.52%,RAB3C;RAB27B;RAB3A;RAB6A;RAB3B;RAB8A
prerank,mannosyltransferase activity (GO:0000030),-0.3476896197877162,-0.9902044200567718,0.458029197080292,0.7549047763528086,1.0,5/21,12.20%,TMTC1;TMTC2;ALG12;ALG8;PIGV
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.28040357013263334,-0.9901793410041789,0.4831858407079646,0.7521491498867482,1.0,16/47,23.45%,SLC47A1;SLC6A6;SLC7A1;SLC7A5;SLC38A11;SLC38A5;SLC1A5;SLC25A44;SLC7A7;SLC36A4;SLC43A1;SLC7A2;SLC3A2;SLC66A1;SLC3A1;SLC38A6
prerank,chemorepellent activity (GO:0045499),0.3179528323892482,0.988623807809259,0.4660831509846827,0.8666648446927805,1.0,4/25,5.72%,NRG3;NRG1;SEMA6D;SEMA3B
prerank,cation:chloride symporter activity (GO:0015377),-0.421437905639087,-0.9865951213719759,0.4838709677419355,0.7584317834999985,1.0,2/10,4.55%,SLC12A7;SLC12A2
prerank,MHC protein binding (GO:0042287),0.3402272672707418,0.9822891014148663,0.47651006711409394,0.8795559603377254,1.0,3/20,9.38%,COL2A1;CD81;KIR3DL2
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.3318451225352306,0.9813943118893148,0.46275395033860045,0.8764544965563755,1.0,3/21,14.36%,GRIK2;P2RX3;P2RX5
prerank,calcium activated cation channel activity (GO:0005227),0.34194738861761004,0.9798010994757229,0.49336283185840707,0.8752073835490736,1.0,3/17,6.21%,KCNMA1;KCNN2;TMEM63A
prerank,aminopeptidase activity (GO:0004177),0.3118608433056311,0.9797533020915274,0.4801864801864802,0.8695134339585615,1.0,5/26,9.98%,TRHDE;MMP16;METAP2;KDM8;JMJD7
prerank,MHC class I protein binding (GO:0042288),-0.37994193432494966,-0.9792989807705365,0.492831541218638,0.7742850401653687,1.0,2/13,7.90%,ABCB9;TAP2
prerank,kinesin binding (GO:0019894),-0.3202452015425198,-0.9785541605068159,0.48473967684021546,0.7733612863845973,1.0,9/27,23.68%,NEK6;TOR1B;CROCC;ACTB;AP1G1;ARHGEF10;PRC1;SPAG9;KIF18B
prerank,lysine-acetylated histone binding (GO:0070577),-0.34194119127513023,-0.9776986207755226,0.5073529411764706,0.7697476264565238,1.0,4/20,10.44%,MLLT3;BRD2;ATAD2B;ZMYND8
prerank,acetylation-dependent protein binding (GO:0140033),-0.34194119127513023,-0.9776986207755226,0.5073529411764706,0.7697476264565238,1.0,4/20,10.44%,MLLT3;BRD2;ATAD2B;ZMYND8
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.27439006584234327,-0.9735068296087859,0.5,0.7777267598235805,1.0,20/53,30.31%,NOS3;DLD;MICAL2;AOX1;ACADL;ACADVL;ACOX1;NOX4;ACOX3;AGPS;KDM1B;POR;KMO;MTRR;NOS1;CRY2;PPOX;MICAL1;STEAP4;FOXRED2
prerank,disordered domain specific binding (GO:0097718),-0.32451054741276353,-0.9721236254008218,0.5067178502879078,0.7783647882701731,1.0,6/23,22.46%,RB1;SMAD2;TP53;FYN;MDM2;HSP90AA1
prerank,microtubule plus-end binding (GO:0051010),-0.3332856299647748,-0.9720921171674496,0.49554367201426025,0.7756119932400586,1.0,6/20,19.18%,CLIP1;DST;DCTN1;PAFAH1B1;FBXW11;CLIP2
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.33034797426547013,-0.9716062009435802,0.5282331511839709,0.7740901409846626,1.0,8/22,18.43%,TAB3;UIMC1;RNF169;IKBKE;RNF168;TNFAIP3;TAB2;IKBKG
prerank,kinase activity (GO:0016301),0.2294893730767289,0.9671797288081091,0.5417607223476298,0.9013820852322894,1.0,23/109,14.79%,DGKK;DGKI;PKMYT1;DGKQ;ITPKA;CDK5;CDKL5;POMK;BCKDK;SPHK1;ETNK1;GK;PIK3C2G;SPHK2;PI4KA;IP6K2;IPPK;CKMT2;CHKA;TAF1;FCSK;CDC7;FN3K
prerank,four-way junction DNA binding (GO:0000400),-0.3441738977161095,-0.9654737186806888,0.5191956124314442,0.7869069203279448,1.0,8/17,30.50%,ABL1;FANCM;WRN;BLM;YY1;HMGB1;XRCC2;RAD51D
prerank,voltage-gated chloride channel activity (GO:0005247),0.39601982887426435,0.9654092422088215,0.5087719298245614,0.9007133119138215,1.0,2/10,7.68%,CLCNKA;CLCN2
prerank,ribonuclease activity (GO:0004540),-0.26701343218150014,-0.9635543716461943,0.5255731922398589,0.7888273639734067,1.0,21/56,26.09%,RNASE7;SAMHD1;KHNYN;ERN1;RNASE3;EXOSC2;EXOSC1;DICER1;EXOSC3;RNASE12;AGO2;N4BP1;EXOSC8;EXOSC5;EXOG;DIS3L2;RCL1;SMG6;ELAC2;EXOSC7;ENDOU
prerank,MAP kinase kinase activity (GO:0004708),0.35099116382359474,0.9622424442656425,0.5045662100456622,0.9042912203937898,1.0,3/15,6.28%,MAPK10;PAK3;MAP2K7
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.35842743593874116,0.9608582467117976,0.5065217391304347,0.90265247172902,1.0,3/14,9.28%,QDPR;PYCR2;ALDH1L2
prerank,aspartic-type peptidase activity (GO:0070001),-0.4009836918608885,-0.9603617359847546,0.5161839863713799,0.7940753763068275,1.0,2/10,11.33%,DDI2;PSEN1
prerank,P-type ion transporter activity (GO:0015662),0.3702124487405474,0.9599373449855523,0.5219298245614035,0.8999053321735039,1.0,2/12,2.92%,ATP2B4;ATP2B2
prerank,chloride transmembrane transporter activity (GO:0015108),-0.3560719942305234,-0.9583218452302987,0.5054945054945055,0.7962115622460798,1.0,2/16,2.73%,SLC26A7;SLC26A2
prerank,pyridoxal phosphate binding (GO:0030170),-0.3347615332293655,-0.9568981525304441,0.5054945054945055,0.7968771635119024,1.0,9/20,29.63%,SRR;PDXK;ABAT;ACCS;CTH;PNPO;PSAT1;GLDC;SHMT1
prerank,N-acyltransferase activity (GO:0016410),0.2897236917508352,0.956554884810176,0.5099337748344371,0.9044460350146275,1.0,7/32,13.72%,CERS6;NAT8;CERS1;PLA2G4E;CERS3;CERS2;SIRT7
prerank,deubiquitinase activity (GO:0101005),-0.24438864875888647,-0.9564490942306271,0.540447504302926,0.7951951822126965,1.0,27/88,21.02%,USP53;EIF3H;USP9X;USP24;OTULIN;MINDY1;STAMBP;JOSD1;USP2;USP13;OTUD1;USP40;OTUD4;USP15;USP18;ATXN3;TNFAIP3;VCPIP1;USP34;USP10;BRCC3;BAP1;USP7;JOSD2;UCHL1;USP1;EIF3F
prerank,cysteine-type peptidase activity (GO:0008234),-0.25191044288020886,-0.9557370731946275,0.5452898550724637,0.7941932503300607,1.0,27/73,23.87%,USP9X;CTSC;USP24;OTULIN;ATG4A;USP2;CASP8;USP13;CAPN2;USP40;USP15;USP18;PDIA3;USP34;CTSZ;USP10;LGMN;CTSH;USP7;UCHL1;USP1;CTSF;CASP2;CTSO;USP16;CASP1;USP12
prerank,protein kinase regulator activity (GO:0019887),-0.23909393155251596,-0.9546907200064023,0.5600706713780919,0.7939493141599991,1.0,34/95,31.31%,PARVA;GPRC5C;CDKN1B;NCK1;CCND3;SH3BP5L;PRKRIP1;RPLP1;TAOK3;CCNY;RGCC;RPTOR;WNT11;SPRY4;MARK2;GMFB;CCNC;CCND1;CNPPD1;CCNYL1;CCNG1;CCNK;CCNE2;CAB39;APC;CCNJ;DNAJC3;CXCL10;CCNH;WNK1;CCND2;PPP1R1B;CCNL1;CDK5R1
prerank,adrenergic receptor binding (GO:0031690),0.348931989705148,0.954386326429962,0.5360169491525424,0.904978247956114,1.0,7/16,20.33%,MAGI2;ADRA2C;ADRA2A;DLG4;ARRDC3;PDE4D;APLP1
prerank,chloride channel inhibitor activity (GO:0019869),0.3855681625921017,0.9485931256423678,0.5258426966292135,0.9171080345001966,1.0,3/10,10.79%,WNK2;WNK3;VTI1B
prerank,cholesterol transfer activity (GO:0120020),-0.34913202420646955,-0.9452515390990325,0.5211267605633803,0.8149711021649111,1.0,4/16,26.19%,PLTP;STARD4;OSBPL2;STARD5
prerank,endopeptidase activity (GO:0004175),-0.20693153554460914,-0.9438381043615287,0.6188118811881188,0.8156476045205227,1.0,69/257,24.07%,ADAMTSL3;SENP1;TRABD2B;USP9X;PCSK7;CTSC;ADAMTS2;PSMA2;USP24;DDI2;MMP2;ACE;ADAM9;TASP1;PSEN2;ECE1;RHBDF2;RHBDD3;PSMB4;AFG3L2;PCSK5;USP2;ADAMTS9;CASP8;USP13;ADAM10;ADAMTS4;TPP2;ADAMTS10;ADAMTS5;ADAMTS20;PSEN1;USP40;ADAMTS17;USP15;THSD4;USP18;ADAM33;PDIA3;HGF;PIK3IP1;USP34;CTSZ;PSMB2;USP10;LGMN;PSMB1;PRSS12;PLAT;CTSH;ZMPSTE24;PSMA8;PREP;HTRA3;USP7;UCHL1;USP1;F3;CTSF;MMP11;PSMA7;CASP2;CTSO;USP16;CASP1;THOP1;USP12;ADAMTSL1;ADAMTS7
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.3000579521266475,0.9413182799343922,0.535632183908046,0.9317412130339486,1.0,6/25,8.86%,AKR1D1;CYP46A1;AKR1C1;CYP26B1;SQLE;CYP27A1
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.29427809652558834,-0.9400393087256698,0.5676625659050967,0.8224896571585043,1.0,5/31,5.94%,SLC12A7;PKD2;SLC12A2;ABCC9;KCNK5
prerank,mRNA 3'-UTR binding (GO:0003730),-0.24552526876043987,-0.9393220433839843,0.5879218472468917,0.821349009859014,1.0,36/79,33.54%,RBMS1;HNRNPA0;LARP1;RNF40;RBMS2;PUM1;SECISBP2;CELF1;TP53;SERBP1;LARP4B;PARN;RC3H1;PABPC4L;RPL5;EXOSC8;RNPS1;ANGEL2;RPS7;RBM24;CCT5;CARHSP1;FXR1;IGF2BP2;ZFP36L1;PABPC1;HNRNPU;UTP23;SECISBP2L;BOLL;CPEB4;RPL41;PUM2;PABPC5;PABPC1L;RNF20
prerank,receptor ligand activity (GO:0048018),0.2001693536829355,0.9368178299541591,0.6432432432432432,0.9385758000686824,1.0,33/245,13.40%,NRG3;NRG1;TAFA1;OSGIN1;CLEC11A;WNT7B;FGF6;TAFA5;TAFA2;GDF1;NBL1;CHGB;SEMA6D;SEMA3B;NPPC;NPY;COLEC10;GRN;TIMP1;FGF5;VEGFA;PDGFA;IL12A;CCK;HMGB2;WNT6;LEFTY1;CCL5;GDF11;METRNL;THPO;BDNF;FGF20
prerank,metalloendopeptidase activity (GO:0004222),-0.245192279703577,-0.9354376068456456,0.5682210708117443,0.8282150355978374,1.0,16/76,12.76%,ADAMTSL3;TRABD2B;ADAMTS2;MMP2;ADAM9;ECE1;AFG3L2;ADAMTS9;ADAM10;ADAMTS4;ADAMTS10;ADAMTS5;ADAMTS20;ADAMTS17;THSD4;ADAM33
prerank,glutathione transferase activity (GO:0004364),-0.31095137509821064,-0.9326497428590477,0.5602189781021898,0.8322362783472936,1.0,12/23,44.43%,GSTT1;GSTT2;GSTM2;HPGDS;GSTK1;ALOX5AP;MGST2;GSTM5;GSTA4;GSTM4;LTC4S;GSTP1
prerank,retinoid binding (GO:0005501),0.3117159354849545,0.9323355878781363,0.5652173913043478,0.9455112794303806,1.0,3/22,11.11%,PTGDS;CYP26B1;ALDH1A2
prerank,phosphate ion binding (GO:0042301),0.37869435422591097,0.9311671369760284,0.5280898876404494,0.9431287779633132,1.0,3/10,10.48%,RPH3A;ADSS2;ADSS1
prerank,ATPase binding (GO:0051117),-0.24367540641052976,-0.9308303746447587,0.5670840787119857,0.8337141299692403,1.0,16/71,18.24%,CAV1;PKD2;ESR1;EGFR;EZR;CHMP4A;SLC2A13;PTPN3;PSEN1;S100A1;ATXN3;ATP6V1E1;DNAJC10;BBC3;ATP6V0A1;PLN
prerank,phosphoric diester hydrolase activity (GO:0008081),0.28248678326264576,0.9293109429694494,0.5586206896551724,0.9427833725085435,1.0,10/35,12.14%,MPPED2;ENPP2;PLCXD3;SMPD3;SMPDL3B;ENPP3;PDE11A;MPPE1;PLD3;GPLD1
prerank,cation transmembrane transporter activity (GO:0008324),-0.2616594559566791,-0.9287130067028652,0.5874125874125874,0.836326167054223,1.0,14/48,23.45%,SLC6A6;SLC7A1;SLC7A5;SLC38A5;SLC1A5;SLC36A4;SLC1A1;SLC7A2;PKD2L1;SLC6A7;SLC1A4;SLC3A2;SLC66A1;SLC38A6
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",-0.2594460052731707,-0.928643731080085,0.5790441176470589,0.8336608601855747,1.0,15/54,18.27%,ACER2;MIER1;HDAC1;SIRT5;TGM2;NADSYN1;NTAN1;ACER3;HDAC4;ASAH1;MIER2;HDAC6;HINT1;HDAC10;MIER3
prerank,gap junction channel activity (GO:0005243),-0.3166728110170386,-0.9284358108287959,0.5557586837294333,0.8313240494934366,1.0,2/22,1.33%,GJC1;GJD3
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.23429388776258034,0.9283404908078876,0.6137931034482759,0.9398081757632347,1.0,12/74,10.42%,DGKK;DGKI;DGKQ;POMK;SPHK1;ETNK1;PKM;GK;PIK3C2G;SPHK2;PI4KA;IPPK
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.3875453396221076,0.928197752874592,0.5852017937219731,0.9344962767278019,1.0,3/10,15.38%,DPYSL5;DPEP1;DPYSL2
prerank,leucine zipper domain binding (GO:0043522),-0.3854342581524989,-0.9277801824654289,0.5536028119507909,0.8302587548536787,1.0,3/10,14.04%,ERC1;AATF;ATF4
prerank,LRR domain binding (GO:0030275),0.3386971805772352,0.9277063134242723,0.5795454545454546,0.9304090624570859,1.0,2/14,2.34%,ROBO1;CRX
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.3462542133174778,-0.926099323153203,0.5737122557726465,0.8316217172827066,1.0,4/15,16.18%,PIK3R1;SOCS2;PIK3R6;PIK3R3
prerank,GDP binding (GO:0019003),-0.2509401927911961,-0.9251675662931681,0.6038394415357766,0.8311140190535121,1.0,28/63,30.62%,GNAI3;RAB7A;RAB2A;RASL12;MIEF1;RAB5B;RAP1A;RAP1B;RAB27A;RAB5A;RRAS;RAB8B;RERG;RAP2A;RRAS2;RAP2C;KRAS;NRAS;RALB;RHEB;RAB9B;RAN;RAP2B;RAB22A;RAB21;RAB18;ARL8B;RAB31
prerank,wide pore channel activity (GO:0022829),-0.31200939539235717,-0.9241950844245369,0.5693430656934306,0.8307941515900087,1.0,2/23,1.33%,GJC1;GJD3
prerank,GABA receptor binding (GO:0050811),-0.3750684133930665,-0.9238728851867298,0.5517857142857143,0.8288847827247735,1.0,5/11,35.28%,TRAK1;GABARAP;ARFGEF2;LHFPL4;GABARAPL2
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.3927991759154038,-0.9233033286688943,0.5482695810564663,0.8274644493919975,1.0,3/10,14.06%,KDM2A;RIOX2;KDM7A
prerank,ionotropic glutamate receptor binding (GO:0035255),0.37990041112359135,0.9227697575075641,0.5882352941176471,0.9387457982923786,1.0,4/10,17.00%,IGSF11;SHANK1;DLG4;SHANK2
prerank,mRNA binding (GO:0003729),-0.20314067009245182,-0.9215537646062775,0.6777583187390543,0.8289198994579208,1.0,90/249,30.95%,RBPMS;RBFOX2;RBMS1;METTL14;DDX3X;HNRNPA0;LARP1;THOC2;RBM5;RPS14;NOVA2;HNRNPR;KHNYN;UPF3B;RNF40;NUP98;SF3B6;RBMS2;SAMD4A;PUM1;HNRNPM;SECISBP2;HNRNPAB;CELF1;SF3B1;RPL26;TP53;SNIP1;SERBP1;LARP4B;PARN;MARF1;AGO2;RBM20;RC3H1;N4BP1;SYNCRIP;PABPC4L;TPR;RPL5;ADARB1;EDC3;FUBP1;RPS3;RBM4B;DCP1A;RNPS1;ANGEL2;PTBP3;TRA2B;RPS7;RBM25;RPL13A;RBM24;MRPL13;EIF3A;RBM15;PCBP1;SRBD1;KHDRBS1;DHX9;CCT5;CARHSP1;FXR1;NCBP3;RPS2;IGF2BP2;ZFP36L1;RBM47;RPS26;HNRNPL;DXO;RBPMS2;NANOS1;LARP6;PABPC1;HNRNPU;HDLBP;TDRD7;UTP23;PPIE;EIF4G3;SHMT1;SRSF6;SSB;RPS13;SECISBP2L;SHFL;BOLL;LUC7L2
prerank,omega peptidase activity (GO:0008242),0.22922284848368646,0.9210300520255421,0.5951219512195122,0.9381068409113739,1.0,17/89,12.76%,USP29;OTUD7A;ASRGL1;USP28;USP25;USP21;CYLD;USP48;USP31;USP38;OTUD7B;MPND;PSMD14;USP11;USP50;USP22;USP5
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",-0.2964296885072347,-0.919724582970418,0.5706618962432916,0.8304748555186588,1.0,10/28,27.97%,DICER1;DBR1;ENDOV;AGO2;EDC3;DROSHA;ELAC2;RPP30;EXO1;POP4
prerank,receptor tyrosine kinase binding (GO:0030971),-0.2539809649967341,-0.9189760321165072,0.5989492119089317,0.8295131360029857,1.0,14/56,16.14%,PTPN14;DOCK4;PTPN1;CBL;GAS6;NCK1;PIK3R1;IRS1;GRB14;TP53;DUSP3;ELMO2;GAB2;ANGPT1
prerank,metal ion:proton antiporter activity (GO:0051139),-0.36258987838300427,-0.9175130063168743,0.5529197080291971,0.8300978413848081,1.0,3/13,11.32%,SLC9A2;SLC9B2;SLC9A5
prerank,protease binding (GO:0002020),-0.22949241839627377,-0.916930788159314,0.6342756183745583,0.8287365149040494,1.0,24/99,20.64%,VWF;ITGB1;GSK3B;ANXA2;DVL3;ITGA3;RNF139;CFLAR;ADAMTS4;TP53;CRADD;SLC2A13;TIMP3;COMP;FLOT1;TNFAIP3;SERPINC1;SUMO1;RAD23A;ADRM1;ANXA9;PTEN;F3;ITGB3
prerank,sodium:proton antiporter activity (GO:0015385),-0.3811940860199158,-0.9164377955660972,0.5708955223880597,0.8272045402659453,1.0,3/11,11.32%,SLC9A2;SLC9B2;SLC9A5
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.3431332596539157,0.9148263173877166,0.5827814569536424,0.9497039968671982,1.0,2/13,3.02%,CCDC88A;RANBP1
prerank,ADP binding (GO:0043531),-0.3039306165375971,-0.9118167742122169,0.563963963963964,0.835530500622768,1.0,4/25,7.78%,MYH9;MIEF1;ERN1;MYO18A
prerank,phospholipase A2 activity (GO:0004623),0.2918372641182248,0.9110007993187966,0.5960698689956332,0.9544317393684101,1.0,4/26,10.06%,PLA2G7;PLA2G3;PLA2G4E;PLA2G6
prerank,frizzled binding (GO:0005109),-0.27636211971948016,-0.9108641788114669,0.584192439862543,0.8351602810563927,1.0,7/34,13.32%,DVL3;ZNRF3;RNF43;LRP6;WNT16;WNT11;MYOC
prerank,ribosome binding (GO:0043022),-0.26137771749949046,-0.9098735709043929,0.6070763500931099,0.8347497873254209,1.0,9/46,16.52%,NAA16;EIF3C;RPSA;NOMO1;NAA15;SERBP1;EEF2;MRPS27;NCLN
prerank,general transcription initiation factor binding (GO:0140296),-0.2963474423976437,-0.9060634328411185,0.6086206896551725,0.8406804210374931,1.0,8/25,23.23%,ESR1;TAF11;TAF1B;PSMC2;DR1;RUVBL2;RELA;TAF13
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.36860497869934744,-0.9053747815284441,0.5845864661654135,0.8395798568066655,1.0,3/12,11.32%,SLC9A2;SLC9B2;SLC9A5
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.35698716705608147,-0.9052737554591811,0.6178571428571429,0.8371091866665715,1.0,3/12,13.97%,TENT4B;TENT4A;TENT2
prerank,manganese ion binding (GO:0030145),0.2502446471393705,0.8993460901018504,0.611764705882353,0.9802602913447596,1.0,13/48,17.96%,MPPED2;B4GALT7;ARG2;MGAT5B;ATP13A2;MPPE1;HMGCL;NUDT16;ADPRM;GALNT3;GALNT2;MGAT1;IMPA1
prerank,thiol-dependent deubiquitinase (GO:0004843),0.22763621173545653,0.8988480605009723,0.6330935251798561,0.9759421683191399,1.0,16/83,12.76%,USP29;OTUD7A;USP28;USP25;USP21;CYLD;USP48;USP31;USP38;OTUD7B;MPND;PSMD14;USP11;USP50;USP22;USP5
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.3478225196898151,0.8987606364654428,0.6008146639511202,0.970499218129896,1.0,7/12,24.93%,DCPS;EIF4E2;CYFIP2;CYFIP1;NCBP2;EIF4E;EIF4E3
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.33946148958485856,-0.8986021582871834,0.581056466302368,0.849972495025643,1.0,2/15,3.63%,SH3PXD2B;PLA2G4A
prerank,phosphatase inhibitor activity (GO:0019212),-0.31286734762717616,-0.8978488435509613,0.6252319109461967,0.84891228713548,1.0,9/20,32.55%,PPP1R2;SAG;PTN;ARPP19;SET;BOD1L1;STYX;PPP1R1B;BOD1
prerank,snRNA binding (GO:0017069),0.25744860354590476,0.897503238343039,0.6278538812785388,0.9681273057441943,1.0,15/42,22.93%,SF3B3;LSM7;TUT1;SNRPB2;HEXIM1;CCNT1;SNRNP70;SNRPC;SNRPD3;LSM8;PRPF8;LSM4;NCBP2;CDK9;ISG20
prerank,RNA cap binding (GO:0000339),0.3237730648275317,0.8973522466902016,0.6020618556701031,0.9630325307143675,1.0,8/16,25.69%,DCPS;EIF4E2;CYFIP2;CYFIP1;NCBP2;EIF4E;EIF4E3;EIF4A1
prerank,RNA methyltransferase activity (GO:0008173),-0.3169110137544979,-0.8972759840986801,0.6046511627906976,0.8475343963842018,1.0,5/19,20.23%,METTL4;TGS1;TRDMT1;TRMT9B;TRMT12
prerank,proton transmembrane transporter activity (GO:0015078),0.26238621177832866,0.8972444933666728,0.6238938053097345,0.9578006975281755,1.0,7/39,15.60%,COX6A2;UQCR10;SLC46A1;ATP6V1B2;UQCRH;COX6A1;SLC4A11
prerank,telomerase RNA binding (GO:0070034),-0.30990721666080556,-0.896671465836524,0.6070763500931099,0.8462556686767254,1.0,10/22,29.47%,TENT4B;XRN1;PARN;TEP1;TERT;SMG6;PINX1;NAF1;HNRNPU;GAR1
prerank,sterol transfer activity (GO:0120015),-0.3240914772800755,-0.8961489263746906,0.6219931271477663,0.8447007830460019,1.0,4/17,26.19%,PLTP;STARD4;OSBPL2;STARD5
prerank,growth factor receptor binding (GO:0070851),-0.22508712137188538,-0.8954460391095764,0.6530612244897959,0.8436844053476887,1.0,15/95,14.62%,HIP1;IL1R1;PDGFD;PTPRJ;IL6ST;IL6R;FGF1;ERN1;FGF7;VEGFC;PSEN1;JAK2;FGF2;PLSCR1;GRB2
prerank,steroid hydroxylase activity (GO:0008395),0.32009812462072723,0.8953446439142373,0.5863539445628998,0.9574295434465411,1.0,3/16,9.78%,CYP46A1;CYP27A1;CYP11B1
prerank,cardiolipin binding (GO:1901612),0.36937406479028295,0.8946030135664939,0.6175824175824176,0.9539635262793024,1.0,1/10,2.00%,MME
prerank,single-stranded DNA helicase activity (GO:0017116),0.3101488508370619,0.8940492274755424,0.6,0.9501184584838939,1.0,2/19,4.13%,WRNIP1;HELQ
prerank,phospholipase activity (GO:0004620),-0.23844772724378027,-0.8935660432947844,0.6505376344086021,0.8451855884244536,1.0,26/67,36.75%,PLCB4;PLA2G4A;PLCB3;NAPEPLD;PLCE1;GDPD1;MGLL;LPL;PDIA3;GDPD3;SMPD2;PLA2G12A;DDHD2;PNPLA8;PLA2G4F;LYPLA1;GDE1;LIPH;PLAAT1;SEC23IP;PLCL1;PLCB2;PLBD1;ABHD12;PLB1;PNPLA6
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.2519966573363413,-0.8903714112647668,0.6429840142095915,0.8499429768891522,1.0,15/51,20.90%,SLCO2A1;SLCO1C1;SLC7A5;SLCO3A1;SLC5A6;SLCO2B1;MFSD2A;SLC25A11;SLC35E4;SLC35E3;SLC20A2;ANKH;SLCO4A1;SLC35D1;SLC5A5
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.3582463090346999,-0.8878116086155681,0.6264150943396226,0.8527913243520358,1.0,2/11,17.22%,PPP1R2;PPP1R1A
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.31891590860983904,0.8865285680258935,0.6241758241758242,0.9646792729836342,1.0,5/16,18.31%,HAAO;ALOX12;TDO2;ALOX5;BCO2
prerank,Hsp90 protein binding (GO:0051879),-0.2746025459096888,-0.8853553358763389,0.6303939962476548,0.8557481869469398,1.0,10/33,18.97%,NR3C1;KDR;SLC12A2;PPEF2;ERN1;UNC45B;PTGES3;HDAC6;RPS3;NOD2
prerank,alkali metal ion binding (GO:0031420),0.343124186796004,0.8832865111641303,0.6138392857142857,0.967462086198904,1.0,7/13,24.12%,ATP1A2;ATP4A;IMPA1;ACAT1;ADPRH;CAPN3;TDG
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.3222017238473697,-0.8775997446467154,0.6259398496240601,0.8703857648383633,1.0,5/16,20.54%,SLC1A5;SLC13A3;SLC25A11;SLC1A1;SLC1A4
prerank,WW domain binding (GO:0050699),0.27948596093117617,0.8774095895828888,0.64,0.9767015571793908,1.0,9/26,23.47%,ENAH;TCEAL6;TRAF4;TCEAL3;LITAF;SCNN1A;TCEAL1;WBP11;DAZAP2
prerank,NADPH binding (GO:0070402),0.3333248605152192,0.876997786918392,0.6190476190476191,0.9724220604857652,1.0,1/13,2.41%,QDPR
prerank,copper ion binding (GO:0005507),-0.26018221461238056,-0.8766828140995723,0.6792114695340502,0.8696139688679478,1.0,21/42,37.66%,ATOX1;LOXL3;PAM;TP53;COX17;AOC3;CCS;SOD1;COA6;SUMF1;TYR;ATP7B;IL1A;PARK7;SCO2;CUTC;HEPH;MT3;LACC1;SNCB;AOC2
prerank,serine-type endopeptidase activity (GO:0004252),0.22189166421392148,0.8766223801485221,0.7390300230946882,0.9681077951727477,1.0,12/80,14.69%,C1RL;CELA3A;TYSND1;RHBDL2;RHBDL3;KLK1;KLK6;PCSK2;HTRA2;PCSK6;ACR;CLPP
prerank,NAD binding (GO:0051287),-0.2846769774873662,-0.8756590202893052,0.6630824372759857,0.8690903608077527,1.0,5/26,14.53%,ZC3HAV1;SIRT5;BDH2;SIRT3;NUDT6
prerank,metalloaminopeptidase activity (GO:0070006),0.314542931479627,0.8740467493733386,0.6310904872389791,0.9689857494982514,1.0,2/16,2.37%,TRHDE;MMP16
prerank,hexosyltransferase activity (GO:0016758),-0.21852998607312946,-0.8734060964222059,0.7678883071553229,0.8712158037292951,1.0,23/101,21.70%,GBE1;EXT1;TMTC1;GCNT2;A4GALT;TMTC2;CSGALNACT1;MGAT4B;B3GNT2;B4GALT4;ALG12;MFNG;PIGV;B4GALT5;HAS1;GBA2;LARGE1;B4GALT1;POGLUT3;GYG1;OGT;POMT1;CHPF2
prerank,exonuclease activity (GO:0004527),-0.2501038872082382,-0.8727217732701829,0.6767857142857143,0.8699411823580994,1.0,17/46,28.68%,MRE11;EXOSC2;EXOSC1;EXOSC3;XRN2;PDE12;EXOSC8;WRN;REXO1;EXOSC5;EXOG;DCLRE1B;REXO5;EXOSC7;DXO;EXO1;APLF
prerank,nuclear import signal receptor activity (GO:0061608),-0.3282179258792499,-0.8710714327062357,0.6390845070422535,0.8708450712666547,1.0,3/15,14.45%,KPNA4;KPNA3;KPNA1
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.23842381614559033,0.867753285865081,0.7218543046357616,0.9788602794105831,1.0,13/57,16.65%,COX6A2;UQCR10;NDUFA1;UQCRH;NDUFA10;CYBRD1;NDUFA5;NDUFS8;NDUFB5;NDUFC1;COX6A1;NDUFS7;NDUFB6
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.29666271079395035,-0.8668081733099168,0.6394052044609665,0.8773407103303599,1.0,9/21,23.44%,WASF2;KCNQ1;EZR;ARFGEF1;ACBD3;WASF1;ARFGEF2;AKAP1;AKAP9
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.30253238700159324,0.86580155940613,0.6532066508313539,0.9783634217637991,1.0,4/18,14.07%,HSD17B12;FAR1;ALDH1A2;AKR1B10
prerank,myosin II binding (GO:0045159),0.36414702733698184,0.8654003535542335,0.6380510440835266,0.9741467841899559,1.0,3/10,12.35%,STXBP5L;GSN;LLGL1
prerank,MAP kinase activity (GO:0004707),-0.33437778246704153,-0.8652682190412274,0.6593806921675774,0.8778969811221462,1.0,5/14,23.50%,MAPK1;MAPK8;MAPK12;MAPK7;MAPK11
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.35153583060649474,0.8652142367066874,0.6423529411764706,0.9694720303344855,1.0,2/11,14.01%,DCPS;NUDT16
prerank,cholesterol binding (GO:0015485),0.23822637706470923,0.8619988472669882,0.6902654867256637,0.9720746486910314,1.0,14/47,21.41%,SULT2B1;CD81;SYP;ERLIN1;OSBPL6;OSBPL5;VDAC2;SIDT1;GRAMD1B;SOAT2;VDAC1;GRAMD1C;SOAT1;SCARB2
prerank,ubiquitin-dependent protein binding (GO:0140036),0.35422956149759044,0.8597447274766687,0.6346153846153846,0.9723054449114504,1.0,4/10,23.45%,ANKRD13B;FAAP20;DNAJB2;IDE
prerank,heme binding (GO:0020037),0.22870230417439114,0.8585181523572953,0.7230769230769231,0.9701006695175332,1.0,12/65,15.30%,CYP46A1;NR1D1;CYP24A1;CYP26B1;CYP51A1;PGRMC1;CYP27A1;CYP11B1;HCCS;THAP4;EIF2AK1;TDO2
prerank,sulfuric ester hydrolase activity (GO:0008484),0.3329801653772807,0.8584346834609738,0.6492027334851936,0.965220112991344,1.0,2/12,8.34%,ARSI;ARSG
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.35738653021352906,0.8561413261643753,0.6508620689655172,0.9653375529595744,1.0,4/10,15.73%,PKP2;CXADR;CD47;SIRPA
prerank,alpha-actinin binding (GO:0051393),-0.28027267716119786,-0.852532095626826,0.6947565543071161,0.9014567431901856,1.0,9/24,20.33%,PKD2;PDLIM5;PDLIM1;SYNPO2;PDLIM3;RARA;MAGI1;PPARG;PKD2L1
prerank,rRNA binding (GO:0019843),0.2493042079205272,0.8520249399372299,0.747016706443914,0.969577519121435,1.0,7/42,10.24%,RPLP0;MTERF4;ANG;MRPL16;ERAL1;PPAN;NOP53
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.2824631522755232,0.8513774280208303,0.6903073286052009,0.9660581084161355,1.0,7/22,19.06%,ATP6V1B2;ATP6V0C;ATP6V0D2;ATP6V0A2;ATP6V0D1;ATP6V1C1;ATP6V1A
prerank,chemokine binding (GO:0019956),-0.27222421067805735,-0.8513585870269808,0.6777996070726916,0.900950597648085,1.0,8/30,24.66%,ITGB1;CCR9;FGF2;ITGA4;ACKR3;ITGB3;ACKR1;HMGB1
prerank,iron ion binding (GO:0005506),0.23729508806487098,0.8473282363763528,0.7231920199501247,0.9698494373626341,1.0,12/48,17.17%,MELTF;FBXL5;ALKBH3;DNAJC24;ISCA2;HAAO;TET1;SCD5;NFU1;ALOX5;ALKBH2;SCD
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.30031544862065673,0.8427582413844189,0.6273584905660378,0.9748999372145354,1.0,5/17,15.01%,AKR1C1;TECR;DHCR24;DPYD;MECR
prerank,CARD domain binding (GO:0050700),-0.32224669889399454,-0.8411002963706361,0.6747826086956522,0.9187394752861854,1.0,5/14,23.26%,NOD1;IRGM;MAVS;NOD2;CASP1
prerank,monocarboxylic acid binding (GO:0033293),0.2922163744984011,0.8390956907980162,0.7025171624713958,0.9776803101047583,1.0,2/18,5.87%,AKR1C1;CYP26B1
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.3526108887218301,0.8374307706035489,0.6795454545454546,0.9715063218030305,1.0,3/10,16.11%,DUSP4;DUSP8;DUSP7
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.3526108887218301,0.8374307706035489,0.6795454545454546,0.9715063218030305,1.0,3/10,16.11%,DUSP4;DUSP8;DUSP7
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.26507713231352603,-0.8365126689184742,0.7214953271028037,0.9252338894203163,1.0,5/29,10.75%,SLC26A7;SLC26A2;SLC1A5;SLC13A3;SLC25A11
prerank,tropomyosin binding (GO:0005523),-0.312415114944099,-0.8352705320636625,0.6921641791044776,0.9248086857861586,1.0,6/16,27.18%,TMOD3;NEBL;LMOD1;CALD1;SMTNL2;TNNT3
prerank,poly(A) binding (GO:0008143),-0.2879441561787152,-0.8342891929508168,0.6885245901639344,0.9238791906604112,1.0,6/21,15.39%,RBPMS;RBMS1;DDX3X;RBMS2;ZC3H14;PABPC4L
prerank,CXCR chemokine receptor binding (GO:0045236),-0.34369426865154623,-0.8339934389233717,0.7072727272727273,0.9216674732035087,1.0,7/11,40.44%,YARS1;CXCL12;CXCL10;CXCL5;ITCH;CXCL1;PPBP
prerank,solute:proton symporter activity (GO:0015295),-0.30301421284210733,-0.8331936366765601,0.7118055555555556,0.9204375203370717,1.0,4/16,13.25%,SLC39A8;SLC17A5;SLC2A13;SLC2A9
prerank,kinase activator activity (GO:0019209),-0.25892413555675325,-0.8292182139798278,0.7219251336898396,0.9248571626708616,1.0,6/30,14.78%,GPRC5C;RPLP1;RGCC;RPTOR;WNT11;MARK2
prerank,hormone receptor binding (GO:0051427),0.3153514121465425,0.8285172534777523,0.709832134292566,0.9849503363771971,1.0,3/14,10.27%,TYK2;NPPC;CCK
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.3104296987452666,0.8258698632915538,0.6917960088691796,0.9850130497445031,1.0,2/14,2.80%,KCNA5;KCNJ3
prerank,anion:anion antiporter activity (GO:0015301),0.2927984993052858,0.8253135369579535,0.7336343115124153,0.9812497895758522,1.0,4/17,8.62%,SLC26A5;SLC4A2;SLC19A1;SLC25A4
prerank,lysine N-methyltransferase activity (GO:0016278),-0.28826581737680923,-0.8250417995228451,0.7049180327868853,0.9299583826114409,1.0,5/20,16.06%,SETD2;SETD3;EHMT1;KMT5A;ANTKMT
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.2641379109215774,-0.8249174672344549,0.7490909090909091,0.9274326269073997,1.0,13/29,32.79%,ACER2;ACER3;OVGP1;GBA2;HYAL2;ENGASE;GLA;HPSE;ABHD10;HYAL3;LCT;GANAB;NEU3
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.2630425498891182,-0.8194922048572504,0.7390476190476191,0.9345458458111111,1.0,9/26,32.55%,PPP1R2;SAG;PPP1R1A;PTN;ARPP19;SET;BOD1L1;PPP1R1B;BOD1
prerank,transferrin receptor binding (GO:1990459),-0.34136247563620303,-0.8163190949095686,0.7070524412296564,0.9374696545731245,1.0,3/10,18.83%,HFE;IKBKG;IKBKB
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.33333097126175,-0.8137911321995105,0.7161904761904762,0.9393033633097139,1.0,1/11,0.16%,LEF1
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.2925471083685388,0.8136028870998997,0.7112068965517241,0.9992862290906437,1.0,5/16,12.19%,MTMR2;MTMR10;MTMR11;MTMR7;INPP5F
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.22568424251934358,-0.8113354574893067,0.8081705150976909,0.9410181439959531,1.0,16/53,23.45%,SLC47A1;SLC7A1;SLC7A5;SLC38A5;SLC1A5;SLC7A7;SLC36A4;SLC43A1;SLC1A1;SLC7A2;SLC6A7;SLC1A4;SLC3A2;SLC66A1;SLC3A1;SLC38A6
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.33118295198169123,-0.810334268013122,0.7111913357400722,0.9399924046075705,1.0,5/11,27.47%,KCNQ1;KCNJ8;KCNE4;KCNH2;KCND3
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.23543029333243107,0.8099913127162343,0.7787810383747178,1.0,1.0,5/38,12.04%,SPOCK1;TFPI2;SERPIND1;SERPINA2;SERPING1
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.2814553929434999,-0.8076487710794303,0.7668393782383419,0.941977048311798,1.0,4/18,16.18%,PIK3R1;SOCS2;PIK3R6;PIK3R3
prerank,potassium:proton antiporter activity (GO:0015386),0.33049156647553046,0.807573844017048,0.7139784946236559,1.0,1.0,2/10,5.25%,SLC9A7;SLC9A9
prerank,serine-type peptidase activity (GO:0008236),0.19656577058669708,0.8052424919453836,0.8993135011441648,1.0,1.0,14/96,14.69%,C1RL;CELA3A;TYSND1;RHBDL2;PRSS57;RHBDL3;KLK1;KLK6;TMPRSS7;PCSK2;HTRA2;PCSK6;ACR;CLPP
prerank,pseudouridine synthase activity (GO:0009982),-0.3177204975827866,-0.805019002498586,0.7563176895306859,0.9440733680348554,1.0,5/13,29.10%,RPUSD4;PUS10;TRUB1;PUSL1;RPUSD2
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.3106862031432813,-0.8044738259853915,0.7526881720430108,0.9423268637975267,1.0,8/14,43.45%,NCF2;NOX4;KMO;MICAL1;AIFM1;NCF1;NCF4;DUOX1
prerank,endopeptidase regulator activity (GO:0061135),-0.2385850627996602,-0.803746028127606,0.8050541516245487,0.9408508804039077,1.0,11/40,23.75%,CAST;PROS1;PSME2;ITIH2;VSIR;APH1A;TFPI;PSME1;ADRM1;RECK;ITIH3
prerank,ion gated channel activity (GO:0022839),-0.27504721285876127,-0.8019510559881786,0.7617260787992496,0.9412392633259353,1.0,6/24,13.28%,TRPM4;ANO1;TTYH2;ANO6;ANO8;TMEM63B
prerank,myosin binding (GO:0017022),-0.22350150916612455,-0.801685310033037,0.833922261484099,0.9389977052010303,1.0,13/55,17.76%,MYRIP;SHROOM4;TRAK1;SHROOM1;ARFGEF1;RHOA;MYOC;MLPH;RAB11A;KIRREL1;RAB39B;CALD1;GIPC1
prerank,sequence-specific mRNA binding (GO:1990825),-0.3284633117855684,-0.8011798641807479,0.710431654676259,0.9371329814911173,1.0,6/10,35.04%,RBM24;DHX9;LARP6;SSB;SHFL;ETF1
prerank,motor activity (GO:0003774),0.2133184985451479,0.7995764471376903,0.827433628318584,1.0,1.0,12/60,15.43%,KIF21A;KIF17;DYNC2H1;KIF26B;KIF5A;KIF3A;DYNC1I1;DYNLRB2;KIF1C;KIF3C;MYO6;KIF21B
prerank,endopeptidase inhibitor activity (GO:0004866),-0.20592803639134585,-0.7909377369361991,0.875,0.951554768300383,1.0,10/82,12.11%,CAST;ANXA2;APP;SPOCK2;PROS1;NGF;ROCK1;BIRC6;ITIH2;TIMP3
prerank,hexose transmembrane transporter activity (GO:0015149),-0.3172660093596592,-0.7867028278931925,0.7666666666666667,0.9556403354149934,1.0,2/12,8.91%,SLC2A1;MFSD4A
prerank,NADP binding (GO:0050661),-0.24474747188429297,-0.786432630371309,0.7992895204262878,0.9533587826587032,1.0,7/32,22.03%,NOS3;GMDS;CAT;DHCR7;LBR;MTRR;NOS1
prerank,chemoattractant activity (GO:0042056),-0.2577683568365421,-0.7843484778057885,0.7820069204152249,0.9540039528325838,1.0,6/26,15.33%,BMP4;FGF7;VEGFC;FGF2;HGF;MIF
prerank,methyltransferase activity (GO:0008168),-0.22718862562315306,-0.7837740103445955,0.8465608465608465,0.9522061572880265,1.0,20/46,37.20%,METTL4;SUV39H1;EHMT1;AS3MT;N6AMT1;DNMT1;ARMT1;GAMT;PRMT3;COQ3;METTL27;EEF1AKMT3;DNMT3B;COMTD1;PRMT7;NSUN4;COMT;EEF1AKMT4;GCSH;NNMT
prerank,"DNA binding, bending (GO:0008301)",-0.3012426015843426,-0.7832789179259156,0.7674418604651163,0.9502225783766276,1.0,1/14,0.16%,LEF1
prerank,phospholipase activator activity (GO:0016004),0.3217286960725819,0.7830446504625458,0.750561797752809,1.0,1.0,6/10,28.72%,CCL5;ARHGAP6;BTK;PDPK1;STX4;SRC
prerank,mRNA methyltransferase activity (GO:0008174),-0.31230663615704723,-0.7819426316113685,0.7282229965156795,0.9497207633777601,1.0,8/12,47.61%,METTL14;METTL16;CMTR2;TRMT61A;PCIF1;TRMT10C;NSUN2;RNMT
prerank,hexosaminidase activity (GO:0015929),-0.3100153184344884,-0.7800678860132011,0.7495682210708118,0.9498089960068701,1.0,5/12,32.00%,CEMIP2;HYAL2;HEXA;HYAL3;CEMIP
prerank,pre-mRNA binding (GO:0036002),0.2476658227519085,0.7795390796807531,0.825,1.0,1.0,3/28,5.26%,CELF5;CELF4;CELF2
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.2438290526199465,-0.7794138449359691,0.8197573656845754,0.9481398407870029,1.0,8/31,21.22%,UBE2K;BIRC6;UBE2J2;UBE2D3;UBE2E2;UBE2L3;AKTIP;UBE2R2
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.2515059831922953,0.7788190121215302,0.8140043763676149,1.0,1.0,4/24,10.34%,CAMK1G;CAMK4;CAMK2B;MYLK3
prerank,active ion transmembrane transporter activity (GO:0022853),-0.23331889888002055,-0.7772295454809304,0.8374291115311909,0.9489491117405449,1.0,14/37,29.29%,SLCO2A1;SLCO1C1;SLCO3A1;UQCR11;SLCO2B1;UQCRFS1;UQCRC1;COX10;SLCO4A1;NDUFA4L2;COX5A;SLCO1B1;SLC22A8;COX4I2
prerank,pyrophosphatase activity (GO:0016462),-0.2192090292202172,-0.7738603171649536,0.8634686346863468,0.9511782545306665,1.0,5/50,8.49%,ENTPD1;DDX3X;ENTPD6;ALPL;BNIP2
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.3301881461025334,-0.7735233497318521,0.7868217054263565,0.9491188495860847,1.0,4/10,25.72%,DSE;GNE;FUOM;GALM
prerank,microtubule motor activity (GO:0003777),0.21613916363521174,0.7715276226907872,0.8545034642032333,1.0,1.0,10/51,15.43%,KIF21A;KIF17;KIF26B;KIF5A;KIF3A;DYNC1I1;DYNLRB2;KIF1C;KIF3C;KIF21B
prerank,poly-purine tract binding (GO:0070717),-0.25423008639327277,-0.7706853224647477,0.8,0.9508131189243209,1.0,4/27,7.26%,RBPMS;RBMS1;DDX3X;RBMS2
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.29502228359801647,0.768956526069909,0.786697247706422,1.0,1.0,12/12,70.52%,ELOVL4;OPN4;GNAT2;OPN1SW;OPN5;OPN3;RHO;GPR88;OPN1MW3;OPN1MW;RRH;GPR52
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.2374897410799139,-0.7654426174860474,0.8389380530973451,0.9556975558878967,1.0,15/34,36.49%,UBE2K;BIRC6;UBE2J2;UBE2D3;UBE2E2;UBE2L3;AKTIP;UBE2R2;UBE2I;CDC34;UBE2H;UBE2A;UBE2T;UBE2G2;UBE2C
prerank,adenylyltransferase activity (GO:0070566),-0.261324538115168,-0.764813495877541,0.7964285714285714,0.9538754824020653,1.0,4/21,13.97%,TENT4B;ABL1;TENT4A;TENT2
prerank,O-acyltransferase activity (GO:0008374),-0.24275484879185358,-0.7641774373016317,0.822262118491921,0.9520216384040195,1.0,7/30,21.53%,PLA2G4A;LPCAT1;MBOAT1;DGAT2;LPCAT3;PIGW;LCAT
prerank,ATPase activator activity (GO:0001671),0.2611896797988066,0.7635386402664854,0.7969432314410481,1.0,1.0,3/20,6.85%,ATP1B1;DNAJB4;DNAJC24
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.22776891528308646,0.7616184889750427,0.8384279475982532,1.0,1.0,8/34,16.65%,NDUFA1;NDUFA10;NDUFA5;NDUFS8;NDUFB5;NDUFC1;NDUFS7;NDUFB6
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.22776891528308646,0.7616184889750427,0.8384279475982532,1.0,1.0,8/34,16.65%,NDUFA1;NDUFA10;NDUFA5;NDUFS8;NDUFB5;NDUFC1;NDUFS7;NDUFB6
prerank,lysophospholipase activity (GO:0004622),-0.26442659992458173,-0.7584692819935519,0.8156934306569343,0.9576794494729202,1.0,4/20,13.54%,PLA2G4A;GDPD1;MGLL;GDPD3
prerank,carboxylic ester hydrolase activity (GO:0052689),0.19218647681244144,0.7583983446713773,0.9352678571428571,1.0,1.0,9/85,11.43%,ENPP2;PGLS;CA2;PGAP1;H6PD;PLA2G7;PLA2G4E;PLA2G6;LIPC
prerank,ribosomal large subunit binding (GO:0043023),-0.31306849505830825,-0.757260946028041,0.7989778534923339,0.956704631275359,1.0,4/11,27.52%,LTN1;RBM3;NEMF;NMD3
prerank,fatty acid synthase activity (GO:0004312),0.3157650143378391,0.7572161090849971,0.7695749440715883,1.0,1.0,2/10,9.17%,ELOVL4;OXSM
prerank,glucose transmembrane transporter activity (GO:0005355),0.2670974001945941,0.7505324132325313,0.823404255319149,1.0,1.0,4/17,11.28%,SLC2A4;SLC2A10;SLC2A8;SLC2A5
prerank,translation elongation factor activity (GO:0003746),-0.2890900014301193,-0.7503109828760132,0.7819420783645656,0.963270049839464,1.0,6/14,26.14%,EEF2;EIF5A;EIF5AL1;GFM2;TUFM;EEF1B2
prerank,UDP-glycosyltransferase activity (GO:0008194),0.19390828368744847,0.7487509597028206,0.9322799097065463,1.0,1.0,6/70,7.40%,MGAT4C;B3GALT1;B3GALT4;B3GALT5;B4GALNT3;CHSY3
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.30468361591509735,0.745812059570547,0.8017057569296375,1.0,1.0,1/10,5.24%,SLC6A11
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.2807341365142111,0.7403947070337423,0.7982062780269058,1.0,1.0,4/14,9.97%,MTMR2;MTMR10;MTMR11;MTMR7
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.30656526519995625,0.7403252708327211,0.8083700440528634,1.0,1.0,2/10,11.98%,PKIB;PRKAR1B
prerank,intracellular chloride channel activity (GO:0061778),-0.2821857154260442,-0.7374614559960992,0.8308270676691729,0.9744921140500509,1.0,4/16,13.10%,ANO1;TTYH2;ANO6;ANO8
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.2821857154260442,-0.7374614559960992,0.8308270676691729,0.9744921140500509,1.0,4/16,13.10%,ANO1;TTYH2;ANO6;ANO8
prerank,fibroblast growth factor binding (GO:0017134),-0.2534852004773157,-0.737456021573893,0.8460076045627376,0.9718923779526925,1.0,6/21,20.64%,THBS1;CEP57;FGFBP3;API5;FGFR4;ITGB3
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.2756807131700379,0.7368865232332235,0.8117913832199547,1.0,1.0,1/13,1.49%,IDI2
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.2998090084630398,0.7363748704568648,0.8235294117647058,1.0,1.0,2/11,7.41%,RYR3;RYR2
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.2184265789517541,-0.7357173874189701,0.8785211267605634,0.971368793019161,1.0,18/40,37.20%,METTL4;PCMTD1;SUV39H1;SETD3;AS3MT;N6AMT1;DNMT1;ARMT1;GAMT;PEMT;DNMT3B;METTL18;COMTD1;PRMT7;COMT;ICMT;FBL;NNMT
prerank,alpha-tubulin binding (GO:0043014),-0.23517435635600129,-0.7315360551147286,0.8360957642725598,0.973892408340313,1.0,15/31,31.31%,SETD2;DIP2B;TTLL7;DNAL1;FYN;HDAC6;WASHC1;TRPV4;ARL4C;EML4;INO80;DLEC1;EFHC2;ARL8B;CDK5R1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.22108327664581598,-0.7304183296807656,0.8874538745387454,0.9725963150047511,1.0,9/35,20.62%,FTO;DUS1L;DUS4L;PUS10;MRPL58;TRDMT1;TRMT9B;TRMT12;TRPT1
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.303241409708734,-0.7194326135502871,0.796028880866426,0.9825799166764007,1.0,5/10,34.76%,HADHB;ECHS1;EHHADH;ECI1;ECHDC3
prerank,DNA replication origin binding (GO:0003688),0.23738771891904467,0.7187250855519992,0.8591549295774648,1.0,1.0,4/23,10.09%,DDX11;MCM8;CDC45;POLA1
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.2942917450104102,-0.7183603986256678,0.8434622467771639,0.9811925940559842,1.0,5/11,32.11%,SLC17A5;SLC2A9;SLC5A3;SLC23A1;SLC23A2
prerank,protein phosphatase activator activity (GO:0072542),0.27529404241304956,0.7158885006549004,0.829004329004329,1.0,1.0,2/13,5.75%,IGFBP3;CALM2
prerank,RNA polymerase binding (GO:0070063),-0.2583875970219625,-0.7134778815094511,0.8475836431226765,0.983807925373532,1.0,6/18,26.88%,NEDD4;STOM;PKN2;BRCA1;DHX9;PHRF1
prerank,DNA polymerase binding (GO:0070182),-0.260684308234328,-0.7126980667122057,0.8589981447124304,0.9820422760591829,1.0,6/18,24.76%,PTGES3;FANCD2;HSP90AA1;SMG6;HMGB1;FANCI
prerank,endonuclease activity (GO:0004519),-0.2015432184125015,-0.7102624886153069,0.9326424870466321,0.9819691270102883,1.0,14/49,26.09%,KHNYN;ERN1;MRE11;N4BP2;DICER1;OGG1;PNKP;AGO2;RPS3;EXOG;RCL1;NTHL1;SMG6;ENDOU
prerank,ribonuclease P RNA binding (GO:0033204),-0.30609950716693723,-0.7094522850155714,0.8587360594795539,0.9802089186268397,1.0,6/10,49.66%,RPP30;POP4;RPP40;RPP14;RPP25;RPP38
prerank,methylation-dependent protein binding (GO:0140034),-0.19475052861050143,-0.7090699809484216,0.9539007092198581,0.978015721597079,1.0,21/57,34.43%,CHD1;KMT2E;CDYL;SUZ12;SGF29;ZMYND8;TDRD3;KDM7A;ZMYND11;ATRX;WDR5;RBBP5;MBTD1;GLYR1;PHF19;CHD8;ING5;KDM4A;CBX5;BPTF;MORC3
prerank,inward rectifier potassium channel activity (GO:0005242),0.2326707208408424,0.7085450596841951,0.8747152619589977,1.0,1.0,4/24,11.48%,KCNJ3;KCNN2;KCNJ6;KCNN3
prerank,channel activity (GO:0015267),0.20531912288900905,0.7078787231113561,0.9450800915331807,1.0,1.0,3/41,4.58%,PDPN;BCL2;AQP4
prerank,peptidase inhibitor activity (GO:0030414),-0.22034105437856652,-0.707601229751396,0.907103825136612,0.9770118357806711,1.0,9/33,26.54%,CAST;PROS1;ITIH2;SIMC1;TFPI;GPC3;RECK;ITIH3;PCSK1N
prerank,FAD binding (GO:0071949),-0.23479483603816909,-0.7013199534722897,0.8992673992673993,0.98108721204735,1.0,11/24,37.65%,MICAL2;AGPS;KDM1B;KMO;MTRR;CRY2;MICAL1;STEAP4;AIFM1;NQO2;DAO
prerank,gated channel activity (GO:0022836),-0.2715032400596014,-0.7010323845675782,0.8785714285714286,0.9787728826412455,1.0,3/14,13.28%,PIEZO2;TMEM266;TMEM63B
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.2214425456813063,0.6987749265463664,0.8920704845814978,1.0,1.0,7/27,16.04%,SLC9A7;SLC9A9;SLC8A2;SLC8A3;SLC8A1;SLC4A11;SLC8B1
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.25853526523938913,0.6975872423799381,0.8883720930232558,1.0,1.0,2/15,8.89%,PLA2G3;PLA2G4E
prerank,telomeric DNA binding (GO:0042162),-0.21873826360333587,-0.6962191888973135,0.9092627599243857,0.981114668895266,1.0,12/32,27.94%,STN1;UPF2;HMBOX1;RPA1;CTC1;TERF2;WRN;TERT;BLM;SMG6;HNRNPD;SMG1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.21730617343168657,0.6943591384258729,0.9223946784922394,1.0,1.0,5/29,11.98%,YWHAG;PKIB;SPRED1;HEXIM1;PRKAR1B
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.22204210199608204,0.691731066581472,0.9157175398633257,1.0,1.0,5/28,12.78%,MAPK10;PAK3;MAP2K7;RPS6KB1;SGK1
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.2741792748144434,-0.6904346710508904,0.8625,0.983925943564575,1.0,4/12,22.61%,HDAC1;H3-3A;RUVBL2;RELA
prerank,MAP kinase phosphatase activity (GO:0033549),0.27389196393067583,0.6865399300238055,0.8477272727272728,1.0,1.0,3/12,16.11%,DUSP4;DUSP8;DUSP7
prerank,methylated histone binding (GO:0035064),0.17738941777892797,0.6816407548201073,0.9882903981264637,1.0,1.0,14/62,18.55%,ZCWPW1;CHD5;TTLL12;UHRF1;KDM8;JMJD7;THAP7;CXXC1;TAF1;PHF13;L3MBTL2;CBX8;MORC4;ING1
prerank,hydro-lyase activity (GO:0016836),-0.20361197249972926,-0.6805823954612898,0.9495495495495495,0.9903123653246303,1.0,4/41,4.79%,HADHB;GMDS;CA4;CDYL
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.21000505900567823,-0.6798347983284555,0.919931856899489,0.9883847323517081,1.0,10/32,23.31%,KDM2A;TET2;FTO;RIOX2;KDM7A;TMLHE;TET3;ALKBH5;BBOX1;ALKBH4
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.2705350450137125,-0.6788142327690173,0.8814432989690721,0.9867687299971579,1.0,3/12,14.75%,AOX1;FDX1;ISCA1
prerank,titin binding (GO:0031432),0.26330352907007654,0.6782631283360816,0.89375,1.0,1.0,5/13,27.74%,CALM2;MYBPC1;CAPN3;CALM1;CALM3
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.27349796893825906,-0.6780303171836511,0.8809106830122592,0.984940755291476,1.0,2/12,13.57%,TRAF5;BABAM2
prerank,tRNA binding (GO:0000049),0.1894304826093477,0.6771777419070345,0.9557522123893806,1.0,1.0,10/43,20.89%,TRMT10B;SARS2;PTCD1;TRMT10A;CARS1;EEF1A1;PUS1;AARS2;ELP1;NSUN6
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.22441353608848003,0.6763686893061572,0.9054054054054054,1.0,1.0,6/22,16.11%,DUSP4;MTMR2;SBF1;DUSP8;DUSP15;DUSP7
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.16985200319980825,0.6745726973013574,0.9863636363636363,1.0,1.0,12/75,16.79%,AKR1C1;DCXR;H6PD;HSD17B7;NSDHL;CBR1;LDHB;UGDH;AKR1B10;PHGDH;PGD;MDH1
prerank,protein phosphatase regulator activity (GO:0019888),0.18105000218486086,0.673587091753422,0.978401727861771,1.0,1.0,7/53,10.10%,PPP2R2B;PPP1R7;PPP2R2C;CALM2;PPME1;RCAN2;PPP1R16A
prerank,cAMP response element binding (GO:0035497),-0.28230619640149723,-0.6733143767506934,0.8782287822878229,0.9864360823058542,1.0,2/10,7.60%,CREB3L2;JUN
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.22571640919774638,0.6703837693896452,0.8914549653579676,1.0,1.0,4/22,14.70%,SYT1;CLU;APOE;LANCL1
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.2689109082076108,-0.6688288011686926,0.8819188191881919,0.9875522316802837,1.0,5/12,25.45%,PIK3R1;IRS1;GAB2;FRS2;SH2B2
prerank,N-methyltransferase activity (GO:0008170),-0.23394091879105308,-0.6658052370079401,0.8967391304347826,0.9877886314244995,1.0,8/20,31.49%,SETD3;ZCCHC4;N6AMT1;METTL5;TRMT1;METTL15;PEMT;METTL18
prerank,tRNA methyltransferase activity (GO:0008175),0.2384398522002799,0.6654643279988453,0.8883720930232558,1.0,1.0,7/16,25.66%,TRMT13;FTSJ1;METTL2B;METTL2A;TRMT5;THUMPD3;THUMPD2
prerank,carboxy-lyase activity (GO:0016831),-0.22344252257544986,-0.6595152069852385,0.9194139194139194,0.9900353051525685,1.0,7/23,25.96%,CSAD;BCKDHA;AZIN1;DDC;PPCDC;MVD;FAHD1
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.25377931925136243,-0.6587732161213488,0.9132007233273056,0.9880404371009481,1.0,9/14,49.66%,TSEN34;ELAC2;RPP30;POP4;RPP40;RPP14;RPP25;TSEN2;RPP38
prerank,lipase activator activity (GO:0060229),0.2703526338730979,0.6583886068614722,0.8819599109131403,1.0,1.0,4/10,22.18%,CCL5;ARHGAP6;BTK;PDPK1
prerank,beta-tubulin binding (GO:0048487),0.20104209122156594,0.6576061448267237,0.9376391982182628,1.0,1.0,6/31,15.61%,PACRG;MAP1S;BBS4;GJB6;RACGAP1;HTT
prerank,microtubule minus-end binding (GO:0051011),-0.2552482757529224,-0.6569348103249467,0.9041095890410958,0.9868434925910995,1.0,3/13,16.89%,MACF1;TUBGCP4;TUBGCP5
prerank,deoxyribonuclease activity (GO:0004536),0.2480008538641041,0.6563470190920978,0.8967889908256881,1.0,1.0,6/14,25.72%,MAP1S;DNASE1L1;APEX1;ERCC5;DNASE1L2;ZRANB3
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.22734775144243255,-0.6559224994788674,0.9306569343065694,0.9826700623747255,1.0,7/21,24.36%,CDK13;CDK12;CDK10;CDK6;CDK11B;CDK14;CCNK
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.22734775144243255,-0.6559224994788674,0.9306569343065694,0.9826700623747255,1.0,7/21,24.36%,CDK13;CDK12;CDK10;CDK6;CDK11B;CDK14;CCNK
prerank,cytokine activity (GO:0005125),0.1512324167731812,0.654948827312828,0.9974358974358974,1.0,1.0,17/131,14.71%,NRG1;WNT7B;CXCL16;GDF1;CCL28;PF4;TIMP1;VEGFA;IL12A;CCL13;WNT6;LEFTY1;CCL5;GDF11;CCL2;WNT4;CCL7
prerank,fibroblast growth factor receptor binding (GO:0005104),0.22148737890462078,0.6531306457965501,0.9213483146067416,1.0,1.0,4/21,17.54%,FGF6;FGF5;FGF20;FGF22
prerank,ribonuclease P activity (GO:0004526),0.261046949535526,0.6530354126785238,0.8694690265486725,1.0,1.0,11/11,73.91%,PRORP;POP7;POP5;RPP21;POP1;RPP38;RPP25;RPP14;RPP40;POP4;RPP30
prerank,purinergic nucleotide receptor activity (GO:0001614),0.23769369725061806,0.6469721082238686,0.9060402684563759,1.0,1.0,3/15,19.03%,P2RX3;P2RX5;PTAFR
prerank,mechanosensitive ion channel activity (GO:0008381),-0.25837604412633397,-0.646485683100444,0.9086021505376344,0.9865555349574339,1.0,1/12,0.70%,PIEZO2
prerank,sulfotransferase activity (GO:0008146),-0.20239153917826513,-0.6458393125687205,0.956442831215971,0.9845750248778234,1.0,8/33,20.64%,CHST15;TPST2;CHST11;SULT1A1;HS3ST1;GAL3ST2;HS6ST1;CHST7
prerank,U6 snRNA binding (GO:0017070),0.24114259180611228,0.6433460436583663,0.9248291571753986,1.0,1.0,5/14,20.62%,LSM7;TUT1;LSM8;PRPF8;LSM4
prerank,ubiquitin binding (GO:0043130),-0.1660965220322681,-0.635684560147972,0.9912280701754386,0.988639902420332,1.0,20/73,26.90%,DDI2;RAE1;NEDD4;USP13;RNF168;VPS36;TNFAIP3;N4BP1;ILRUN;UBXN11;RAD23A;IKBKG;ADRM1;UCHL1;MDM2;BUB3;USP16;UBXN7;UBXN2A;ASCC2
prerank,adenyl nucleotide binding (GO:0030554),0.2473844793831918,0.6253981595321156,0.918918918918919,1.0,1.0,2/11,13.33%,PFN1;BAG1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.2473844793831918,0.6253981595321156,0.918918918918919,1.0,1.0,2/11,13.33%,PFN1;BAG1
prerank,endoribonuclease activity (GO:0004521),-0.1939461734820041,-0.6244033632200503,0.9637681159420289,0.9928523984015943,1.0,9/32,26.09%,KHNYN;ERN1;DICER1;ENDOV;AGO2;EXOG;RCL1;SMG6;ENDOU
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.21034594188508896,-0.6220843214444923,0.9653916211293261,0.9915671090759401,1.0,9/24,33.98%,ZDHHC6;ZDHHC3;ZDHHC1;ZDHHC4;GLUL;ZDHHC12;GOLGA7B;ZDHHC9;ZDHHC22
prerank,antiporter activity (GO:0015297),-0.21742798371995398,-0.6156993872761836,0.9486238532110092,0.9926162115859581,1.0,6/20,31.12%,SLC25A11;SLC35E4;SLC35E3;SLC35D1;SLC35C1;SLC25A10
prerank,ATPase regulator activity (GO:0060590),-0.18378187151846165,-0.6137769701452706,0.9745916515426497,0.991104222192193,1.0,8/38,18.89%,DNAJC1;DNAJA2;DNAJB6;FNIP2;DNAJC10;SIL1;PLN;DNAJC19
prerank,hyaluronic acid binding (GO:0005540),-0.26095938676659375,-0.6122590740705157,0.9345794392523364,0.9893585833242815,1.0,5/10,32.00%,LAYN;HYAL2;LYVE1;IMPG2;CEMIP
prerank,chemokine receptor activity (GO:0004950),-0.20225014055839835,-0.6106288716865079,0.9584837545126353,0.9877764197569554,1.0,10/24,43.40%,CCR9;ACKR3;CMKLR1;GPR75;GPR17;CCRL2;CXCR6;CCR1;CCR10;CXCR5
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.2319668529097872,-0.6067336600576709,0.9446428571428571,0.9872413924099679,1.0,14/14,76.83%,CAPN2;CAPN15;CAPN11;CAPN12;CAPN10;CAPN8;CAPNS2;CAPN9;CAPN6;CAPN1;CAPN13;CAPN5;CAPNS1;CAPN3
prerank,lipoprotein particle receptor binding (GO:0070325),0.1944726466681853,0.6049821697545564,0.9605568445475638,1.0,1.0,1/27,0.51%,SYT1
prerank,receptor antagonist activity (GO:0048019),0.21200930842416393,0.5904571206717585,0.9515011547344111,1.0,1.0,16/17,61.82%,CCL5;ESR2;DKK3;DKK4;IL18BP;IL1RN;DKK1;ADH7;WFIKKN2;DKKL1;LRPAP1;AGTR2;FST;WFIKKN1;PXDN;IGSF1
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.25079010113878836,-0.5882418900208336,0.9576427255985267,0.9930500915632179,1.0,2/10,16.83%,NCF2;NOX4
prerank,ferrous iron binding (GO:0008198),0.19461121700181133,0.5878259293403049,0.9667458432304038,1.0,1.0,3/21,10.02%,ALKBH3;DNAJC24;HAAO
prerank,carbohydrate kinase activity (GO:0019200),-0.23611918425425787,-0.5720036599395643,0.9676258992805755,0.9967114603370071,1.0,3/11,16.63%,GALK2;GNE;GALK1
prerank,O-methyltransferase activity (GO:0008171),-0.2428857834770255,-0.5719807264953208,0.9690909090909091,0.9943092365527101,1.0,3/10,35.97%,CMTR2;COQ3;COMT
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.21575748618973853,-0.5704637793083501,0.9796672828096118,0.9924148222372025,1.0,5/15,39.52%,CCR9;CMKLR1;GPR17;CCRL2;CCR1
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.18215356066617552,-0.5627605527533432,0.9841269841269841,0.9924069797741099,1.0,11/27,34.32%,POLR2G;TENT2;POLR3F;TERT;MED20;POLR2C;POLR2L;POLR3K;POLR1H;POLR2E;POLR3A
prerank,potassium ion leak channel activity (GO:0022841),0.20981960733446142,0.5539672663376919,0.9703196347031964,1.0,1.0,4/15,21.98%,KCNK12;KCNK10;KCNK9;KCNK4
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",-0.23076110822922657,-0.5505779712225278,0.9636048526863085,0.9935786417394915,1.0,3/10,27.65%,DCLRE1B;DCLRE1A;EXO1
prerank,palmitoyltransferase activity (GO:0016409),0.1712443605584037,0.5504842626860476,0.9777777777777777,1.0,1.0,6/28,16.68%,ZDHHC8;ZDHHC13;ZDHHC20;ZDHHC24;ZDHHC7;YKT6
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.21224456432771802,0.5488927695570788,0.9760869565217392,1.0,1.0,2/13,11.11%,ALDH1L2;ALDH1A2
prerank,CoA hydrolase activity (GO:0016289),-0.19809317570228632,-0.5392809867272853,0.9723247232472325,0.9939925882001021,1.0,10/16,48.62%,ACOT9;ACOT6;ACOT11;NUDT7;ACOT13;HIBCH;ACOT12;ABCD1;BAAT;ACOT4
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.1979113052321384,0.5336348294294441,0.9629629629629629,1.0,1.0,2/15,11.11%,ALDH1L2;ALDH1A2
prerank,cytochrome-c oxidase activity (GO:0004129),0.195087589140007,0.5284502320484237,0.9873417721518988,1.0,1.0,2/15,14.81%,COX6A2;COX6A1
prerank,leak channel activity (GO:0022840),0.18267259436135716,0.5092570523128787,0.986784140969163,1.0,1.0,5/18,21.98%,KCNK12;KCNK10;KCNK9;NALCN;KCNK4
prerank,acyl-CoA hydrolase activity (GO:0047617),0.1799537411589267,0.4988820677984661,0.9977973568281938,1.0,1.0,3/17,13.51%,PLA2G6;ACOT2;ACOT7
prerank,ubiquitin-specific protease binding (GO:1990381),0.16804822908816872,0.48357213351571254,0.9885321100917431,1.0,1.0,19/19,83.22%,LCOR;SELENOS;RHBDD2;DERL2;AMFR;BAG6;SYVN1;SART3;PRKN;SPATA2;DERL3;DERL1;CLTC;VCP;PARK7;CHMP3;PTEN;RAD23A;SUMO1
prerank,C-C chemokine receptor activity (GO:0016493),-0.1634138599817922,-0.47853013659070615,0.9927140255009107,1.0,1.0,9/21,46.47%,CCR9;ACKR3;GPR75;CCRL2;CXCR6;CCR1;CCR10;CXCR5;CXCR2
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.16130504874574386,0.47192511947419985,1.0,1.0,1.0,3/21,14.06%,POLD4;POLA1;POLE4
prerank,C-C chemokine binding (GO:0019957),-0.15715726820981182,-0.4663028252097413,0.998165137614679,1.0,1.0,9/22,46.47%,CCR9;ACKR3;ACKR1;CCRL2;CXCR6;CCR1;CCR10;CXCR5;CXCR2
prerank,gamma-tubulin binding (GO:0043015),0.16124045128273337,0.46333878689151675,1.0,1.0,1.0,5/21,18.60%,ARHGEF7;PAK1;TUBGCP2;RACGAP1;CDK5RAP2
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.18227466733617864,0.46023744579732634,1.0,1.0,1.0,11/11,81.79%,HMCES;APEX1;HMGA2;NEIL2;APEX2;NEIL1;NEIL3;ALKBH1;APLF;NTHL1;RPS3
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.14315373487046099,0.4527472349433079,1.0,1.0,1.0,5/27,17.90%,POLR3H;POLR2D;POLR1A;POLRMT;POLR1B
prerank,CCR chemokine receptor binding (GO:0048020),-0.14416387499187394,-0.446695417107616,1.0,0.9998384283882155,1.0,2/28,9.04%,CCL25;NES
prerank,DNA polymerase activity (GO:0034061),0.14113362051698253,0.4191311134060809,1.0,0.9988847279684715,1.0,3/22,14.06%,POLD4;POLA1;POLE4
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.13986850301427997,-0.38242037394087014,1.0,0.9996573609002064,1.0,1/16,4.68%,CD38
